Quarterlytics / Financial Services / Asset Management / Hercules Capital

Hercules Capital

htgc · NASDAQ Financial Services
Claim this profile
Ticker htgc
Exchange NASDAQ
Sector Financial Services
Industry Asset Management
Employees 51-200
← All annual reports
FY2005 Annual Report · Hercules Capital
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)
È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES

EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2005

OR

‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES

EXCHANGE ACT OF 1934
For the transition period from

to

Commission File No. 814-00792
Hercules Technology Growth Capital, Inc.

(Exact name of Registrant as specified in its charter)

Maryland
(State or other jurisdiction of
incorporation or organization)

74-3113410
(I.R.S. Employer
Identification Number)

525 University Avenue, Suite 700
Palo Alto, California 94301
(Address of principal executive offices)
(650) 289-3060
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12 (b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:

Title of each class

Name of each exchange on which registered

Common Shares, par value $0.001 per share

NASDAQ National Market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities

Act. Yes ‘ No È

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the

Act. Yes ‘ No È

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past 90 days: YES È NO ‘

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and

will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference
in Part III of this Form 10-K or any amendment to this Form 10-K. È

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See

definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ‘

Accelerated filer ‘
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ‘ No È
The aggregate market value of the voting and non-voting common stock held by non-affiliates of the registrant as of the last
business day of the registrant’s most recently completed second fiscal quarter was approximately $78.1 million based upon a closing
price of $12.90 reported for such date by the NASDAQ National Market. Common shares held by each executive officer and director
and by each person who owns 5% or more of the outstanding common shares have been excluded in that such persons may be deemed
to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

Non-accelerated filer È

The number of outstanding common shares of the registrant as of February 10, 2006 was 9,801,965.

DOCUMENTS INCORPORATED BY REFERENCE
Documents incorporated by reference: Portions of Hercules Technology Growth Capital, Inc.’s Proxy Statement for its
2006 Annual Meeting of Shareholders to be held on May 30, 2006 are incorporated by reference in the Annual Report on Form
10-K in response to Part III, Items 10, 11, 12, 13 and 14.

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
FORM 10-K
ANNUAL REPORT

Part I.

Item 1.
Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 1A. Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 1B. Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 2.
Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 3.
Submission of Matters to a Vote of Security Holders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 4.

Part II.

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases
of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 6.
Selected Consolidated Financial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations . . . .
Item 7A. Quantitative and Qualitative Disclosures About Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 8.
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure . . . .
Item 9A. Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 9B. Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 10. Directors and Executive Officers of the Registrant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 11. Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder

Part III.

Page

1
28
43
43
43
43

43
46
47
61
61
86
86
86

86
93

Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 13. Certain Relationships and Related Transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Principle Accountant Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 14.

97
101
103

Part IV.

Item 15. Exhibits and Financial Statements
Signatures

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

104
106

Hercules Technology Growth Capital, Inc., our logo and other trademarks of Hercules Technology Growth
Capital, Inc. are the property of Hercules Technology Growth Capital, Inc. All other trademarks or trade names
referred to in this Annual Report on Form 10-K are the property of their respective owners.

In this Annual Report on Form 10-K, or Annual Report, the “Company”, “we”, “us” and “our” refer to

Hercules Technology Growth Capital, Inc. and its wholly owned subsidiaries and its affiliated securitization
trusts unless the context otherwise requires.

Item 1. Business

PART I

GENERAL

We are a specialty finance company that provides debt and equity growth capital to technology-related and
life sciences companies at all stages of development. We primarily finance privately-held companies backed by
leading venture capital and private equity firms and also may finance certain select publicly-traded companies
that lack access to public capital or are sensitive to equity ownership dilution. We source our investments through
our principal office located in Silicon Valley, as well as our additional offices in the Boston, Boulder and
Chicago areas. Our goal is to be the leading structured mezzanine capital provider of choice for venture capital
and private equity backed technology-related companies requiring sophisticated and customized financing
solutions. We invest primarily in structured mezzanine debt and, to a lesser extent, in senior debt and equity. We
use the term “structured mezzanine debt investment” to refer to any debt investment, such as a senior or
subordinated secured loan, that is coupled with an equity component, including warrants, options or rights to
purchase common or preferred stock. Our structured mezzanine debt investments will typically be secured by
some or all of the assets of the portfolio company.

We focus our investments in companies active in the technology industry sub-sectors characterized by
products or services that require advanced technologies, including computer software and hardware, networking
systems, semiconductors, semiconductor capital equipment, information technology infrastructure or services,
Internet consumer and business services, telecommunications, telecommunications equipment, media, and life
sciences. Within the life sciences sub-sector, we focus on medical devices, bio-pharmaceutical, health care
services and information systems companies. We refer to all of these companies as “technology-related”
companies and intend, under normal circumstances, to invest at least 80% of the value of our assets in such
businesses.

Our investment objective is to maximize our portfolio’s total return by generating current income from our

debt investments and capital appreciation from our equity-related investments. We are an internally-managed,
non-diversified closed-end investment company that has elected to be treated as a business development
company under the Investment Act of 1940.

Our primary business objectives are to increase our net income, net operating income and net asset value by
investing in structured mezzanine debt and equity of venture capital and private equity backed technology-related
companies with attractive current yields and the potential for equity appreciation and realized gains. Our
structured debt investments typically include warrants or other equity interests, giving us the potential to realize
equity-like returns on a portion of our investment. In some cases, we receive the right to make additional equity
investments in our portfolio companies in connection with future equity financing rounds. Capital that we
provide directly to venture capital and private equity backed technology-related companies is generally used for
growth, and in select cases for acquisitions or recapitalizations.

Our portfolio is comprised of, and we anticipate that our portfolio will continue to be comprised of,
investments in technology-related companies at various stages of their development. Our emphasis is on private
companies following or in connection with their first institutional round of equity financing, which we refer to as
emerging-growth companies, and private companies in later rounds of financing, which we refer to as expansion-
stage companies. To a lesser extent, we make investments in established companies comprised of private

1

companies in one of their final rounds of equity financing prior to a liquidity event or select publicly-traded
companies that lack access to public capital or are sensitive to equity ownership dilution.

From incorporation through December 31, 2005, we were taxed as a corporation under Subchapter C of the
Internal Revenue Code of 1986, as amended, which we refer to in this report as the Code. We currently intend to
seek to be treated for federal income tax purposes as a RIC under Subchapter M of the Code with the filing of our
federal corporate income tax return for 2006, which election, when actually made, would be effective as of
January 1, 2006. As a RIC, we generally will not pay corporate-level federal income taxes on any ordinary
income or capital gains that we distribute to our stockholders as dividends. We may be required, however, to pay
corporate-level federal income taxes on gains built into our assets as of the effective date of our RIC election. See
“Certain United States Federal Income Tax Considerations—Conversion to Regulated Investment Company
Status.” To obtain and maintain the federal income tax benefits of RIC status, we must meet specified
source-of-income and asset diversification requirements and distribute annually an amount equal to at least 90%
of the sum of our net ordinary income and realized net short-term capital gains in excess of realized net long-
term capital losses, if any, out of assets legally available for distribution. See “Distributions.” There is no
assurance that we will meet these tests and be eligible to make a RIC election. As of the date of this report, we
cannot determine the probability that during 2006 we will qualify as a RIC when we file our 2006 tax return. If
we do not qualify or elect to make a RIC election, we would continue to be taxed as a C corporation.

We commenced investment operations in September 2004. At December 31, 2005, we had outstanding
structured mezzanine debt investments in 31 portfolio companies representing approximately $171.8 million and
equity investments of $4.9 million for a total investment portfolio at fair value of $176.7 million. In addition, at
December 31, 2005, we had unfunded contractual commitments of $30.2 million.

At December 31, 2005, the weighted average yield to maturity of our loan obligations was approximately

12.87%. Yields to maturity are computed using interest rates as of December 31, 2005 and include amortization
of loan facility fees, original issue discounts, commitment fees and market premiums or discounts over the
expected life of the debt investments, weighted by their respective costs when averaged and are based on the
assumption that all contractual loan commitments have been fully funded.

CORPORATE HISTORY AND OFFICES

We were founded by Mr. Henriquez, our Chief Executive Officer, Mr. Howard, our Senior Managing
Director, and Mr. Harvey, our Chief Legal Officer, in December 2003, and we were incorporated in Maryland on
December 18, 2003. We were initially capitalized with approximately $2.6 million in net proceeds from the sale
of preferred stock in February 2004.

In June 2004, we completed a private offering of units, each unit consisting of two shares of our common

stock and two warrants to purchase one share of our common stock. We received approximately $23.9 million in
total net proceeds from this private offering, net of placement fees and before other offering and organizational
expenses. All of the then outstanding preferred stock was exchanged for units immediately prior to the closing of
our June 2004 private offering.

In June 2005, we completed a public offering of 6,000,000 shares of our common stock at a price of $13.00
per share resulting in net proceeds to the company of approximately $70.9 million after deducting offering costs.

Our principal executive offices are located at 525 University Avenue, Suite 700, Palo Alto, California 94301
and our telephone number is (650) 289-3060. We also originate our investments through our additional offices in
the Boston, Boulder and Chicago areas. We maintain a website on the Internet at www.herculestech.com.
Information contained in our website is not incorporated by reference into this Annual Report, and you should
not consider that information as part of this Annual Report.

2

OUR MARKET OPPORTUNITY

We believe that technology-related companies compete in one of the largest and most rapidly growing
sectors of the U.S. economy and that continued growth is supported by ongoing innovation and performance
improvements in technology products as well as the adoption of technology across virtually all industries in
response to competitive pressures. We believe that an attractive market opportunity exists for a specialty finance
company focused primarily on structured mezzanine investments in technology-related companies for the
following reasons:

•

Technology-related companies are underserved by traditional lending sources;

• Unfulfilled demand exists for structured debt financing by technology-related companies;

•

Structured mezzanine debt products are less dilutive and complement equity financing from venture
capital and private equity funds; and

• Average valuations for private technology-related companies are lower than in recent years.

Emerging-Growth and Expansion-Stage Technology-related Companies Underserved by Traditional
Lenders. We believe many viable technology-related companies backed by financial sponsors have been unable
to obtain sufficient growth financing from traditional lenders, including financial services companies such as
commercial banks and finance companies, in part because traditional lenders have continued to consolidate and
have adopted a more risk-averse approach to lending that has resulted in tightened credit standards in recent
years. More importantly, we believe traditional lenders are typically unable to underwrite the risk associated with
financial sponsor-backed emerging-growth or expansion-stage companies effectively.

The unique cash flow characteristics of many technology-related companies as a result of significant

research and development expenditures and high projected revenue growth often render them difficult to evaluate
from a credit perspective. The balance sheets of emerging-growth and expansion-stage companies often include a
disproportionately large amount of intellectual property assets, which makes the process of valuing that collateral
more difficult. Finally, the speed of innovation in technology and rapid shifts in consumer demand and market
share require an in-depth understanding of technology products and markets. These attributes can make it
difficult for lenders to analyze technology-related companies using traditional underwriting methods.

We believe traditional lenders are generally refraining from entering the structured mezzanine debt
marketplace for emerging-growth and expansion-stage companies, instead preferring the risk-reward profile of
senior debt. Traditional lenders generally do not have flexible product offerings that meet the needs of
technology-related companies. The financing products offered by traditional lenders typically impose on
borrowers many restrictive covenants and conditions, including limiting cash flows and requiring a significant
depository relationship to facilitate rapid liquidation.

Unfulfilled Demand for Structured Debt Financing by Technology-related Companies. Private debt
capital from specialty finance companies continues to be an important source of funding for technology-related
companies. We believe that the level of demand for debt financing to emerging-growth and expansion-stage
companies is a function of the level of annual venture equity investment activity. In 2005, venture capital-backed
companies received, in approximately 2,200 transactions, equity financing in an aggregate amount of
approximately $22.1 billion, as reported by Dow Jones VentureOne. According to Dow Jones VentureOne, as of
December 31, 2005, there were a total of approximately 5,400 private companies that had received aggregate
venture capital equity investments of approximately $132 billion over the prior six years. We believe a range of
$20 billion to $25 billion in annual equity investments to venture-backed companies will be sustainable for future
years.

We believe that demand for structured debt financing is currently unfulfilled, in part because the historically

largest capital providers to technology-related companies have exited the market while at the same time lending

3

requirements of traditional lenders have become more stringent. We therefore believe we entered the structured
lending market for technology-related companies at an opportune time.

Structured Mezzanine Debt Products Complement Equity Financing From Venture Capital and Private

Equity Funds. We believe that structured debt securities will continue to be viewed as an attractive source of
capital that will augment the capital provided by venture capital and private equity funds. We believe that our
structured mezzanine debt products provide access to growth capital for technology-related companies that may
not otherwise be able to obtain financing other than through incremental investments by their existing equity
investors. As such, we provide portfolio companies and their financial sponsors with an opportunity to
complement and diversify their capital sources. Generally, we believe emerging-growth and expansion-stage
companies target a portion of their capital to be debt in an attempt to enable those companies to achieve a higher
valuation through internal growth. In addition, because financial-sponsor backed companies have recently been
more mature prior to reaching a liquidity event, our investments could provide the debt capital needed to grow or
recapitalize during the extended period prior to liquidity events.

Lower Valuations for Private Technology-Related Companies. During the downturn in technology
industries that began in 2000, the markets saw sharp and broad declines in valuations of venture capital and
private equity-backed technology-related companies. According to Dow Jones VentureOne, as of December 31,
2005, median pre-money valuations for venture capital-backed companies in 2005 was $15.2 million, which was
slightly lower than 1998 levels of $15.5 million and compares to $25.0 million in 2000 and $16.0 million in
2001. We believe that the valuations currently assigned to venture capital and private equity-backed technology-
related companies in private financing rounds will allow us to build a portfolio of equity-related securities at
attractive valuation levels.

OUR BUSINESS STRATEGY

Our strategy to achieve our investment objective includes the following key elements:

Leverage the Experience and Industry Relationships of Our Management Team. We have assembled a
team of senior investment professionals with extensive experience as venture capitalists, commercial lenders, and
originators of structured debt and equity investments in technology-related companies. Members of our
management team also have operational, research and development and finance experience with technology-
related companies. We have established contacts with leading venture capital and private equity fund sponsors,
public and private companies, research institutions and other industry participants, which should enable us to
identify and attract well-positioned prospective portfolio companies.

We will concentrate our investing activities in industries in which our investment professionals have

extensive investment experience. Our investment professionals have, on average, more than 15 years of
experience as equity investors in, and/or lenders to, technology-related companies. In addition, our team
members have originated structured mezzanine investments in over 200 technology-related companies,
representing over $1 billion in investments, and have developed a network of industry contacts with investors and
other participants within the venture capital and private equity communities. We believe that our focus on
financing technology-related companies will enable us to leverage our expertise in structuring prospective
investments to assess the value of both tangible and intangible assets, to evaluate the business prospects and
operating characteristics of technology-related companies, and to identify and originate potentially attractive
investments with these types of companies.

Mitigate Risk of Principal Loss and Build a Portfolio of Equity-Related Securities. We expect that our
investments will have the potential to produce attractive risk adjusted returns through current income, in the form
of interest and fee income, as well as capital appreciation from our equity-related investments. We believe that
we can mitigate the risk of loss on our debt investments through the combination of loan principal amortization,
cash interest payments, relatively short maturities for our debt instruments, taking security interests in the assets

4

of our portfolio companies, as well as requiring prospective portfolio companies to have certain amounts of
available cash at the time of our investment and the continued support from a venture capital or private equity
firm at the time we make our investment.

Our structured debt investments typically include warrants or other equity interests, giving us the potential
to realize equity-like returns on a portion of our investment. In addition, we expect, in some cases, to receive the
right to make additional equity investments in our portfolio companies in connection with future equity financing
rounds. We believe that the valuations currently assigned to technology-related companies in private financing
rounds as a result of the recent downturn in technology-related industries will allow us to build a portfolio of
equity-related securities at attractive valuation levels, which we believe will create the potential for meaningful
long-term capital gains in connection with the future liquidity events of these technology-related companies.

Provide Customized Financing Complementary to Financial Sponsors’ Capital. We offer a broad range of

investment structures and possess expertise and experience to effectively structure and price investments in
technology-related companies. Unlike many of our competitors that structure their products to fit a specific set of
investment parameters, we have the flexibility to structure our investments to suit the particular needs of our
portfolio companies. We offer customized financing solutions ranging from senior debt to equity capital, with a
focus on structured mezzanine debt.

We use our strong relationships in the financial sponsor community to originate investment opportunities.
Because venture capital and private equity funds typically invest solely in the equity securities of their portfolio
companies, we believe that our debt investments will be viewed as an attractive source of capital, both by the
portfolio company and by the portfolio company’s financial sponsor. In addition, we believe that many venture
capital and private equity fund sponsors encourage their portfolio companies to use debt financing for a portion
of their capital needs as a means of potentially enhancing equity returns, minimizing equity dilution and
increasing valuations prior to a subsequent equity financing round or a liquidity event.

Invest at Various Stages of Development. We provide growth capital to technology-related companies at all

stages of development, from emerging-growth companies, to expansion-stage companies to established
companies. We believe that this provides us with a broader range of potential investment opportunities than those
available to many of our competitors, who generally choose to make investments during a particular stage in a
company’s development. Because of the flexible structure of our investments and the extensive experience of our
investment professionals, we believe we are well positioned to take advantage of these investment opportunities
at all stages of prospective portfolio companies’ development.

Benefit from Our Efficient Organizational Structure. We believe that the perpetual nature of our corporate
structure enables us to be a long-term partner for our portfolio companies in contrast to traditional mezzanine and
investment funds, which typically have a limited life. In addition, because of our access to the equity markets, we
believe that we may benefit from a lower cost of capital than that available to private investment funds. We are
not subject to requirements to return invested capital to investors nor do we have a finite investment horizon.
Capital providers that are subject to such limitations are often required to seek a liquidity event more quickly
than they otherwise might, which can result in a lower overall return on an investment.

Deal Sourcing Through Our Proprietary Database. We have developed a proprietary and comprehensive

structured query language-based (SQL) database system to track various aspects of our investment process
including sourcing, originations, transaction monitoring and post-investment performance. As of December 31,
2005, our proprietary SQL-based database system included over 7,900 technology-related companies and over
1,480 venture capital private equity sponsors/investors, as well as various other industry contacts. This
proprietary SQL system allows us to maintain, cultivate and grow our industry relationships while providing us
with comprehensive details on companies in the technology-related industries and their financial sponsors.

5

OUR INVESTMENTS AND OPERATIONS

We invest in debt securities and, to a lesser extent, equity securities, with a particular emphasis on structured

mezzanine debt.

We generally seek to invest in companies that have been operating for at least six to 12 months prior to the

date of our investment. We expect that such entities will, at the time of investment, be generating revenues or
will have a business plan that anticipates generation of revenues within 24 months. Further, we anticipate that on
the date of our investment we will obtain a lien on available assets, which may or may not include intellectual
property (other than any tangible assets specifically financed with senior debt), and these companies will have
sufficient cash on their balance sheet to amortize their debt for at least nine to 18 months following our
investment. We generally require that a prospective portfolio company, in addition to having sufficient capital to
support leverage, demonstrate an operating plan capable of generating cash flows or raising the additional capital
necessary to cover its operating expenses and service its debt.

We expect that our investments will generally range from $1.0 million to $20.0 million. Our debt
investments generally have an average initial principal balance of between $3.0 million and $7.0 million and
have maturities of two to seven years, with an expected average term of three years. We typically structure our
debt securities to provide for amortization of principal over the life of the loan, but may include an interest-
only period, and our loans will be collateralized by a security interest in the borrower’s assets, although we
may not have the first claim on these assets and the assets may not include intellectual property. Our debt
investments carry fixed or variable contractual interest rates typically ranging from 8% to 14%. In addition to
the cash yields received on our loans, in some instances, certain loans may also include any of the following:
end of term payments, exit fees, balloon payment fees or prepayment fees, which we may be required to
include in income prior to receipt. We also generate revenue in the form of commitment and facility fees, and
to a lesser extent, due diligence fees. In addition, our structured mezzanine debt investments will have equity
enhancement features, typically in the form of warrants or other equity-related securities designed to provide
us with an opportunity for capital appreciation. We generally expect that the warrants typically will be
immediately exercisable upon issuance and will remain exercisable for the lesser of seven years or three years
after an initial public offering. The exercise prices for the warrants varies from nominal exercise prices to
exercise prices that are at or above the current fair market value of the equity for which we receive warrants.
We may structure warrants to provide minority rights provisions and put rights upon the occurrence of certain
events. We generally target a total annualized return (including interest, fees and value of warrants) of 12% to
25% for our debt investments.

Typically, our debt and equity investments take one of the following forms:

•

Structured Mezzanine Debt. We seek to invest a majority of our assets in structured mezzanine debt of
prospective portfolio companies. Traditional “mezzanine” debt is a layer of high-coupon financing
between debt and equity that most commonly takes the form of subordinated debt coupled with
warrants, combining the cash flow and risk characteristics of both senior debt and equity. However, our
structured mezzanine investments may be the only debt capital on the balance sheet of our portfolio
companies, and in many cases we have a first lien security interest in all of our portfolio company’s
assets (other than any tangible assets specifically financed with senior debt). Our structured mezzanine
debt investments typically have maturities of between two and seven years, with full amortization for
emerging-growth or expansion-stage companies and little or no amortization for select established
companies. Our structured mezzanine debt investments carry a contractual interest rate between 8% and
14% and may include an additional end-of-term payment, are in an amount between $3 million and $20
million with an average initial principal balance of between $3 million and $7 million (although this
investment size may vary proportionately as the size of our capital base changes) and have an average
term of three years. In some cases we collateralize our investments by obtaining security interests in our
portfolio companies’ assets, which may include their intellectual property. In other cases we may obtain
a negative pledge covering a company’s intellectual property. We may structure our mezzanine debt

6

•

•

investments with restrictive affirmative and negative covenants, default penalties, lien protection, equity
calls, take control provisions and board observation rights.

Senior Debt. We seek to invest a limited portion of our assets in senior debt of prospective portfolio
companies. Senior debt has a senior position with respect to a borrower’s scheduled interest and
principal payments and holds a first priority security interest in the assets pledged as collateral. Senior
debt also may impose covenants on a borrower with regard to cash flows and changes in capital
structure, among other items. Our senior debt investments carry a contractual interest rate between 8%
and 12%, are in an amount between $1 million and $5 million with an average initial principal balance
of $2 million, and have an average term of under three years. In some cases we collateralize our
investments by obtaining security interests in our portfolio companies’ assets, which may include their
intellectual property. In other cases we may obtain a negative pledge covering a company’s intellectual
property. Our senior loans, in certain instances, may be tied to the financing of specific assets. In
connection with a senior debt investment, we may also provide the borrower with a working capital
line-of-credit that will carry an interest rate ranging from the Prime Rate to 12%, generally maturing in
one year, and will be secured by accounts receivable and/or inventory.

Equity-Related Securities. The equity-related securities we hold consist primarily of warrants or other
equity interests obtained in connection with our structured mezzanine debt investments. In addition to
the warrants received as a part of a structured mezzanine debt financing, we typically receive the right to
make equity investments in a portfolio company in connection with the next equity financing round for
that company. This right will provide us with the opportunity to further enhance our returns over time
through opportunistic equity investments in our portfolio companies. Equity-related investments are
typically in the form of preferred or common equity and may be structured with a dividend yield,
providing us with a current return, and with customary anti-dilution protection and preemptive rights. In
the future, we may achieve liquidity through a merger or acquisition of a portfolio company, a public
offering of a portfolio company’s stock or by exercising our right, if any, to require a portfolio company
to buy back the equity-related securities we hold.

A comparison of the typical features of our various investment alternatives is set forth in the chart below.

Senior Debt

Structured Mezzanine Debt

Equity Securities

Typical Structure

Term or Revolving Debt

Term Debt with Warrants

Investment Horizon

Usually under 3 years

Long Term, ranging from
2 to 7 years, with an
average of 3 years

Preferred Stock or
Common Stock

Long Term

Ranking/Security

Senior/First Lien

Senior or Junior Lien

None/Unsecured

Covenants

Generally
Comprehensive

Less Restrictive; Mostly
Financial; Maintenance-
Based

Risk Tolerance

Low

Medium

None

High

Coupon/Dividend

Cash Pay—Floating or
Fixed Rate

Cash Pay—Fixed Rate;
Payment-in-kind in
limited cases

Payment-in kind in
limited cases

Customization or
Flexibility

Standard

More Flexible

Flexible

Equity Dilution

None to Low

Low

High

7

Investment Criteria

We have identified several criteria that we believe will prove important in achieving our investment

objective with respect to prospective portfolio companies. These criteria provide general guidelines for our
investment decisions.

Portfolio Composition. While we focus our investments in venture capital and private equity backed
technology-related companies, we seek to diversify across various financial sponsors as well as across various
stages of companies’ development and various technology industry sub-sectors and geographies.

Continuing Support from One or More Financial Sponsors. We generally invest in companies in which
one or more established financial sponsors have previously invested and continue to make a contribution to the
management of the business. We believe that having established financial sponsors that have meaningful
commitments to the business is a key characteristic of a prospective portfolio company. In addition, we look for
representatives of one or more financial sponsors to maintain seats on the Board of Directors of a prospective
portfolio company as an indication of such commitment.

Company Stage of Development. While we invest in companies at various stages of development, we

generally require that prospective portfolio companies be beyond the seed stage of development and generally have
received or have commitments for their first institutional round of equity financing. We expect a prospective
portfolio company to demonstrate its ability to increase its revenues and operating cash flow over time. The
anticipated growth rate of a prospective portfolio company is a key factor in determining the value that we ascribe
to any warrants or other equity securities that we may acquire in connection with an investment in debt securities.

Operating Plan. We generally require that a prospective portfolio company, in addition to having sufficient

access to capital to support leverage, demonstrate an operating plan capable of generating cash flows or the
ability to raise the additional capital necessary to cover its operating expenses and service its debt. Specifically,
we require that a prospective portfolio company demonstrate at the time of our proposed investment that it has
cash on its balance sheet, or is in the process of completing a financing so that it will have cash on its balance
sheet, sufficient to support its operations for a minimum of 9 to 18 months.

Security Interest. In many instances we generally seek a first priority security interest in all of the portfolio
company’s tangible and intangible assets as collateral for our debt investment, subject in some cases to permitted
exceptions. In some cases we may only obtain a negative pledge covering a company’s intellectual property.
Although we do not intend to operate as an asset-based lender, the estimated liquidation value of the assets, if
any, collateralizing the debt securities that we hold is an important factor in our credit analysis. We evaluate both
tangible assets, such as accounts receivable, inventory and equipment, and intangible assets, such as intellectual
property, customer lists, networks and databases.

Covenants. Our investments typically include cross-default and material adverse change provisions, require

the portfolio company to provide periodic financial reports and operating metrics and will typically limit the
portfolio company’s ability to incur additional debt, sell assets, engage in transactions with affiliates and
consummate an extraordinary transaction, such as a merger or recapitalization without our consent. In addition,
we may require other performance or financial based covenants, as we deem appropriate.

Exit Strategy. Prior to making a debt investment that is accompanied by an equity-related security in a
prospective portfolio company, we analyze the potential for that company to increase the liquidity of its equity
through a future event that would enable us to realize appreciation in the value of our equity interest. Liquidity
events may include an initial public offering, a private sale of our equity interest to a third party, a merger or an
acquisition of the company or a purchase of our equity position by the company or one of its stockholders.

8

Investment Process

We have organized our management team around the four key elements of our investment process:

• Origination;

• Underwriting;

• Documentation; and

•

Loan and Compliance Administration.

Our investment process is summarized in the following chart:

Origination

The origination process for our investments includes sourcing, screening, preliminary due diligence and deal

structuring and negotiation, all leading to an executed non-binding term sheet. Our investment origination team,
which consists of nine professionals headed by our Chief Executive Officer, Mr. Henriquez, will be responsible
for sourcing potential investment opportunities. The origination team utilizes their extensive relationships with
various leading financial sponsors, management contacts within technology-related companies, trade sources,
technology conferences and various publications to source prospective portfolio companies.

In addition, we have developed a proprietary and comprehensive SQL-based database system to track

various aspects of our investment process including sourcing, originations, transaction monitoring and post-
investment performance. As of December 31, 2005, our proprietary SQL-based database system included over
7,900 technology-related companies and over 1,480 venture capital private equity sponsors/investors, as well as
various other industry contacts. This proprietary SQL system allows our origination team to maintain, cultivate
and grow our industry relationships while providing our origination team with comprehensive details on
companies in technology industries and their financial sponsors.

If a prospective portfolio company generally meets certain underwriting criteria, we perform preliminary
due diligence, which may include high level company and technology assessments, evaluation of its financial

9

sponsors’ support, market analysis, competitive analysis, evaluation of select management, risk analysis and
transaction size, pricing, return analysis and structure analysis. If the preliminary due diligence is satisfactory,
and the origination team recommends moving forward, we then structure, negotiate and execute a non-binding
term sheet with the potential portfolio company. Upon execution of a term sheet, the investment opportunity
moves to the underwriting process to complete formal due diligence review and approval.

Underwriting

The underwriting review includes formal due diligence and approval of the proposed investment in the

portfolio company.

Due Diligence. Our due diligence on a prospective investment is typically completed by two or more
investment professionals which we define as the underwriting team. The underwriting team for a proposed
investment consists of the deal sponsor who possesses specific industry knowledge and is responsible for
originating and managing the transaction, other investment professional(s) who perform due diligence, credit and
corporate financial analyses and, as needed, our Chief Legal Officer. To ensure consistent underwriting, we use
our standardized due diligence methodologies, which include due diligence on financial performance and credit
risk as well as an analysis of the operations, accounting policies and the legal and regulatory framework of a
prospective portfolio company. The members of the underwriting team work together to conduct due diligence
and understand the relationships among the prospective portfolio company’s business plan, operations and
financial performance.

As part of our evaluation of a proposed investment, the underwriting team prepares an investment
memorandum for presentation to the investment committee. In preparing the investment memorandum, the
underwriting team typically meets with key management of the company and selects its financial sponsors and
assembles information critical to the investment decision. If and when appropriate, the investment professionals
may also contact industry experts and customers, vendors or, in some cases, competitors of the company.

Approval Process. The sponsoring managing director or principal presents the investment memorandum to

our investment committee for consideration. The unanimous approval of our investment committee is required
before we proceed with any investment. The members of our investment committee are our Chief Executive
Officer, our Senior Managing Director, our Chief Legal Officer and our Vice President of Finance. The
investment committee generally meets weekly and more frequently on an as-needed basis.

Documentation

Our documentation group, headed by our Chief Legal Officer, administers the front-end documentation
process for our loans. This group is responsible for documenting the term sheet approved by the investment
committee to memorialize the transaction with a portfolio company. This group negotiates loan documentation
and, subject to the approval of the Chief Legal Officer, final documents are prepared for execution by all parties.
The documentation group generally uses the services of external law firms to complete the necessary
documentation.

Loan and Compliance Administration

Our loan and compliance administration group, headed by our Vice President of Finance, administers loans

and tracks covenant compliance on our investments and oversees periodic reviews of our critical functions to
ensure adherence with our internal policies and procedures. After funding of a loan in accordance with the
investment committee’s approval, the loan is recorded in our SQL-based database system. The loan and
compliance administration group is also responsible for ensuring timely interest and principal payments and
collateral management and advises the investment committee on the financial performance and trends of each
portfolio company, including any covenant violations that occur, to aid us in assessing the appropriate course of
action for each portfolio company and evaluating overall portfolio quality. In addition, the loan and compliance

10

administration group advises the Valuation Committee of the board regarding the credit and investment grading
for each portfolio company as well as changes in the value of collateral that may occur.

The loan and compliance administration group monitors our portfolio companies in order to determine
whether the companies are meeting our financing criteria and their respective business plans and also monitors
the financial trends of each portfolio company from its monthly or quarterly financial statements to assess the
appropriate course of action for each company and to evaluate overall portfolio quality. In addition, our
management team closely monitors the status and performance of each individual company through our
SQL-based database system and periodic contact with our portfolio companies’ management teams and their
respective financial sponsors.

Credit and Investment Grading System. Our loan and compliance administration group uses an investment

grading system to characterize and monitor our expected level of returns on both the debt investments and/or
equity positions for each investment in our portfolio. Our loan and compliance administration group monitors
and, when appropriate, recommends changes to investment gradings. Our investment committee reviews the
recommendations and/or changes to the investment gradings, which are submitted on a quarterly basis to the
Valuation Committee and our Board of Directors for approval.

We use the following investment grading system as amended in January 2006 and approved by our Board of

Directors:

1

2

3

4

5

Loans involve the least amount of risk in our portfolio. The borrower is performing above expectations,
and the trends and risk profile is generally favorable.

The borrower is performing as expected and the risk profile is neutral to favorable. All new loans are
initially graded 2.

The borrower may be performing below expectations and that the loan’s risk has increased materially
since origination. We increase procedures to monitor a borrower that may have limited amounts of cash
remaining on the balance sheet, is approaching its next equity capital raise within the next three to six
months, or if the estimated fair value of the enterprise maybe lower than when the loan was originated.
We will generally lower the loan grade to a level 3 even if the company is performing in accordance to
plan as it approaches the need to raise additional cash to fund its operations. Once the borrower closes
its new equity capital raise, we may increase the loan grade back to grade 2.

The borrower is performing materially below expectations and that the loan risk has substantially
increased since origination. Loans graded 4 may experience some partial loss or full return of principal
but are expected to realize some loss of interest which is not anticipated to be repaid in full, which, to
the extent not already reflected, may require the fair value of the loan to be reduced to the amount we
anticipate will be recovered. Grade 4 investments are closely being monitored.

The borrower is in workout, materially performing below expectations and significant risk of principal
loss is probable. Loans graded 5 will experience some partial principal loss or full loss of remaining
principal outstanding is expected. Grade 5 loans will require the fair value of the loans be reduced to
the amount we anticipate, if any, will be recovered.

As of December 31, 2005, our investments had a weighted average investment grading of 2.05.

Managerial Assistance

As a business development company, we offer, and provide upon request, managerial assistance to our

portfolio companies. This assistance could involve, among other things, monitoring the operations of our
portfolio companies, participating in board and management meetings, consulting with and advising officers of
portfolio companies and providing other organizational and financial guidance. We may receive fees for these
services.

11

COMPETITION

Our primary competitors provide financing to prospective portfolio companies and include financial
institutions, venture capital funds, private equity funds, investment funds and investment banks. Many of these
entities have greater financial and managerial resources than we have, and the 1940 Act imposes certain
regulatory restrictions on us as a business development company to which many of our competitors are not
subject. However, we believe that few of our competitors possess the expertise to properly structure and price
debt investments to venture capital and private equity backed technology-related companies. We believe that our
specialization in financing these technology-related companies will enable us to assess the value of intellectual
property assets, evaluate the business prospects and operating characteristics of prospective portfolio companies
and, as a result, identify investment opportunities that produce attractive risk-adjusted returns. For additional
information concerning the competitive risks we face, see “Risk Factors—Risks Related to our Business and
Structure—We operate in a highly competitive market for investment opportunities, and we may not be able to
compete effectively.”

CORPORATE STRUCTURE

We are a Maryland corporation and an internally-managed, non-diversified closed-end investment company
that has elected to be regulated as a business development company under the 1940 Act. Hercules Technology II,
L.P., our wholly-owned subsidiary, has applied to be licensed under the Small Business Investment Act of 1958
as a Small Business Investment Company. See “Regulation” below for further information about small business
investment company regulation. Hercules Technology SBIC Management, LLC, another wholly-owned
subsidiary, functions as the general partner of our subsidiary Hercules Technology II, L.P. Hercules Funding I
LLC, our wholly owned subsidiary, and Hercules Funding Trust I function as vehicles to collateralize loans
under our securitized credit facility with Citigroup Global Markets Realty Corp.

BROKERAGE ALLOCATION AND OTHER PRACTICES

Since we generally acquire and dispose of our investments in privately negotiated transactions, we rarely

use brokers in the normal course of business. In those cases where we do use a broker, we do not execute
transactions through any particular broker or dealer, but will seek to obtain the best net results for Hercules,
taking into account such factors as price (including the applicable brokerage commission or dealer spread), size
of order, difficulty of execution, and operational facilities of the firm and the firm’s risk and skill in positioning
blocks of securities. While we generally seek reasonably competitive execution costs, we may not necessarily
pay the lowest spread or commission available. Subject to applicable legal requirements, we may select a broker
based partly upon brokerage or research services provided to us. In return for such services, we may pay a higher
commission than other brokers would charge if we determine in good faith that such commission is reasonable in
relation to the services provided. For the years ended December 31, 2005 and 2004 we paid $4,000 and $0 in
brokerage commissions, respectively.

EMPLOYEES

As of December 31, 2005, we had 19 employees, including 12 investment and portfolio management
professionals, operations professionals and legal counsel, all of whom have extensive prior experience working
on financing transactions for technology-related companies. We intend to hire additional professionals with
business lending experience as well as additional administrative personnel, and we expect to expand our
management team and hire additional Managing Directors. We believe that our relations with our employees are
good.

12

ELECTION TO BE REGULATED AS A BUSINESS DEVELOPMENT COMPANY AND A
REGULATED INVESTMENT COMPANY

Since our incorporation, we have seen taxed as a corporation under Subchapter C. We currently intend to
seek to be treated for federal income tax purposes as a RIC under Subchapter M of the Code with the filing of our
federal corporate income tax return for 2006, which election, when actually made, would be effective as of
January 1, 2006. As a RIC, we generally will not pay corporate-level federal income taxes on any ordinary
income or capital gains that we distribute to our stockholders as dividends. We may be required, however, to pay
corporate-level federal income taxes on gains built into our assets as of the effective date of our RIC election. See
“Certain United States Federal Income Tax Considerations—Conversion to Regulated Investment Company
Status.” To obtain and maintain the federal income tax benefits of RIC status, we must meet specified
source-of-income and asset diversification requirements and distribute annually an amount equal to at least 90%
of the sum of our net ordinary income and realized net short-term capital gains in excess of realized net long-
term capital losses, if any, out of assets legally available for distribution. See “Distributions.” There is no
assurance that we will meet these tests and be eligible to make a RIC election. As of the date of this report, we
cannot determine the probability that during 2006, we will qualify as a RIC when we file our 2006 tax return. If
we do not qualify or do not elect to make a RIC election, we would continue to be taxed as a C corporation.

We were initially capitalized in February 2004 and in June 2004 we completed a private placement of 904,635

units at a price of $30.00 per unit, raising an aggregate of approximately $23.9 million in net proceeds. Each such
unit consisted of two shares of our common stock, one warrant to purchase one share of our common stock with up
to a 1-year term and one warrant to purchase one share of our common stock with a 5-year term. We paid a
placement fee to JMP Securities LLC, the initial purchaser in such private placement, of $2.10 per unit.

In January 2005, investment funds managed by JMP Asset Management LLC completed the purchase of

72,000 units at a price of $30.00 per unit, less a placement fee of $2.10 per unit pursuant to an option granted to
JMP Asset Management LLC in connection with our June 2004 private offering. In addition, in January 2005
Mr. Henriquez, our Chief Executive Officer, and Mr. Howard, our Senior Managing Director, purchased the
equivalent of 40,000 units and 13,500 units, respectively, and four other employees purchased an aggregate of 8,567
units, in each case at a price of $30.00 per unit. In connection with such transactions, we raised an aggregate of
approximately $3.9 million in net proceeds. In addition, 1-year warrants to purchase 1,175,963 shares of our
common stock were exercised in February 2005, generating proceeds to us of approximately $12.4 million.

In June 2005, we completed a public offering of 6,000,000 shares of our common stock, par value $0.001 per

share, at a price of $13.00 per share, which we refer to as our initial public offering. Our initial public offering
resulted in net proceeds to the company of approximately $70.9 million after deducting the offering costs.

Our election to be regulated as a business development company and our election to be treated as a RIC will

require certain actions and effect a number of changes to our activities and policies.

We will report our investments at market value or fair value with changes in value reported through our
statement of operations.

In accordance with the requirements of Article 6 of Regulation S-X, we will report all of our investments,
including loans, at market value or for investments that do not have a readily available market value, their “fair
value” determined by our Board of Directors, with changes in these values reported through our consolidated
statement of operations under the caption of “unrealized appreciation (depreciation) on investments.” See
“Determination of Net Asset Value.”

Our income tax expense should be reduced or eliminated.

With the filing of our 2006 tax return, we intend to seek to be treated as a RIC under Subchapter M of the Code

effective as of January 1, 2006. This election should reduce or eliminate the federal corporate-level income tax we
will be required to pay after such election. So long as we meet certain minimum distribution, source-of-income and
asset diversification requirements, we generally should be required to pay income taxes only on the portion of our
taxable income we do not distribute (actually or constructively) and certain built-in gains.

13

Change in Dividend Policy.

On October 27, 2005, we declared a dividend of $0.025 per share for stockholders of record on November 1,
2005. The dividend totaled approximately $245,000 and was distributed on November 17, 2005. On December 9,
2005 we declared a dividend of $0.30 per common share for stockholders of record on January 6, 2006. The
dividend was approximately $2.9 million and was distributed on January 27, 2006.

If we qualify and elect to be a RIC, we intend to distribute quarterly dividends to our stockholders following

the effective date of such our election to be treated as a RIC. We intend to distribute to our stockholders all or
substantially all of our income, except for certain realized net long-term capital gains. In addition, prior to the
end of our first tax year as a RIC, we will be required to make a distribution to our stockholders equal to the
amount of any earnings and profits from the period prior to our RIC election. We intend to make deemed
distributions to our stockholders of any retained net long-term capital gains. If this happens, you will be treated
as if you received an actual distribution of the capital gains and reinvested the net after-tax proceeds in us. You
also may be eligible to claim a tax credit (or, in certain circumstances, a tax refund) equal to your allocable share
of the tax we pay on the deemed distribution.

Warrants.

Under the 1940 Act, a business development company is subject to restrictions on the amount of warrants,

options or rights to purchase shares of capital stock that it may have outstanding at any time. In particular, the
amount of capital stock that would result from the conversion or exercise of all outstanding warrants, options or
rights to purchase capital stock cannot exceed 25% of the business development company’s total outstanding
shares of capital stock. This amount is reduced to 20% of the business development company’s total outstanding
shares of capital stock if the amount of warrants, options or rights issued pursuant to an executive compensation
plan would exceed 15% of the business development company’s total outstanding shares of capital stock.

Exemptive Relief.

On June 21, 2005, we filed a request with the SEC for exemptive relief to allow us to take certain actions that

would otherwise be prohibited by the 1940 Act, as applicable to business development companies. Specifically,
although we cannot provide any assurance that we will receive any such exemptive relief, we requested that the
SEC permit us to issue stock options to our non-employee directors as contemplated by Section 61(a)(3)(B)(i)(II) of
the 1940 Act. We have received comments from the SEC staff and have filed our initial response.

On May 3, 2005 Hercules Technology II, L.P. filed an application with the Small Business Administration
to become licensed as a small business investment company. Subsequently, on September 28, 2005 we filed an
exemptive relief application requesting that the SEC permit us to exclude the indebtedness of our wholly-owned
subsidiary, Hercules Technology II, L.P., from the 200% asset coverage requirements applicable to us.

We intend to request exemptive relief to permit us to grant restricted stock awards to our officers and
employees. However, there is no assurance that we will receive any such exemptive relief. If we do not receive
such exemptive relief we may have to change our compensation structure.

REGULATION

The following discussion is a general summary of the material prohibitions and descriptions governing
business development companies generally. It does not purport to be a complete description of all of the laws and
regulations affecting business development companies.

We have elected to be treated as a business development company under the 1940 Act and intend to seek to
be treated as a RIC under Subchapter M of the Code as of January 1, 2006. A business development company is a
unique kind of investment company that primarily focuses on investing in or lending to private companies and
making managerial assistance available to them. A business development company provides stockholders with
the ability to retain the liquidity of a publicly-traded stock, while sharing in the possible benefits of investing in
emerging-growth or expansion-stage privately-owned companies. The 1940 Act contains prohibitions and

14

restrictions relating to transactions between business development companies and their directors and officers and
principal underwriters and certain other related persons and requires that a majority of the directors be persons
other than “interested persons,” as that term is defined in the 1940 Act. In addition, the 1940 Act provides that we
may not change the nature of our business so as to cease to be, or to withdraw our election as, a business
development company unless approved by a majority of our outstanding voting securities. A majority of the
outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (i) 67% or more of
such company’s shares present at a meeting if more than 50% of the outstanding shares of such company are
present or represented by proxy, or (ii) more than 50% of the outstanding shares of such company.

Qualifying Assets

Under the 1940 Act, a business development company may not acquire any asset other than assets of the
type listed in Section 55(a) of the 1940 Act, or “qualifying assets,” unless, at the time the acquisition is made,
qualifying assets represent at least 70% of the company’s total assets. The principal categories of qualifying
assets relevant to our business are the following:

•

Securities of an “eligible portfolio company” purchased in transactions not involving any public
offering. An “eligible portfolio company” is defined in the 1940 Act as any issuer which:

•

•

•

is organized under the laws of, and has its principal place of business in, the United States;

is not an investment company (other than a small business investment company wholly-owned by
the business development company) or a company that would be an investment company but for
certain exclusions under the 1940 Act; and

satisfies any of the following:

•

•

•

does not have outstanding any class of securities with respect to which a broker or dealer may
extend margin credit;

is controlled by a business development company or a group of companies including a business
development company and the business development company has an affiliated person who is a
director of the eligible portfolio company; or

is a small and solvent company having total assets of not more than $4 million and capital and
surplus of not less than $2 million.

•

•

•

•

Securities of any eligible portfolio company that we control.

Securities purchased in a private transaction from a U.S. issuer that is not an investment company and is
in bankruptcy and subject to reorganization.

Securities of an eligible portfolio company purchased from any person in a private transaction if there is
no ready market for such securities and we already own 60% of the outstanding equity of the eligible
portfolio company.

Securities received in exchange for or distributed on or with respect to securities described above, or
pursuant to the conversion of warrants or rights relating to such securities.

• Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year

or less from the time of investment.

Significant Managerial Assistance

A business development company must have been organized and have its principal place of business in the

United States and must be operated for the purpose of making investments in the types of securities described
above. However, in order to count portfolio securities as qualifying assets for the purpose of the 70% test, the
business development company must either control the issuer of the securities or must offer to make available to

15

the issuer of the securities (other than small and solvent companies described above) significant managerial
assistance; except that, where the business development company purchases such securities in conjunction with
one or more other persons acting together, one of the other persons in the group may make available such
managerial assistance. Making available significant managerial assistance means, among other things, any
arrangement whereby the business development company, through its directors, officers or employees, offers to
provide and, if accepted, does so provide, significant guidance and counsel concerning the management,
operations or business objectives and policies of a portfolio company through monitoring of portfolio company
operations, selective participation in board and management meetings, consulting with and advising a portfolio
company’s officers or other organizational or financial guidance.

Temporary Investments

Pending investment in other types of qualifying assets, as described above, our investments may consist of

cash, cash equivalents, U.S. government securities or high quality debt securities maturing in one year or less
from the time of investment, which we refer to, collectively, as temporary investments, so that 70% of our assets
are qualifying assets. Typically, we will invest in U.S. treasury bills or in repurchase agreements, provided that
such agreements are fully collateralized by cash or securities issued by the U.S. government or its agencies. A
repurchase agreement involves the purchase by an investor, such as us, of a specified security and the
simultaneous agreement by the seller to repurchase it at an agreed upon future date and at a price which is greater
than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction
on the proportion of our assets that may be invested in such repurchase agreements. However, if more than 25%
of our total assets constitute repurchase agreements from a single counterparty, we would not meet the
diversification tests imposed on us by the Code in order to qualify as a RIC for federal income tax purposes.
Thus, we do not intend to enter into repurchase agreements with a single counterparty in excess of this limit. We
will monitor the creditworthiness of the counterparties with which we enter into repurchase agreement
transactions.

Senior Securities; Coverage Ratio

We will be permitted, under specified conditions, to issue multiple classes of indebtedness and one class of

stock senior to our common stock if our asset coverage, as defined in the 1940 Act, is at least equal to 200%
immediately after each such issuance. In addition, while any senior securities remain outstanding, we must make
provisions to prohibit any dividend distribution to our stockholders or the repurchase of such securities or shares
unless we meet the applicable asset coverage ratios at the time of the dividend distribution or repurchase. We
may also borrow amounts up to 5% of the value of our total assets for temporary or emergency purposes. For a
discussion of the risks associated with the resulting leverage, see “Risk Factors—Because we borrow money,
there could be increased risk in investing in our company.”

Code of Ethics

We have adopted and will maintain a code of ethics pursuant to Rule 17j-1 under the 1940 Act that
establishes procedures for personal investments and restricts certain personal securities transactions. Personnel
subject to the code may invest in securities for their personal investment accounts, including securities that may
be purchased or held by us, so long as such investments are made in accordance with the code’s requirements.
Our code of ethics will generally not permit investments by our employees in securities that may be purchased or
held by us. We may be prohibited under the 1940 Act from conducting certain transactions with our affiliates
without the prior approval of our directors who are not interested persons and, in some cases, the prior approval
of the SEC.

Our code of ethics was filed with the SEC as an exhibit to the registration statement (Registration

No. 333-126604) for our initial public offering and is available on our website at www.herculestech.com. You
may also read and copy the code of ethics at the SEC’s Public Reference Room in Washington, D.C. You may

16

obtain information on the operation of the Public Reference Room by calling the SEC at 1-202-942-8090. In
addition, the code of ethics is available on the EDGAR Database on the SEC’s Internet site at http://
www.sec.gov. You may obtain copies of the code of ethics, after paying a duplicating fee, by electronic request
at the following email address: publicinfo@sec.gov, or by writing the SEC’s Public Reference Section,
Washington, D.C. 20549.

Privacy Principles

We are committed to maintaining the privacy of our stockholders and safeguarding their non-public
personal information. The following information is provided to help you understand what personal information
we collect, how we protect that information and why, in certain cases, we may share information with select
other parties.

Generally, we do not receive any non-public personal information relating to our stockholders, although
certain non-public personal information of our stockholders may become available to us. We do not disclose any
non-public personal information about our stockholders or former stockholders to anyone, except as permitted by
law or as is necessary in order to service stockholder accounts (for example, to a transfer agent).

We restrict access to non-public personal information about our stockholders to our employees with a

legitimate business need for the information. We maintain physical, electronic and procedural safeguards
designed to protect the non-public personal information of our stockholders.

Proxy Voting Policies and Procedures

We vote proxies relating to our portfolio securities in the best interest of our stockholders. We review on a

case-by-case basis each proposal submitted to a stockholder vote to determine its impact on the portfolio
securities held by us. Although we generally vote against proposals that may have a negative impact on our
portfolio securities, we may vote for such a proposal if there exists compelling long-term reasons to do so.

Our proxy voting decisions are made by our investment committee, which is responsible for monitoring

each of our investments. To ensure that our vote is not the product of a conflict of interest, we require that:
(i) anyone involved in the decision making process disclose to our Chief Compliance Officer any potential
conflict that he or she is aware of and any contact that he or she has had with any interested party regarding a
proxy vote; and (ii) employees involved in the decision making process or vote administration are prohibited
from revealing how we intend to vote on a proposal in order to reduce any attempted influence from interested
parties.

Other

We will be periodically examined by the SEC for compliance with the 1934 Act and the 1940 Act.

We are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect
us against larceny and embezzlement. Furthermore, as a business development company, we are prohibited from
protecting any director or officer against any liability to our stockholders arising from willful misfeasance, bad
faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.

We are required to adopt and implement written policies and procedures reasonably designed to prevent
violation of the federal securities laws, review these policies and procedures annually for their adequacy and the
effectiveness of their implementation. We have designated Mr. Harvey, our Chief Legal Officer, to be our Chief
Compliance Officer to be responsible for administering these policies and procedures.

17

Small Business Administration Regulations

Hercules Technology II, L.P., our wholly-owned subsidiary, is seeking to be licensed by the Small Business

Administration as a small business investment company (SBIC) under Section 301(c) of the Small Business
Investment Act of 1958. The Small Business Investment Company regulations currently limit the amount that is
available to borrow by any SBIC to $124.4 million. There is no assurance that we will draw up to the maximum
limit available under the Small Business Investment Company program.

Small business investment companies are designed to stimulate the flow of private equity capital to eligible

small businesses. Under present Small Business Administration regulations, eligible small businesses include
businesses that have a tangible net worth not exceeding $18 million and have average annual fully taxed net
income not exceeding $6 million for the two most recent fiscal years. In addition, a small business investment
company must devote 20% of its investment activity to “smaller” concerns as defined by the Small Business
Administration. A smaller concern is one that has a tangible net worth not exceeding $6 million and has average
annual fully taxed net income not exceeding $2 million for the two most recent fiscal years. Small Business
Administration regulations also provide alternative size standard criteria to determine eligibility, which depend
on the industry in which the business is engaged and are based on such factors as the number of employees and
gross sales. According to Small Business Administration regulations, small business investment companies may
make long-term loans to small businesses, invest in the equity securities of such businesses and provide them
with consulting and advisory services. Through our wholly-owned subsidiary Hercules Technology II, L.P., we
plan to provide long-term loans to qualifying small businesses, and in connection therewith, make equity
investments.

If we receive a small business investment company license, Hercules Technology II, L.P. will be

periodically examined and audited by the Small Business Administration’s staff to determine its compliance with
small business investment company regulations.

In January 2005, the Company formed Hercules Technology II, L.P. (“HT II”) and Hercules Technology

SBIC Management, LLC (HTM). On May 3, 2005, HT II filed an application with the Small Business
Administration (the “SBA”) to become licensed as a Small Business Investment Company (“SBIC”) and on
June 24, 2005, the HT II received a letter of acknowledgement of receipt of this application. Upon receipt of this
letter from the SBA, HT II was eligible to make pre-approved investments. If HT II’s application to the SBIC
program is ultimately approved by the SBA, then it will be able to borrow funds from the SBA against eligible
pre-approved investments and additional deposits to regulatory capital. We have received comments from the
SBA on our license application and have filed responses.

During 2005, HT II funded two preapproved loans of which one was fully repaid in October 2005. At
December 31, 2005, the Company has a net investment of $2.5 million in HT II and there is one outstanding loan
in the amount of $2.0 million. HTM is a wholly-owned subsidiary of the Company. The Company is the sole
limited partner of HT II and HTM is the general partner.

18

CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS

The following discussion is a general summary of the material United States federal income tax
considerations applicable to us and to an investment in our shares. This summary does not purport to be a
complete description of the income tax considerations applicable to such an investment. For example, we have
not described tax consequences that we assume to be generally known by investors or certain considerations that
may be relevant to certain types of holders subject to special treatment under United States federal income tax
laws, including stockholders subject to the alternative minimum tax, tax-exempt organizations, insurance
companies, dealers in securities, pension plans and trusts, and financial institutions. This summary assumes that
investors hold our common stock as capital assets (within the meaning of the Code). The discussion is based
upon the Code, Treasury regulations, and administrative and judicial interpretations, each as in effect as of the
date of this report and all of which are subject to change, possibly retroactively, which could affect the
continuing validity of this discussion. We have not sought and will not seek any ruling from the Internal Revenue
Service regarding this offering. This summary does not discuss any aspects of United States estate or gift tax or
foreign, state or local tax. It does not discuss the special treatment under United States federal income tax laws
that could result if we invested in tax-exempt securities or certain other investment assets in which we do not
currently intend to invest.

A “U.S. stockholder” generally is a beneficial owner of shares of our common stock who is for United

States federal income tax purposes:

•

•

•

•

a citizen or individual resident of the United States including an alien individual who is a lawful
permanent resident of the United States or meets the “substantial presence” test under Section 7701(b)
of the Code;

a corporation or other entity taxable as a corporation, for United States federal income tax purposes,
created or organized in or under the laws of the United States or any political subdivision thereof;

a trust over which a court in the United States has primary supervision over its administration or over
which United States persons have control; or

an estate, the income of which is subject to United States federal income taxation regardless of its
source.

A “Non-U.S. stockholder” is a beneficial owner of shares of our common stock that is not a United States

stockholder.

If a partnership (including an entity treated as a partnership for United States federal income tax purposes)
holds shares of our common stock, the tax treatment of a partner in the partnership will generally depend upon
the status of the partner and the activities of the partnership. A prospective stockholder who is a partner of a
partnership holding shares of our common stock should consult his, her or its tax advisors with respect to the
purchase, ownership and disposition of shares of our common stock.

Tax matters are very complicated and the tax consequences to an investor of an investment in our shares
will depend on the facts of his, her or its particular situation. We encourage investors to consult their own tax
advisors regarding the specific consequences of such an investment, including tax reporting requirements, the
applicability of federal, state, local and foreign tax laws, eligibility for the benefits of any applicable tax treaty
and the effect of any possible changes in the tax laws.

Our Taxation as a Corporation under Subchapter C of the Code and not as a Regulated Investment
Company

Until such time as we elect to be treated and qualify as a RIC under Subchapter M of the Code, and for any

other period in which we fail to qualify as a RIC, we will be taxed as a corporation under Subchapter C of the
Code and will therefore be subject to corporate-level federal income tax on all of our income at regular corporate
rates. We will not be able to deduct distributions to stockholders, nor will they be required to be made.

19

Distributions made prior to such election, to the extent of our current and accumulated earnings and profits, are
taxable to our stockholders and, provided certain holding period and other requirements were met (if made in a
taxable year beginning on or before December 31, 2008), could qualify for treatment as “qualified dividend
income” eligible for the 15% maximum rate applicable to U.S. stockholders taxed as individuals. Subject to
certain limitations under the Code, corporate distributees would be eligible for the dividends received deduction.
Distributions in excess of our current and accumulated earnings and profits would be treated first as a return of
capital to the extent of the stockholder’s tax basis, and any remaining distributions would be treated as a capital
gain.

Election to be Taxed as a Regulated Investment Company

In conjunction with the filing of our December 31, 2006 tax return, we intend to seek to be treated as a RIC
under Subchapter M of the Code effective as of January 1, 2006. However, such an election and qualification to
be treated as a RIC requires that we comply with certain requirements contained in Subchapter M of the Code
that may affect our ability to pursue additional business opportunities or strategies which, if we were to
determine we should pursue, may diminish the desirability of or impede our ability to qualify as a RIC. For
example, a RIC must meet certain requirements, including source-of-income, asset diversification and income
distribution requirements. The income source requirement mandates that we receive 90% or more of our income
from qualified earnings, typically referred to as “good income.” Qualified earnings may exclude such income as
management fees received in connection with our SBIC or other potential outside managed funds and certain
other fees. As of the date of this report, we cannot determine the probability that during 2006 we will qualify as a
RIC when we file our 2006 federal tax return.

As a RIC, we generally will not have to pay corporate-level federal income taxes on any ordinary income or

realized capital gains that we distribute to our stockholders as dividends. We may be required, however, to pay
federal income taxes on gains built into our assets as of the effective date of our RIC election. See “Certain
United States Federal Income Tax Considerations—Conversion to Regulated Investment Company Status.” To
qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification
requirements (as described below), and we must distribute all of our earnings and profits for periods prior to our
qualification as a RIC. In addition, in order to obtain the federal income tax benefits allowable to RICs, we must
distribute to our stockholders, for each taxable year, at least 90% of our “investment company taxable income,”
which is generally our net ordinary income plus the excess, if any, of realized net short-term capital gains over
realized net long-term capital losses (the “Annual Distribution Requirement”).

Conversion to Regulated Investment Company Status

We intend to seek to be treated as a RIC under Subchapter M of the Code as of January 1, 2006. Prior to the

effective date of our RIC election, we will be taxable as a regular corporation under Subchapter C of the Code.
We anticipate that, on the effective date of that election, we may hold assets (including intangible assets not
reflected on the balance sheet, such as goodwill) with “built-in gains,” which are assets whose fair market value
as of the effective date of the election exceeds their tax basis. In general, a corporation that converts to taxation
as a RIC must pay corporate level tax on any of the net built-in gains it recognizes during the 10-year period
beginning on the effective date of its election to be treated as a RIC. Alternatively, the corporation may elect to
recognize all of its built-in gain at the time of its conversion and pay tax on the built-in gain at that time. We may
or may not make this election. If we do make the election, we will mark our portfolio to market at the time of our
RIC election, pay tax on any resulting taxable income, and distribute resulting earnings at that time or before the
end of the first tax year in which we qualify as a RIC. If we do not make the election we will pay such corporate
level tax that is payable at the time the built-in gains are recognized (which generally will be the years in which
the built-in gain assets are sold in a taxable transaction). The amount of this tax will vary depending on the assets
that are actually sold by us in this 10-year period, the actual amount of net built-in gain or loss present in those
assets as of the effective date of our election to be treated as a RIC and effective tax rates. Recognized built-in
gains that are ordinary in character and the excess of short-term capital gains over long-term capital losses will be
included in our investment company taxable income, and generally we must distribute annually at least 90% of

20

any such amounts (net of corporate taxes we pay on those gains) in order to be eligible for RIC tax treatment.
Any such amount distributed likely will be taxable to stockholders as ordinary income. Built-in gains (net of
taxes) that are recognized within the 10-year period and that are long-term capital gains likely will also be
distributed (or deemed distributed) annually to our stockholders. Any such amount distributed (or deemed
distributed) likely will be taxable to stockholders as capital gains.

One requirement to qualify as a RIC is that, by the end of our first taxable year as a RIC, we must eliminate

the earnings and profits accumulated while we were taxable as a C corporation. We would accomplish this by
paying to our stockholders a cash dividend representing all of our accumulated earnings and profits for the period
from our inception through the end of 2006. The actual amount of that dividend will be based on a number of
factors, including our results of operations through the end of 2005. The dividend, if any, of our accumulated
earnings and profits will be taxable to stockholders as ordinary income. The dividend will be in addition to the
dividends we intend to pay (or be deemed to have distributed) during our 2006 tax year equal to our net income
for that period. On October 27, 2005, the Company declared a dividend of $0.025 per share for stockholders of
record on November 1, 2005. The dividend totaled approximately $245,000 and was distributed on
November 17, 2005. On December 9, 2005 we declared a dividend of $0.30 per common share for stockholders
of record on January 6, 2006. The dividend totaled approximately $2.9 million and was distributed on
January 27, 2006.

Taxation as a Regulated Investment Company

For any taxable year in which we:

•

•

qualify as a RIC; and

satisfy the Annual Distribution Requirement;

we generally will not be subject to federal income tax on the portion of our investment company taxable income
and net capital gain (i.e., net realized long-term capital gains in excess of net realized short-term capital losses)
we distribute to stockholders with respect to that year. (However, as described above, we will be subject to
federal income taxes on certain dispositions of assets that had built-in gains as of the effective date of our
conversion to RIC status (unless we elect to be taxed on such gains as of such date). In addition, if we
subsequently acquire built-in gain assets from a C corporation in a carryover basis transaction, then we may be
subject to tax on the gains recognized by us on dispositions of such assets unless we make a special election to
pay corporate-level tax on such built-in gain at the time the assets are acquired.) We will be subject to United
States federal income tax at the regular corporate rates on any income or capital gain not distributed (or deemed
distributed) to our stockholders.

As a RIC, we will be subject to a 4% nondeductible federal excise tax on certain undistributed income
unless we distribute in a timely manner an amount at least equal to the sum of (1) 98% of our ordinary income
for each calendar year, (2) 98% of our capital gain net income for the 1-year period ending October 31 in that
calendar year and (3) any income realized, but not distributed, in the preceding year (the “Excise Tax Avoidance
Requirement”). We will not be subject to excise taxes on amounts on which we are required to pay corporate
income tax (such as retained net capital gains). We currently intend to make sufficient distributions each taxable
year to satisfy the Excise Tax Avoidance Requirement.

In order to qualify as a RIC for federal income tax purposes and obtain the tax benefits of RIC status, in

addition to satisfying the Annual Distribution Requirement, we must, among other things:

•

•

have in effect at all times during each taxable year an election to be regulated as a business development
company under the 1940 Act;

derive in each taxable year at least 90% of our gross income from (a) dividends, interest, payments with
respect to certain securities loans, gains from the sale of stock or other securities, or other income

21

derived with respect to our business of investing in such stock or securities and (b) net income derived
from an interest in a “qualified publicly traded limited partnership” (the “90% Income Test”); and

•

diversify our holdings so that at the end of each quarter of the taxable year:

•

•

at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities,
securities of other RICs, and other securities if such other securities of any one issuer do not
represent more than 5% of the value of our assets or more than 10% of the outstanding voting
securities of such issuer; and

no more than 25% of the value of our assets is invested in (i) securities (other than U.S. government
securities or securities of other RICs) of one issuer, (ii) securities of two or more issuers that are
controlled, as determined under applicable tax rules, by us and that are engaged in the same or
similar or related trades or businesses or (iii) securities of one or more “qualified publicly traded
partnerships” (the “Diversification Tests”).

We may be required to recognize taxable income in circumstances in which we do not receive cash. For
example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount
(such as debt instruments with payment-in-kind interest or, in certain cases, increasing interest rates or issued
with warrants), we must include in income each year a portion of the original issue discount that accrues over the
life of the obligation, regardless of whether cash representing such income is received by us in the same taxable
year. Because any original issue discount accrued will be included in our investment company taxable income for
the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the Annual
Distribution Requirement, even though we will not have received any corresponding cash amount.

Gain or loss realized by us from the sale or exchange of warrants acquired by us as well as any loss

attributable to the lapse of such warrants generally will be treated as capital gain or loss. Such gain or loss
generally will be long-term or short-term, depending on how long we held a particular warrant.

We are authorized to borrow funds and to sell assets in order to satisfy the Annual Distribution Requirement
and the Excise Tax Avoidance Requirement (collectively, the “Distribution Requirements”). However, under the
1940 Act, we are not permitted to make distributions to our stockholders while our debt obligations and other
senior securities are outstanding unless certain “asset coverage” tests are met. See “Regulation—Senior
Securities; Coverage Ratio.” Moreover, our ability to dispose of assets to meet the Distribution Requirements
may be limited by (1) the illiquid nature of our portfolio, or (2) other requirements relating to our status as a RIC,
including the Diversification Tests. If we dispose of assets in order to meet the Distribution Requirements, we
may make such dispositions at times that, from an investment standpoint, are not advantageous.

Any transactions in options, futures contracts, hedging transactions, and forward contracts will be subject to

special tax rules, the effect of which may be to accelerate income to us, defer losses, cause adjustments to the
holding periods of our investments, convert long-term capital gains into short-term capital gains, convert short-
term capital losses into long-term capital losses or have other tax consequences. These rules could affect the
amount, timing and character of distributions to stockholders. We do not currently intend to engage in these types
of transactions.

A RIC is limited in its ability to deduct expenses in excess of its “investment company taxable income”
(which is, generally, ordinary income plus net realized short-term capital gains in excess of net realized long-
term capital losses). If our expenses in a given year exceed investment company taxable income (e.g., as the
result of large amounts of equity-based compensation), we would experience a net operating loss for that year.
However, a RIC is not permitted to carry forward net operating losses to subsequent years. In addition, expenses
can be used only to offset investment company taxable income, not net capital gain. Due to these limits on the
deductibility of expenses, we may for tax purposes have aggregate taxable income for several years that we are
required to distribute and that is taxable to our stockholders even if such income is greater than the aggregate net

22

income we actually earned during those years. Such required distributions may be made from our cash assets or
by liquidation of investments, if necessary. We may realize gains or losses from such liquidations. In the event
we realize net capital gains from such transactions, you may receive a larger capital gain distribution than you
would have received in the absence of such transactions.

Following the effective date of our election to be treated as a RIC, assuming we qualify as a RIC, our
corporate-level federal income tax should be substantially reduced or eliminated and, as explained above, a
portion of our distributions or deemed distributions may be characterized as long-term capital gain in the hands
of stockholders. See “Election to be Taxed as a Regulated Investment Company” above.

Except as otherwise provided, the remainder of this discussion assumes that we qualify as a RIC and have

satisfied the Annual Distribution Requirement.

Taxation of U.S. Stockholders

For federal income tax purposes, distributions by us generally are taxable to U.S. stockholders as ordinary

income or capital gains. Distributions of our “investment company taxable income” (which is, generally, our
ordinary income plus net realized short-term capital gains in excess of net realized long-term capital losses) will
be taxable as ordinary income to U.S. stockholders to the extent of our current or accumulated earnings and
profits, whether paid in cash or reinvested in additional common stock. For taxable years beginning on or before
December 31, 2008, to the extent such distributions paid by us are attributable to dividends from U.S.
corporations and certain qualified foreign corporations, such distributions may be designated by us as “qualified
dividend income” eligible to be taxed in the hands of non-corporate stockholders at the rates applicable to long-
term capital gains, provided holding period and other requirements are met at both the stockholder and company
levels. In this regard, it is anticipated that distributions paid by us generally will not be attributable to dividends
and, therefore, generally will not be qualified dividend income. Distributions of our net capital gains (which is
generally our realized net long-term capital gains in excess of realized net short-term capital losses) properly
designated by us as “capital gain dividends” will be taxable to a U.S. stockholder as long-term capital gains
(currently at a maximum rate of 15%) in the case of individuals, trusts or estates, regardless of the U.S.
stockholder’s holding period for his, her or its common stock and regardless of whether paid in cash or
reinvested in additional common stock. Distributions in excess of our current and accumulated earnings and
profits first will reduce a U.S. stockholder’s adjusted tax basis in such stockholder’s common stock and, after the
adjusted basis is reduced to zero, will constitute capital gains to such U.S. stockholder.

We currently intend to retain all of our realized net long-term capital gains in excess of realized net short-
term capital losses, but to designate the retained net capital gain as a “deemed distribution.” In that case, among
other consequences, we will pay tax on the retained amount, each U.S. stockholder will be required to include
his, her or its share of the deemed distribution in income as if it had been actually distributed to the U.S.
stockholder, and the U.S. stockholder will be entitled to claim a credit equal to his, her or its allocable share of
the tax paid thereon by us. The amount of the deemed distribution net of such tax will be added to the U.S.
stockholder’s cost basis for his, her or its common stock. Since we expect to pay tax on any retained net capital
gains at our regular corporate tax rate, and since that rate is in excess of the maximum rate currently payable by
individuals on long-term capital gains, the amount of tax that individual stockholders will be treated as having
paid and for which they will receive a credit will exceed the tax they owe on the retained net capital gain. Such
excess generally may be claimed as a credit against the U.S. stockholder’s other federal income tax obligations or
may be refunded to the extent it exceeds a stockholder’s liability for federal income tax. A stockholder that is not
subject to federal income tax or otherwise required to file a federal income tax return would be required to file a
federal income tax return on the appropriate form in order to claim a refund for the taxes we paid. For federal
income tax purposes, the tax basis of shares owned by a stockholder will be increased by an amount equal under
current law to the difference between the amount of undistributed capital gains included in the stockholder’s
gross income and the tax deemed paid by the stockholder as described in this paragraph. In order to utilize the
deemed distribution approach, we must provide written notice to our stockholders prior to the expiration of 60

23

days after the close of the relevant taxable year. We cannot treat any of our investment company taxable income
as a “deemed distribution.” We may, in the future, make actual distributions to our stockholders of some or all of
realized net long-term capital gains in excess of realized net short-term capital losses.

For purposes of determining (1) whether the Annual Distribution Requirement is satisfied for any year and
(2) the amount of capital gain dividends paid for that year, we may, under certain circumstances, elect to treat a
dividend that is paid during the following taxable year as if it had been paid during the taxable year in question.
If we make such an election, the U.S. stockholder will still be treated as receiving the dividend in the taxable year
in which the distribution is made. However, any dividend declared by us in October, November or December of
any calendar year, payable to stockholders of record on a specified date in such a month and actually paid during
January of the following year, will be treated as if it had been received by our U.S. stockholders on December 31
of the year in which the dividend was declared.

If an investor purchases shares of our common stock shortly before the record date of a distribution, the

price of the shares will include the value of the distribution and the investor will be subject to tax on the
distribution even though economically it may represent a return of his, her or its investment.

A stockholder generally will recognize taxable gain or loss if the stockholder sells or otherwise disposes of

his, her or its shares of our common stock. Any gain arising from such sale or disposition generally will be
treated as long-term capital gain or loss if the stockholder has held his, her or its shares for more than one year.
Otherwise, it will be classified as short-term capital gain or loss. However, any capital loss arising from the sale
or disposition of shares of our common stock held for six months or less will be treated as long-term capital loss
to the extent of the amount of capital gain dividends received, or undistributed capital gain deemed received,
with respect to such shares. In addition, all or a portion of any loss recognized upon a disposition of shares of our
common stock may be disallowed if other shares of our common stock are purchased (whether through
reinvestment of distributions or otherwise) within 30 days before or after the disposition. In such a case, the basis
of the newly purchased shares will be adjusted to reflect the disallowed loss.

For taxable years beginning on or before December 31, 2008, individual U.S. stockholders are subject to a

maximum federal income tax rate of 15% on their net capital gain (i.e., the excess of realized net long-term
capital gain over realized net short-term capital loss for a taxable year) including any long-term capital gain
derived from an investment in our shares. Such rate is lower than the maximum rate on ordinary income
currently payable by individuals. Corporate U.S. stockholders currently are subject to federal income tax on net
capital gain at the maximum 35% rate also applied to ordinary income. Non-corporate stockholders with net
capital losses for a year (i.e., capital losses in excess of capital gains) generally may deduct up to $3,000 of such
losses against their ordinary income each year; any net capital losses of a non-corporate stockholder in excess of
$3,000 generally may be carried forward and used in subsequent years as provided in the Code. Corporate
stockholders generally may not deduct any net capital losses for a year, but may carry back such losses for three
years or carry forward such losses for five years.

We will send to each of our U.S. stockholders, as promptly as possible after the end of each calendar year, a

notice detailing, on a per share and per distribution basis, the amounts includible in such U.S. stockholder’s
taxable income for such year as ordinary income and as long-term capital gain. In addition, the federal tax status
of each year’s distributions generally will be reported to the Internal Revenue Service (including the amount of
dividends, if any, eligible for the 15% “qualified dividend income” rate). Distributions may also be subject to
additional state, local, and foreign taxes depending on a U.S. stockholder’s particular situation. Dividends
distributed by us generally will not be eligible for the corporate dividends-received deduction or the preferential
rate applicable to “qualified dividend income.”

We may be required to withhold federal income tax (“backup withholding”), currently at a rate of 28%,
from all taxable distributions to any non-corporate U.S. stockholder (1) who fails to furnish us with a correct
taxpayer identification number or a certificate that such stockholder is exempt from backup withholding, or

24

(2) with respect to whom the Internal Revenue Service (the “IRS”) notifies us that such stockholder has failed to
properly report certain interest and dividend income to the IRS and to respond to notices to that effect. An
individual’s taxpayer identification number is his or her social security number. Any amount withheld under
backup withholding is allowed as a credit against the U.S. stockholder’s federal income tax liability, provided
that proper information is provided to the IRS.

Taxation of Non-U.S. Stockholders

Whether an investment in the shares is appropriate for a Non-U.S. stockholder will depend upon that
person’s particular circumstances. An investment in the shares by a Non-U.S. stockholder may have adverse tax
consequences. Non-U.S. stockholders should consult their tax advisors before investing in our common stock.

In general, dividend distributions (other than certain distributions derived from net long-term capital gains)

paid by us to a Non-U.S. stockholder are subject to withholding of U.S. federal income tax at a rate of 30% (or
lower applicable treaty rate) even if they are funded by income or gains (such as portfolio interest, short-term
capital gains, or foreign-source dividend and interest income) that, if paid to a Non-U.S. stockholder directly,
would not be subject to withholding. If the distributions are effectively connected with a U.S. trade or business of
the Non-U.S. stockholder, (and, if an income tax treaty applies, attributable to a permanent establishment in the
United States), we will not be required to withhold federal tax if the Non-U.S. stockholder complies with
applicable certification and disclosure requirements, although the distributions will be subject to federal income
tax at the rates applicable to U.S. stockholders. (Special certification requirements apply to a Non-U.S.
stockholder that is a foreign partnership or a foreign trust, and such entities are urged to consult their own tax
advisors.)

For taxable years beginning prior to January 1, 2008, except as provided below, we generally will not be
required to withhold any amounts with respect to certain distributions of (i) U.S.-source interest income, and
(ii) net short-term capital gains in excess of net long-term capital losses, in each case to the extent we properly
designate such distributions. We may or may not make any such designations. In respect of distributions
described in clause (i) above, we will be required to withhold amounts with respect to distributions to a Non-U.S.
stockholder:

•

•

•

•

that has not provided a satisfactory statement that the beneficial owner is not a U.S. person;

to the extent that the dividend is attributable to certain interest on an obligation if the Non-U.S.
stockholder is the issuer or is a 10% stockholder of the issuer;

that is within certain foreign countries that have inadequate information exchange with the United
States; or

to the extent the dividend is attributable to interest paid by a person that is a related person of the
Non-U.S. stockholder and the Non-U.S. stockholder is a “controlled foreign corporation” for United
States federal income tax purposes.

The cash dividend(s) we intend to pay to our stockholders representing all of our accumulated earnings and
profits, if any, for the period from our inception through the effective date of our election to be treated as a RIC,
generally will be taxable to Non-U.S. stockholders in the same manner as other dividend distributions described
above.

Actual or deemed distributions of our net capital gains to a Non-U.S. stockholder, and gains realized by a

Non-U.S. stockholder upon the sale of our common stock, will not be subject to federal withholding tax and
generally will not be subject to federal income tax unless the distributions or gains, as the case may be, are
effectively connected with a U.S. trade or business of the Non-U.S. stockholder (and, if an income tax treaty
applies, are attributable to a permanent establishment maintained by the Non-U.S. stockholder in the U.S.), or in
the case of an individual stockholder, the stockholder is present in the U.S. for a period or periods aggregating
183 days or more during the year of the sale or capital gain dividend and certain other conditions are met.

25

If we distribute our net capital gains in the form of deemed rather than actual distributions, a Non-U.S.
stockholder will be entitled to a federal income tax credit or tax refund equal to the stockholder’s allocable share
of the tax we pay on the capital gains deemed to have been distributed. In order to obtain the refund, the
Non-U.S. stockholder must obtain a U.S. taxpayer identification number and file a federal income tax return even
if the Non-U.S. stockholder would not otherwise be required to obtain a U.S. taxpayer identification number or
file a federal income tax return. For a corporate Non-U.S. stockholder, distributions (both actual and deemed),
and gains realized upon the sale of our common stock that are effectively connected to a U.S. trade or business
may, under certain circumstances, be subject to an additional “branch profits tax” at a 30% rate (or at a lower rate
if provided for by an applicable treaty). Accordingly, investment in the shares may not be appropriate for a
Non-U.S. stockholder.

A Non-U.S. stockholder who is a non-resident alien individual, and who is otherwise subject to withholding

of federal tax, may be subject to information reporting and backup withholding of federal income tax on
dividends unless the Non-U.S. stockholder provides us or the dividend paying agent with an IRS Form W-8BEN
(or an acceptable substitute or successor form) or otherwise meets documentary evidence requirements for
establishing that it is a Non-U.S. stockholder or otherwise establishes an exemption from backup withholding.

Non-U.S. persons should consult their own tax advisors with respect to the United States federal income tax

and withholding tax, and state, local and foreign tax consequences of an investment in the shares.

Failure to Qualify as a Regulated Investment Company

If we were unable to qualify for treatment as a RIC, we would be subject to tax on all of our taxable income

at regular corporate rates. We would not be able to deduct distributions to stockholders, nor would they be
required to be made. Such distributions (if made in a taxable year beginning on or before December 31, 2008)
would be taxable to our stockholders and provided certain holding period and other requirements were met, could
qualify for treatment as “qualified dividend income” eligible for the 15% maximum rate to the extent of our
current and accumulated earnings and profits. Subject to certain limitations under the Code, corporate
distributees would be eligible for the dividends received deduction. Distributions in excess of our current and
accumulated earnings and profits would be treated first as a return of capital to the extent of the stockholder’s tax
basis, and any remaining distributions would be treated as a capital gain. To requalify as a RIC in a subsequent
taxable year, we would be required to satisfy the RIC qualification requirements for that year and dispose of any
earnings and profits from any year in which we failed to qualify as a RIC. Subject to a limited exception
applicable to RICs that qualified as such under Subchapter M of the Code for at least one year prior to
disqualification and that requalify as a RIC no later than the second year following the nonqualifying year, we
could be subject to tax on any unrealized net built-in gains in the assets held by us during the period in which we
failed to qualify as a RIC that are recognized within the subsequent 10 years, unless we made a special election to
pay corporate-level tax on such built-in gain at the time of our requalification as a RIC.

DIVIDEND REINVESTMENT PLAN

We have adopted a dividend reinvestment plan (the “DRP”), through which all dividend distributions are

paid to our stockholders in the form of additional shares of our common stock, unless a stockholder elects to
receive cash as provided below. In this way, a stockholder can maintain an undiluted investment in our common
stock and still allow us to pay out the required distributable income.

No action is required on the part of a registered stockholder to receive a dividend distribution in shares of

our common stock. A registered stockholder may elect to receive an entire dividend distribution in cash by
notifying American Stock Transfer & Trust Company, the plan administrator and our transfer agent and registrar,
so that such notice is received by the plan administrator no later than 3 days prior to the payment date for
dividend distributions to stockholders. The plan administrator will set up an account for shares acquired through

26

the DRP for each stockholder who has not elected to receive distributions in cash (each a “Participant”) and hold
such shares in non-certificated form. Upon request by a Participant, received not less than 3 days prior to the
payment date, the plan administrator will, instead of crediting shares to the Participant’s account, issue a
certificate registered in the Participant’s name for the number of whole shares of our common stock and a check
for any fractional share.

Those stockholders whose shares are held by a broker or other financial intermediary may receive

distributions in cash by notifying their broker or other financial intermediary of their election.

We expect to use primarily newly-issued shares to implement the DRP, whether our shares are trading at a
premium or at a discount to net asset value. The number of shares to be issued to a stockholder is determined by
dividing the total dollar amount of the dividend distribution payable to such stockholder by the market price per
share of our common stock at the close of regular trading on the Nasdaq National Market on the valuation date
for such dividend distribution. Market price per share on that date will be the closing price for such shares on the
Nasdaq National Market or, if no sale is reported for such day, at the average of their electronically-reported bid
and asked prices. The number of shares of our common stock to be outstanding after giving effect to payment of
the distribution cannot be established until the value per share at which additional shares will be issued has been
determined and elections of our stockholders have been tabulated.

There is no charge to our stockholders for receiving their dividend distributions in the form of additional

shares of our common stock. The plan administrator’s fees for handling dividend distributions in stock are paid
by us. There are no brokerage charges with respect to shares we have issued directly as a result of dividend
distributions payable in stock. If a Participant elects by internet or by written or telephonic notice to the plan
administrator to have the plan administrator sell part or all of the shares held by the plan administrator in the
Participant’s account and remit the proceeds to the Participant, the plan administrator is authorized to deduct a
$15.00 transaction fee plus brokerage commissions from the proceeds.

Any shares issued in connection with a stock split or stock dividend will be added to a Participant’s account

with the Plan Administrator. The Plan Administrator may curtail or suspend transaction processing until the
completion of such stock split or payment of such stock dividend.

Stockholders who receive dividend distributions in the form of stock are subject to the same federal, state

and local tax consequences as are stockholders who elect to receive their dividend distributions in cash. A
stockholder’s basis for determining gain or loss upon the sale of stock received in a dividend distribution from us
will be equal to the total dollar amount of the dividend distribution payable to the stockholder.

The DRP may be terminated by us upon notice in writing mailed to each Participant at least 30 days prior to

any record date for the payment of any dividend distribution by us. All correspondence concerning the DRP,
including requests for additional information, should be directed to the plan administrator by mail at American
Stock Transfer & Trust Company, Attn: Dividend Reinvestment Department, P.O. Box 922, Wall Street Station,
New York, NY 10269-0560 or by phone at 1-866-669-9888.

DETERMINATION OF NET ASSET VALUE

We determine the net asset value per share of our common stock quarterly. The net asset value per share is

equal to the value of our total assets minus liabilities and any preferred stock outstanding divided by the total
number of shares of common stock outstanding. As of the date of this report, we do not have any preferred stock
outstanding.

At December 31, 2005, approximately 91% of our total assets represented investments in portfolio
companies recorded at fair value. Value, as defined in Section 2(a) (41) of the 1940 Act, is (i) the market price

27

for those securities for which a market quotation is readily available and (ii) for all other securities and assets,
fair value is as determined in good faith by the Board of Directors in accordance with established valuation
procedures and the recommendation of the Valuation Committee of the Board of Directors. Since there is
typically no readily available market value for the investments in our portfolio, we value substantially all of our
investments at fair value as determined in good faith by our management pursuant to a valuation policy and a
consistent valuation process. Due to the inherent uncertainty in determining the fair value of investments that do
not have a readily available market value, the fair value of our investments determined in good faith by our
management may differ significantly from the value that would have been used had a ready market existed for
such investments, and the differences could be material.

There is no single standard for determining fair value in good faith. As a result, determining fair value requires
that judgment be applied to the specific facts and circumstances of each portfolio investment. Unlike banks, we are
not permitted to provide a general reserve for anticipated loan losses. Instead, we must determine the fair value of
each individual investment on a quarterly basis. We will record unrealized depreciation on investments when we
believe that an investment has decreased in value, including where collection of a loan or realization of an equity
security is doubtful. Conversely, we will record unrealized appreciation if we believe that the underlying portfolio
company has appreciated in value and, therefore, our investment has also appreciated in value, where appropriate.

As a business development company, we invest primarily in illiquid securities including debt and equity-

related securities of private companies. Our investments are generally subject to some restrictions on resale and
generally have no established trading market. Because of the type of investments that we make and the nature of
our business, our valuation process requires an analysis of various factors. Our valuation methodology includes
the examination of, among other things, the underlying investment performance, financial condition and market
changing events that impact valuation.

When a qualifying external event such as a significant purchase transaction, public offering, or subsequent

debt or equity sale occurs, the pricing indicated by the external event will be used to corroborate our private debt
or equity valuation. Securities that are traded in the over-the-counter market or on a stock exchange will be
valued at the prevailing bid price on the valuation date.

Item 1A. Risk Factors

Investing in our common stock and warrants involves a high degree of risk. You should carefully consider
these risks, together with all of the other information included in this Annual Report on Form 10-K, before you
decide whether to make an investment in our common stock or warrants. The risks set forth below are not the
only risks we face. If any of the following risks occur, our business, financial condition and results of operations
could be materially adversely affected. In such case, our net asset value and the trading price of our common
stock and warrants could decline, and you may lose all or part of your investment.

Risks Related to our Business and Structure

We have a limited operating history as a business development company, which may affect our ability to
manage our business and may impair your ability to assess our prospects.

We were incorporated in December 2003 and commenced investment operations in September 2004. We are

subject to all of the business risks and uncertainties associated with any new business enterprise, including the
risk that we will not achieve our investment objective and that the value of our common stock or warrants could
decline substantially. We have limited operating history as a business development company and have not yet
been able to elect to be treated as a RIC for tax purposes. As a result, we have limited operating results under
these regulatory frameworks that can demonstrate to you either their effect on the business or our ability to
manage the business within these frameworks. See “Regulation” and “Certain United States Federal Income Tax
Considerations.” If we fail to maintain our status as a business development company or fail to qualify as a RIC,
our operating flexibility and results of operations would be significantly effected.

28

We are dependent upon key management personnel for our future success, particularly Manuel A.
Henriquez, and if we are not able to hire and retain qualified personnel, or if we lose any member of our
senior management team, our ability to implement our business strategy could be significantly harmed.

We depend upon the members of our senior management, particularly Mr. Henriquez, as well as other key

personnel for the identification, final selection, structuring, closing and monitoring of our investments. These
employees have critical industry experience and relationships on which we rely to implement our business plan.
If we lose the services of Mr. Henriquez, or of any other senior management members, we may not be able to
operate the business as we expect, and our ability to compete could be harmed, which could cause our operating
results to suffer. We believe our future success will depend, in part, on our ability to identify, attract, and retain
sufficient numbers of highly skilled employees. If we do not succeed in identifying, attracting, and retaining such
personnel, we may not be able to operate our business as we expect.

Our business model depends to a significant extent upon strong referral relationships with venture capital
and private equity fund sponsors, and our inability to develop or maintain these relationships, or the failure
of these relationships to generate investment opportunities, could adversely affect our business.

We expect that members of our management team will maintain their relationships with venture capital and
private equity firms, and we will rely to a significant extent upon these relationships to provide us with our deal
flow. If we fail to maintain our existing relationships or to develop new relationships with other firms or sources of
investment opportunities, then we will not be able to grow our investment portfolio. In addition, persons with whom
members of our management team have relationships are not obligated to provide us with investment opportunities
and, therefore, there is no assurance that such relationships will lead to the origination of debt or other investments.

We operate in a highly competitive market for investment opportunities, and we may not be able to compete
effectively.

A large number of entities compete with us to make the types of investments that we plan to make in
prospective portfolio companies. We compete with a large number of venture capital and private equity firms, as
well as with other investment funds, investment banks, and other sources of financing, including traditional
financial services companies such as commercial banks and finance companies. Many of our competitors are
substantially larger and have considerably greater financial, technical, marketing and other resources than we do.
For example, some competitors may have a lower cost of funds and/or access to funding sources that are not
available to us. This may enable some competitors to make commercial loans with interest rates that are
comparable to or lower than the rates that we typically offer. We may lose prospective portfolio companies if we
do not match competitors’ pricing, terms, and structure. If we do match competitors’ pricing, terms, or structure,
we may experience decreased net interest income and increased risk of credit losses. In addition, some of our
competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a
wider variety of investments, establish more relationships, and build their market shares. Furthermore, many
potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a business
development company or that the Code, would impose on us as a RIC. If we are not able to compete effectively,
our business, financial condition, and results of operations will be adversely affected. As a result of this
competition, there can be no assurance that we will be able to identify and take advantage of attractive
investment opportunities that we identify, or that we will be able to fully invest our available capital.

Because we intend to distribute substantially all of our income to our stockholders if we are treated as a
RIC, we will continue to need additional capital to finance our growth. If additional funds are unavailable
or not available on favorable terms, our ability to grow will be impaired.

In order to satisfy the requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or

avoid payment of income taxes, we intend as a RIC to distribute to our stockholders substantially all of our
ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we

29

currently intend to retain, pay applicable income taxes with respect thereto, and elect to treat as deemed
distributions to our stockholders. As a business development company, we generally are required to meet a
coverage ratio of total assets to total borrowings and other senior securities, which includes all of our borrowings
and any preferred stock that we may issue in the future, of at least 200%. This requirement limits the amount that
we may borrow. Because we will continue to need capital to grow our loan and investment portfolio, this
limitation may prevent us from incurring debt and require us to raise additional equity at a time when it may be
disadvantageous to do so. While we expect to be able to borrow and to issue additional debt and equity securities,
we cannot assure you that debt and equity financing will be available to us on favorable terms, or at all, and debt
financings may be restricted by the terms of any of our outstanding borrowings. In addition, as a business
development company, we generally are not permitted to issue equity securities priced below net asset value
without stockholder approval and approval of our independent directors. If additional funds are not available to
us, we could be forced to curtail or cease new lending and investment activities, and our net asset value could
decline.

Because we borrow money, there could be increased risk in investing in our company.

Lenders have fixed dollar claims on our assets that are superior to the claims of stockholders, and we have
granted, and may in the future grant, lenders a security interest in our assets in connection with borrowings. In
the case of a liquidation event, those lenders would receive proceeds before our stockholders. In addition,
borrowings, also known as leverage, magnify the potential for gain or loss on amounts invested and, therefore,
increase the risks associated with investing in our securities. Leverage is generally considered a speculative
investment technique. If the value of our assets increases, then leveraging would cause the net asset value
attributable to our common stock to increase more than it otherwise would have had we not leveraged.
Conversely, if the value of our assets decreases, leveraging would cause the net asset value attributable to our
common stock to decline more than it otherwise would have had we not leveraged. Similarly, any increase in our
revenue in excess of interest expense on our borrowed funds would cause our net income to increase more than it
would without the leverage. Any decrease in our revenue would cause our net income to decline more than it
would have had we not borrowed funds and could negatively affect our ability to make distributions on common
stock. Our ability to service any debt that we incur will depend largely on our financial performance and will be
subject to prevailing economic conditions and competitive pressures.

As of December 31, 2005, we had outstanding indebtedness of $25 million pursuant to our bridge loan from
an affiliate of Farallon Capital Management, L.L.C. On August 1, 2005, the Company, through Hercules Funding
Trust I, an affiliated statutory trust, executed a $100 million securitized credit facility with Citigroup Global
Market Realty Corp., which we refer to as the Citigroup Facility. As of December 31, 2005, we had drawn $51.0
million under the Citigroup Facility. We expect, in the future, to borrow from, and issue senior debt securities to,
banks, insurance companies and other lenders, including additional borrowings pursuant to the Citigroup Facility.
See “Obligations and Indebtedness—Warehouse Facility.” In addition, we expect to continue to pursue financing
from the Small Business Administration under its Small Business Investment Company program. See
“Obligations and Indebtedness—SBIC Financing” and “Regulation—Small Business Administration
Regulations.”

As a business development company, we generally are required to meet a coverage ratio of total assets to

total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we
may issue in the future, of at least 200%. If this ratio declines below 200%, we may not be able to incur
additional debt and may need to sell a portion of our investments to repay some debt when it is disadvantageous
to do so, and we may not be able to make distributions.

30

Illustration. The following table illustrates the effect of leverage on returns from an investment in our

common stock assuming various annual returns, net of expenses. The calculations in the table below are
hypothetical and actual returns may be higher or lower than those appearing in the table below.

Assumed return on our portfolio (net of expenses)

-10%

-5%

0%

5%

10%

Corresponding return to stockholder (1) . . . . . . . . . . . . . . . . . . . .

-21.0% -12.6% -4.1% 4.4% 12.8%

(1) Assumes $193.6 million in total assets, $76.0 million in debt outstanding, $114.4 million in stockholders’

equity, and an average cost of funds of 6.15%, which is the approximate cost of funds of the warehouse
facility we entered into on August 1, 2005. Actual interest payments may be different.

Because most of our investments typically are not in publicly-traded securities, there is uncertainty
regarding the value of our investments, which could adversely affect the determination of our net asset
value.

We expect our investments to continue to consist primarily of securities issued by privately-held companies,
the fair value of which is not readily determinable. In addition, we are not permitted to maintain a general reserve
for anticipated loan losses. Instead, we are required by the 1940 Act to specifically value each investment and
record an unrealized gain or loss for any asset that we believe has increased or decreased in value. We value
these securities at fair value as determined in good faith by our Board of Directors, based on the
recommendations of our Board of Directors’ Valuation Committee. The Valuation Committee utilizes its best
judgment in arriving at the fair value of these securities. However, the Board of Directors retains ultimate
authority as to the appropriate valuation of each investment. Because such valuations are inherently uncertain and
may be based on estimates, our determinations of fair value may differ materially from the values that would be
assessed if a ready market for these securities existed. Our net asset value could be adversely affected if our
determinations regarding the fair value of our investments were materially higher than the values that we
ultimately realize upon the disposal of such securities.

Regulations governing our operations as a business development company affect our ability to, and the
manner in which, we raise additional capital, which may expose us to risks.

Our business will require a substantial amount of capital. We may acquire additional capital from the
issuance of senior securities, including borrowings, securitization transactions or other indebtedness, or the
issuance of additional shares of our common stock. However, we may not be able to raise additional capital in the
future on favorable terms or at all. We may issue debt securities, other evidences of indebtedness or preferred
stock, and we may borrow money from banks or other financial institutions, which we refer to collectively as
“senior securities,” up to the maximum amount permitted by the 1940 Act. The 1940 Act permits us to issue
senior securities in amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after
each issuance of senior securities. Our ability to pay dividends or issue additional senior securities would be
restricted if our asset coverage ratio were not at least 200%. If the value of our assets declines, we may be unable
to satisfy this test. If that happens, we may be required to liquidate a portion of our investments and repay a
portion of our indebtedness at a time when such sales may be disadvantageous. As a result of issuing senior
securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure,
preferred stockholders would have separate voting rights and might have rights, preferences, or privileges more
favorable than those of our common stockholders and the issuance of preferred stock could have the effect of
delaying, deferring, or preventing a transaction or a change of control that might involve a premium price for
holders of our common stock or otherwise be in your best interest.

To the extent that we are constrained in our ability to issue debt or other senior securities, we will depend on
issuances of common stock to finance operations. As a business development company, we are generally not able
to issue our common stock at a price below net asset value without first obtaining required approvals from our

31

stockholders and our independent directors. If we raise additional funds by issuing more common stock or senior
securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our
stockholders at that time will decrease, and you might experience dilution. In addition to issuing securities to
raise capital as described above, we anticipate that, in the future, we may securitize our loans to generate cash for
funding new investments. An inability to successfully securitize our loan portfolio could limit our ability to grow
our business and fully execute our business strategy.

Our ability to invest in certain private and public companies may be limited in certain circumstances.

As a business development company, we must not acquire any assets other than “qualifying assets” unless,
at the time of and after giving effect to such acquisition, at least 70% of our total assets are qualifying assets. We
expect that substantially all of our assets will be “qualifying assets,” although we may decide to make other
investments that are not “qualifying assets” to the extent permitted by the 1940 Act.

Currently, if we acquire debt or equity securities from an issuer that has outstanding marginable securities at

the time that we make an investment, these acquired assets cannot be treated as qualifying assets. This result is
dictated by the definition of “eligible portfolio company” under the 1940 Act, which in part looks to whether a
company has outstanding marginable securities. For a more detailed discussion of the definition of an “eligible
portfolio company” and the marginable securities requirement, see the section entitled “Regulation—Qualifying
Assets.”

Amendments promulgated in 1998 by the Federal Reserve expanded the definition of a marginable security
under the Federal Reserve’s margin rules to include any non-equity security. Thus, any debt securities issued by
any entity are marginable securities under the Federal Reserve’s current margin rules. As a result, the staff of the
SEC has raised the question to the business development company industry as to whether a private company that
has outstanding debt securities would qualify as an “eligible portfolio company” under the 1940 Act.

The SEC has issued proposed rules to correct the unintended consequence of the Federal Reserve’s 1998
margin rule amendments of apparently limiting the investment opportunities of business development companies.
In general, the SEC’s proposed rules would define an eligible portfolio company as any company that does not
have securities listed on a national securities exchange or association. We are currently in the process of
reviewing the SEC’s proposed rules and assessing their impact, to the extent that such proposed rules are
subsequently approved by the SEC, on our investment activities.

Until the SEC or its staff has taken a final public position with respect to the issue discussed above, we will
continue to monitor this issue closely, and we may be required to adjust our investment focus to comply with any
future administrative position or action taken by the SEC.

We may have difficulty paying our required distributions if we recognize income before or without receiving
cash representing such income.

In accordance with generally accepted accounting principles and tax requirements, we include in income

certain amounts that we have not yet received in cash, such as contracted payment-in-kind interest, which
represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the
cash yields received on our loans, in some instances, certain loans may also include any of the following:
end-of-term payments, exit fees, balloon payment fees, or prepayment fees. The increases in loan balances as a
result of contracted payment-in-kind arrangements are included in income for the period in which such
payment-in-kind interest was received, which is often in advance of receiving cash payment, and are separately
identified on our statements of cash flows. We also may be required to include in income certain other amounts
that we will not receive in cash.

Any warrants that we receive in connection with our debt investments will generally be valued as part of the

negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price

32

for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result
in “original issue discount” for tax purposes, which we must recognize as ordinary income, increasing the
amount that we are required to distribute to qualify for the federal income tax benefits applicable to RICs.
Because these warrants would not produce distributable cash for us at the same time as we are required to make
distributions in respect of the related original issue discount, we would need to obtain cash from other sources to
satisfy such distribution requirements. If we are unable to obtain cash from other sources to satisfy such
distribution requirements, we may fail to qualify for the federal income tax benefits allowable to RICs and, thus,
become subject to a corporate-level income tax on all our income.

Other features of the debt instruments that we hold may also cause such instruments to generate an original
issue discount, resulting in a dividend distribution requirement in excess of current cash interest received. Since
in certain cases we may recognize income before or without receiving cash representing such income, we may
have difficulty meeting the requirement to distribute at least 90% of our net ordinary income and realized net
short-term capital gains in excess of realized net long-term capital losses, if any. If we are unable to meet these
distribution requirements, we will not qualify for the federal income tax benefits allowable to a RIC.
Accordingly, we may have to sell some of our assets, raise additional debt or equity capital or reduce new
investment originations to meet these distribution requirements. See “Certain United States Federal Income Tax
Considerations—Taxation as a Regulated Investment Company.”

There is a risk that you may not receive distributions or that our distributions may not grow over time.

We intend to make distributions on a quarterly basis to our stockholders. We cannot assure you that we will

achieve investment results that will allow us to make a specified level of cash distributions or year-to-year
increases in cash distributions. In addition, due to the asset coverage test applicable to us as a business
development company, we may be limited in our ability to make distributions.

If we are unable to manage our future growth effectively, we may be unable to achieve our investment
objective, which could adversely affect our financial condition and results of operations and cause the value
of your investment to decline.

Our ability to achieve our investment objective will depend on our ability to sustain growth. Sustaining
growth will depend, in turn, on our senior management team’s ability to identify, evaluate, finance and invest in
suitable companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is
largely a function of our marketing capabilities, our management of the investment process, our ability to provide
efficient services and our access to financing sources on acceptable terms. Failure to manage our future growth
effectively could have a material adverse effect on our business, financial condition, and results of operations.

Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our
business, and if we fail to achieve our investment objective, the net asset value of our common stock may
decline.

We could experience fluctuations in our quarterly and annual operating results due to a number of factors,
some of which are beyond our control, including the interest rate payable on the debt securities that we acquire,
the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of
realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general
economic conditions. As a result of these factors, results for any period should not be relied upon as being
indicative of performance in future periods.

Fluctuations in interest rates may adversely affect our profitability.

A portion of our income will depend upon the difference between the rate at which we borrow funds and the

interest rate on the debt securities in which we invest. Because we will borrow money to make investments, our

33

net investment income is dependent upon the difference between the rate at which we borrow funds and the rate
at which we invest these funds. Typically, we anticipate that our interest-earning investments will accrue and pay
interest at fixed rates, and that our interest-bearing liabilities will accrue interest at variable rates. As a result,
there can be no assurance that a significant change in market interest rates will not have a material adverse effect
on our net investment income. We anticipate using a combination of equity and long-term and short-term
borrowings to finance our investment activities.

A significant increase in market interest rates could harm our ability to attract new portfolio companies and
originate new loans and investments. We expect that most of our initial investments in debt securities will be at
fixed rates. However, in the event that we make investments in debt securities at variable rates, a significant
increase in market interest rates could also result in an increase in our non-performing assets and a decrease in
the value of our portfolio because our floating-rate loan portfolio companies may be unable to meet higher
payment obligations. In periods of rising interest rates, our cost of funds would increase, resulting in a decrease
in our net investment income. In addition, a decrease in interest rates may reduce net income, because new
investments may be made at lower rates despite the increased demand for our capital that the decrease in interest
rates may produce. We may, but will not be required to, hedge against the risk of adverse movement in interest
rates in our short-term and long-term borrowings relative to our portfolio of assets. If we engage in hedging
activities, it may limit our ability to participate in the benefits of lower interest rates with respect to the hedged
portfolio. Adverse developments resulting from changes in interest rates or hedging transactions could have a
material adverse effect on our business, financial condition, and results of operations.

If we are unable to continue to borrow money in order to leverage our equity capital, then our ability to
make new investments and to execute our business plan will be impaired.

As of December 31, 2005, we had borrowed $25 million pursuant to our Bridge Loan Credit Facility. On
August 1, 2005, the Company, through Hercules Funding Trust I, an affiliated statutory trust, executed a $100
million securitized credit facility with Citigroup Global Market Realty Corp., which we refer to as the Citigroup
Facility. As of December 31, 2005, we had drawn $51.0 million under the Citigroup Facility. We expect to incur
additional indebtedness if our subsidiary obtains a small business investment company license, from the Small
Business Administration. There can be no assurance that we will be successful in obtaining any additional debt
capital on terms acceptable to us or at all. If we are unable to obtain debt capital, then our equity investors will
not benefit from the potential for increased returns on equity resulting from leverage to the extent that our
investment strategy is successful.

It is likely that the terms of any long-term or revolving credit or warehouse facility we may enter into in the
future could constrain our ability to grow our business.

On August 1, 2005, the Company, through Hercules Funding Trust I, an affiliated statutory trust, executed a

$100 million securitized credit facility with Citigroup. We expect to enter into additional revolving credit or
warehouse facilities in the future. While there can be no assurance that we will be able to borrow from banks or
other financial institutions, we expect that we will, at some time in the future, obtain a long-term or revolving
credit facility or a warehouse facility. The current lenders have, and any future lender or lenders will have fixed
dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over
our stockholders with respect to our assets. In addition, we may grant a security interest in our assets in
connection with any such borrowing. We expect such a facility to contain customary default provisions such as a
minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality
standards. An event of default under any credit facility would likely result, among other things, in termination of
the availability of further funds under that facility and an accelerated maturity date for all amounts outstanding
under the facility, which would likely disrupt our business and, potentially, the business of the portfolio
companies whose loans that we financed through the facility. This could reduce our revenues and, by delaying
any cash payment allowed to us under our facility until the lender has been paid in full, reduce our liquidity and
cash flow and impair our ability to grow our business and maintain our status as a RIC.

34

If we are unable to satisfy Code requirements for qualification as a RIC, then we will continue to be subject
to corporate-level income tax, which would adversely affect our results of operations and financial
condition.

We intend to seek to be treated as a RIC for federal income tax purposes with the filing of our federal

corporate income tax return for 2006, which election when when actually made, would be effective as of
January 1, 2006. After we make this election, and if we qualify, to be treated as a RIC, we can generally avoid
corporate-level federal income taxes on income distributed to our stockholders as dividends. As a RIC, we could
be subject to tax on any unrealized net built-in gains in the assets held by us during the period in which we were
not (or in which we failed to qualify as) a RIC that are recognized within the following 10 years, unless we make
a special election to pay corporate-level tax on such built-in gain at the time of our RIC election or an exception
applies. See “Certain United States Federal Income Tax Considerations—Conversion to Regulated Investment
Company Status.” We will not qualify for this the tax treatment allowable to RICs if we are unable to comply
with the source of income, diversification and distribution requirements contained in Subchapter M of the Code,
or if we fail to maintain our election to be regulated as a business development company under the 1940 Act. If
we fail to qualify for the federal income tax benefits allowable to RICs for any reason and remain or become
subject to a corporate-level income tax, the resulting taxes could substantially reduce our net assets, the amount
of income available for distribution to our stockholders, and the actual amount of our distributions. Such a failure
would have a material adverse effect on us, the net asset value of our common stock, and the total return, if any,
obtainable from your investment in our common stock. For additional information regarding our regulatory
requirements, see “Regulation” and “Certain United States Federal Income Tax Considerations.” Any net
operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e.,
net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise
required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net
operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset
ordinary income or capital gains.

Changes in laws or regulations governing our business could negatively affect the profitability of our
operations.

Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern business

development companies, small business investment companies, RICs, or non-depository commercial lenders
could significantly affect our operations and our cost of doing business. We are subject to federal, state, and local
laws and regulations and are subject to judicial and administrative decisions that affect our operations, including
our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the
terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws,
regulations, or decisions change, or if we expand our business into jurisdictions that have adopted more stringent
requirements than those in which we currently conduct business, then we may have to incur significant expenses
in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable
laws, regulations, and decisions, then we may lose licenses needed for the conduct of our business and be subject
to civil fines and criminal penalties, any of which could have a material adverse effect upon our business, results
of operations, or financial condition.

We are exposed to increased costs and risks associated with complying with regulations of corporate
governance and disclosure standards.

Section 404 of the Sarbanes-Oxley Act of 2002 requires management’s annual review and evaluation of our

internal control systems and attestations of the effectiveness of these systems by our independent auditors. We
are commencing evaluation, documentation and testing of our internal control systems and procedures and
considering improvements that may be necessary in order for us to comply with the requirements of Section 404
by the end of 2006. This process has required us to hire outside advisory services and will result in additional
accounting and legal expenses. We may encounter problems or delays in completing the review and evaluation,
the implementation of improvements and the receipt of a positive attestation by our independent auditors. While

35

we believe that we currently have adequate internal controls over financial reporting, in the event that our chief
executive officer, principal financial and accounting officer or independent auditors determine that our controls
over financial reporting are not effective as defined under Section 404, investor perceptions of our company may
be adversely affected and could cause a decline in the market price of our stock.

Risks Related to Our Investments

Our investments are concentrated in a limited number of technology-related companies, which subjects us
to the risk of significant loss if any of these companies default on their obligations under any of their debt
securities that we hold, or if any of the technology-related industry sectors experience a downturn.

We have invested and intend to continue investing in a limited number of technology-related companies. A
consequence of this limited number of investments is that the aggregate returns we realize may be significantly
adversely affected if a small number of investments perform poorly or if we need to write down the value of any
one investment. Beyond the asset diversification requirements to which we will be subject as a RIC, we do not
have fixed guidelines for diversification or limitations on the size of our investments in any one portfolio
company and our investments could be concentrated in relatively few issuers. In addition, we have invested in
and intend to continue investing, under normal circumstances, at least 80% of the value of our total assets
(including the amount of any borrowings for investment purposes) in technology-related and life-science
companies. As a result, a downturn in technology-related and life-science industry sectors could materially
adversely affect us.

Our investments may be concentrated in emerging-growth or expansion-stage portfolio companies, which
may have limited operating histories and financial resources.

We expect that our portfolio will continue to consist primarily of investments in emerging-growth and
expansion-stage privately-owned businesses, which may have relatively limited operating histories. Compared to
larger established or publicly-owned firms, these companies may be particularly vulnerable to economic
downturns, may have more limited access to capital and higher funding costs, may have a weaker financial
position, and may need more capital to expand or compete. These businesses also may experience substantial
variations in operating results. They may face intense competition, including from companies with greater
financial, technical, and marketing resources. Furthermore, some of these companies do business in regulated
industries and could be affected by changes in government regulation. Accordingly, these factors could impair
their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their
obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies.

Our investment strategy focuses on technology-related and life-science companies, which are subject to
many risks, including volatility, intense competition, shortened product life cycles, and periodic downturns,
and you could lose all or part of your investment.

We have invested and will continue investing primarily in technology-related and life-science companies,

many of which may have narrow product lines and small market shares, which tend to render them more
vulnerable to competitors’ actions and market conditions, as well as to general economic downturns. The
revenues, income (or losses), and valuations of technology-related and life-science companies can and often do
fluctuate suddenly and dramatically. In addition, technology- related markets are generally characterized by
abrupt business cycles and intense competition. Beginning in mid-2000, there was substantial excess production
capacity and a significant slowdown in many technology-related industries. This overcapacity, together with a
cyclical economic downturn, resulted in substantial decreases in the market capitalization of many technology-
related and life-science companies. While such valuations have recovered to some extent, such decreases in
market capitalization may occur again, and any future decreases in technology-related and life-science company
valuations may be substantial and may not be temporary in nature. Therefore, our portfolio companies may face
considerably more risk of loss than do companies in other industry sectors.

36

Because of rapid technological change, the average selling prices of products and some services provided by
technology-related and life-science companies have historically decreased over their productive lives. As a result,
the average selling prices of products and services offered by technology-related and life-science companies may
decrease over time, which could adversely affect their operating results, their ability to meet obligations under
their debt securities and the value of their equity securities. This could, in turn, materially adversely affect our
business, financial condition and results of operations.

We have invested in and may continue investing in technology-related and life-science companies that do
not have venture capital or private equity firms as equity investors, and these companies may entail a higher
risk of loss than do companies with institutional equity investors, which could increase the risk of loss of
your investment.

Our portfolio companies will often require substantial additional equity financing to satisfy their continuing
working capital and other cash requirements and, in most instances, to service the interest and principal payments
on our investment. Portfolio companies that do not have venture capital or private equity investors may be unable
to raise any additional capital to satisfy their obligations or to raise sufficient additional capital to reach the next
stage of development. Portfolio companies that do not have venture capital or private equity investors may be
less financially sophisticated and may not have access to independent members to serve on their boards, which
means that they may be less successful than portfolio companies sponsored by venture capital or private equity
firms. Accordingly, financing these types of companies may entail a higher risk of loss than would financing
companies that are sponsored by venture capital or private equity firms.

Economic recessions or downturns could impair the ability of our portfolio companies to repay loans,
which, in turn, could increase our non-performing assets, decrease the value of our portfolio, reduce our
volume of new loans, and harm our operating results, which might have an adverse effect on our results of
operations.

Many of our portfolio companies may be susceptible to economic slowdowns or recessions and may be
unable to repay our loans during such periods. Therefore, our non-performing assets are likely to increase and the
value of our portfolio is likely to decrease during such periods. Adverse economic conditions also may decrease
the value of collateral securing some of our loans and the value of our equity investments. Economic slowdowns
or recessions could lead to financial losses in our portfolio and a decrease in revenues, net income, and assets.
Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets,
or result in a decision by lenders not to extend credit to us.

A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders

could lead to defaults and, potentially, termination of the portfolio company’s loans and foreclosure on its
secured assets, which could trigger cross-defaults under other agreements and jeopardize the portfolio company’s
ability to meet its obligations under the debt securities that we hold. We may incur expenses to the extent
necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company. In
addition, if a portfolio company goes bankrupt, even though we may have structured our investment as senior
debt or secured debt, depending on the facts and circumstances, including the extent to which we actually
provided significant “managerial assistance,” if any, to that portfolio company, a bankruptcy court might
re-characterize our debt holding and subordinate all or a portion of our claim to that of other creditors. These
events could harm our financial condition and operating results.

The inability of our portfolio companies to commercialize their technologies or create or develop
commercially viable products or businesses would have a negative impact on our investment returns.

The possibility that our portfolio companies will not be able to commercialize their technology, products or

business concepts presents significant risks to the value of our investment. Additionally, although some of our
portfolio companies may already have a commercially successful product or product line when we invest,

37

technology-related and life-science products and services often have a more limited market- or life -span than
have products in other industries. Thus, the ultimate success of these companies often depends on their ability to
continually innovate, or raise additional capital, in increasingly competitive markets. Their inability to do so
could affect our investment return. In addition, the intellectual property held by our portfolio companies often
represents a substantial portion of the collateral, if any, securing our investments. We cannot assure you that any
of our portfolio companies will successfully acquire or develop any new technologies, or that the intellectual
property the companies currently hold will remain viable. Even if our portfolio companies are able to develop
commercially viable products, the market for new products and services is highly competitive and rapidly
changing. Neither our portfolio companies nor we have any control over the pace of technology development.
Commercial success is difficult to predict, and the marketing efforts of our portfolio companies may not be
successful.

An investment strategy focused primarily on privately-held companies presents certain challenges,
including the lack of available information about these companies, a dependence on the talents and efforts
of only a few key portfolio company personnel, and a greater vulnerability to economic downturns.

We invest primarily in privately-held companies. Generally, very little public information exists about these
companies, and we are required to rely on the ability of our management team to obtain adequate information to
evaluate the potential returns from investing in these companies. If we are unable to uncover all material
information about these companies, then we may not make a fully informed investment decision, and we may
lose money on our investments. Also, privately-held companies frequently have less diverse product lines and a
smaller market presence than do larger competitors. Privately-held companies are, thus, generally more
vulnerable to economic downturns and may experience more substantial variations in operating results than do
larger competitors. These factors could affect our investment returns.

In addition, our success depends, in large part, upon the abilities of the key management personnel of our

portfolio companies, who are responsible for the day-to-day operations of our portfolio companies. Competition
for qualified personnel is intense at any stage of a company’s development, and high turnover of personnel is
common in technology-related companies. The loss of one or more key managers can hinder or delay a
company’s implementation of its business plan and harm its financial condition. Our portfolio companies may
not be able to attract and retain qualified managers and personnel. Any inability to do so may negatively impact
our investment returns.

If our portfolio companies are unable to protect their intellectual property rights, then our business and
prospects could be harmed. If our portfolio companies are required to devote significant resources to
protecting their intellectual property rights, then the value of our investment could be reduced.

Our future success and competitive position depend in part upon the ability of our portfolio companies to

obtain and maintain proprietary technology used in their products and services, which will often represent a
significant portion of the collateral, if any, securing our investment. The portfolio companies will rely, in part, on
patent, trade secret, and trademark law to protect that technology, but competitors may misappropriate their
intellectual property, and disputes as to ownership of intellectual property may arise. Portfolio companies may,
from time to time, be required to institute litigation in order to enforce their patents, copyrights, or other
intellectual property rights, to protect their trade secrets, to determine the validity and scope of the proprietary
rights of others, or to defend against claims of infringement. Such litigation could result in substantial costs and
diversion of resources. Similarly, if a portfolio company is found to infringe upon or misappropriate a third
party’s patent or other proprietary rights, that portfolio company could be required to pay damages to such third
party, alter its own products or processes, obtain a license from the third party, and/or cease activities utilizing
such proprietary rights, including making or selling products utilizing such proprietary rights. Any of the
foregoing events could negatively affect both the portfolio company’s ability to service our debt investment and
the value of any related debt and equity securities that we own, as well as any collateral securing our investment.

38

Some of our portfolio companies may need additional capital, which may not be readily available.

Our portfolio companies will often require substantial additional equity financing to satisfy their continuing

working capital and other requirements, and in most instances to service the interest and principal payments on
our investment. Each round of venture financing is typically intended to provide a company with only enough
capital to reach the next stage of development. We cannot predict the circumstances or market conditions under
which our portfolio companies will seek additional capital. It is possible that one or more of our portfolio
companies will not be able to raise additional financing or may be able to do so only at a price or on terms
unfavorable to us, either of which would negatively impact our investment returns. Some of these companies
may be unable to obtain sufficient financing from private investors, public capital markets, or traditional lenders.
Accordingly, financing these types of companies may entail a higher risk of loss than would financing companies
that are able to utilize traditional credit sources.

If our investments do not meet our performance expectations, you may not receive distributions.

We intend to make distributions on a quarterly basis to our stockholders. We may not be able to achieve
operating results that will allow us to make distributions at a specific level or to increase the amount of these
distributions from time to time. In addition, due to the asset coverage test applicable to us as a business
development company, we may be limited in our ability to make distributions. See “Regulation.” Also,
restrictions and provisions in any future credit facilities may limit our ability to make distributions. If and when
we qualify as a RIC, if we do not distribute a certain percentage of our income annually, we will suffer adverse
tax consequences, including failure to obtain, or possible loss of, the federal income tax benefits allowable to
RICs. See “Certain United States Federal Income Tax Considerations—Taxation as a Regulated Investment
Company.” We cannot assure you that you will receive distributions at a particular level or at all.

Any unrealized depreciation that we experience on our loan portfolio may be an indication of future
realized losses, which could reduce our income available for distribution.

As a business development company, we are required to carry our investments at market value or, if no

market value is ascertainable, at the fair value as determined in good faith by our Board of Directors in
accordance with procedures approved by our Board of Directors. Decreases in the market values or fair values of
our investments will be recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio
could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to
the affected loans. This could result in realized losses in the future and ultimately in reductions of our income
available for distribution in future periods.

The lack of liquidity in our investments may adversely affect our business and, if we need to sell any of our
investments, we may not be able to do so at a favorable price. As a result, we may suffer losses.

We generally invest in debt securities with terms of up to seven years and hold such investments until

maturity, and we do not expect that our related holdings of equity securities will provide us with liquidity
opportunities in the near-term. We invest and expect to continue investing in companies whose securities are not
publicly traded and whose securities are and will be subject to legal and other restrictions on resale or whose
securities are and will be less liquid than are publicly-traded securities. The illiquidity of these investments may
make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a
portion of our portfolio quickly, we may realize significantly less than the value at which we had previously
recorded these investments. As a result, we do not expect to achieve liquidity in our investments in the near-term.
However, to maintain our qualification as a business development company and as a RIC, we may have to
dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory
frameworks. Our investments are usually subject to contractual or legal restrictions on resale, or are otherwise
illiquid, because there is usually no established trading market for such investments. The illiquidity of most of
our investments may make it difficult for us to dispose of the investments at a favorable price and, as a result, we
may suffer losses.

39

If the assets securing the loans that we make decrease in value, then we may lack sufficient collateral to
cover losses.

We believe that our portfolio companies generally will be able to repay our loans from their available
capital, from future capital-raising transactions, or from cash flow from operations. However, to attempt to
mitigate credit risks, we will typically take a security interest in the available assets of these portfolio companies,
including the equity interests of their subsidiaries and, in some cases, the equity interests of our portfolio
companies held by their stockholders. In many cases, our loans will include a period of interest-only payments.
There is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a
timely manner, may be difficult to appraise, and may fluctuate in value based upon the success of the business
and market conditions, including as a result of the inability of a portfolio company to raise additional capital. In
some circumstances, our lien could be subordinated to claims of other creditors. Additionally, a deterioration in a
portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be
accompanied by a deterioration in the value of the collateral for the loan. Moreover, in the case of some of our
structured mezzanine debt, we may not have a first lien position on the collateral. Consequently, the fact that a
loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s
terms, or that we will be able to collect on the loan should we be forced to enforce our remedies. In addition,
because we invest in technology-related companies, a substantial portion of the assets securing our investment
may be in the form of intellectual property, if any, inventory and equipment and, to a lesser extent, cash and
accounts receivable. Intellectual property, if any, that is securing our loan could lose value if, among other things,
the company’s rights to the intellectual property are challenged or if the company’s license to the intellectual
property is revoked or expires. Inventory may not be adequate to secure our loan if our valuation of the inventory
at the time that we made the loan was not accurate or if there is a reduction in the demand for the inventory.
Similarly, any equipment securing our loan may not provide us with the anticipated security if there are changes
in technology or advances in new equipment that render the particular equipment obsolete or of limited value, or
if the company fails to adequately maintain or repair the equipment. Any one or more of the preceding factors
could materially impair our ability to recover principal in a foreclosure.

Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such
companies.

We invest primarily in debt securities issued by our portfolio companies. In some cases portfolio companies

will be permitted to have other debt that ranks equally with, or senior to, the debt securities in which we invest.
Such debt instruments may provide that the holders thereof are entitled to receive payment of interest or principal
on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we
invest. Also, in the event of insolvency, liquidation, dissolution, reorganization, or bankruptcy of a portfolio
company, holders of debt instruments ranking senior to our investment in that portfolio company would typically
be entitled to receive payment in full before we receive any distribution in respect of our investment. After
repaying such senior creditors, such portfolio company might not have any remaining assets to use for repaying
its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to
share on a pari passu basis any distributions with other creditors holding such debt in the event of an insolvency,
liquidation, dissolution, reorganization, or bankruptcy. In addition, we would not be in a position to control any
portfolio company by investing in its debt securities. As a result, we are subject to the risk that a portfolio
company in which we invest may make business decisions with which we disagree and the management of such
companies, as representatives of the holders of their common equity, may take risks or otherwise act in ways that
do not best serve our interests as debt investors.

Our equity investments are highly speculative, and we may not realize gains from these investments. If our
equity investments do not generate gains, then the return on our invested capital will be lower than it would
otherwise be, which could result in a decline in the value of shares of our common stock.

When we invest in debt securities, we generally expect to acquire warrants or other equity securities as well.

Our goal is ultimately to dispose of these equity interests and realize gains upon disposition of such interests.

40

Over time, the gains that we realize on these equity interests may offset, to some extent, losses that we
experience on defaults under debt securities that we hold. However, the equity interests that we receive may not
appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our
equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient
to offset any other losses that we experience.

We do not control any of our portfolio companies and therefore our portfolio companies may make
decisions with which we disagree.

We do not control any of our portfolio companies, even though we may have board observation rights and

our debt agreements may contain certain restrictive covenants. As a result, we are subject to the risk that a
portfolio company in which we invest may make business decisions with which we disagree and the management
of such company, as representatives of the holders of their common equity, may take risks or otherwise act in
ways that do not serve our interests as debt investors.

Prepayments of our debt investments by our portfolio companies could adversely impact our results of
operations and reduce our return on equity.

We are subject to the risk that the investments we make in our portfolio companies may be repaid prior to
maturity. When this occurs, we will generally reinvest these proceeds in temporary investments, pending their
future investment in new portfolio companies. These temporary investments will typically have substantially
lower yields than the debt being prepaid and we could experience significant delays in reinvesting these amounts.
Any future investment in a new portfolio company may also be at lower yields than the debt that was repaid. As a
result, our results of operations could be materially adversely affected if one or more of our portfolio companies
elects to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity,
which could result in a decline in the market price of our common stock.

We may not realize gains from our equity investments.

When we invest in debt securities, we generally expect to acquire warrants or other equity securities as well.

However, the equity interests we receive may not appreciate in value and, in fact, may decline in value.
Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on
the disposition of any equity interests may not be sufficient to offset any other losses we experience.

Our common stock price may be volatile and may decrease substantially.

The trading price of our common stock and warrants following this offering may fluctuate substantially. The
price of the common stock and warrants that will prevail in the market after this offering may be higher or lower
than the price you paid and the liquidity of our common stock and warrants may be limited, in each case
depending on many factors, some of which are beyond our control and may not be directly related to our
operating performance. These factors include, but are not limited to, the following:

•

•

•

•

•

•

price and volume fluctuations in the overall stock market from time to time;

significant volatility in the market price and trading volume of securities of RICs, business development
companies or other financial services companies;

any inability to deploy or invest our capital;

fluctuations in interest rates;

any shortfall in revenue or net income or any increase in losses from levels expected by investors or
securities analysts;

operating performance of companies comparable to us;

41

•

•

•

•

•

•

•

•

changes in regulatory policies or tax guidelines with respect to RICs or business development
companies;

our not electing or losing RIC status;

actual or anticipated changes in our earnings or fluctuations in our operating results, or changes in the
expectations of securities analysts;

changes in the value of our portfolio of investments;

realized losses in investments in our portfolio companies;

general economic conditions and trends;

loss of a major funded source; or

departures of key personnel.

In the past, following periods of volatility in the market price of a company’s securities, securities class

action litigation has often been brought against that company. Due to the potential volatility of our stock price
and warrant price, we may be the target of securities litigation in the future. Securities litigation could result in
substantial costs and could divert management’s attention and resources from our business.

Investing in shares of our common stock or warrants may involve an above average degree of risk.

The investments we make in accordance with our investment objective may result in a higher amount of
risk, volatility or loss of principal than alternative investment options. Our investments in portfolio companies
may be highly speculative and aggressive, and therefore, an investment in our common stock, warrants, and
warrants shares may not be suitable for investors with lower risk tolerance.

Provisions of the Maryland General Corporation Law, and of our charter and bylaws, could deter takeover
attempts and have an adverse impact on the price of our common stock or warrants.

The Maryland General Corporation Law and our charter and bylaws contain provisions that may have the
effect of discouraging, delaying, or making difficult a change in control of our company or the removal of our
incumbent directors. We will be covered by the Business Combination Act of the Maryland General Corporation
Law to the extent that such statute is not superseded by applicable requirements of the 1940 Act. However, our
Board of Directors has adopted a resolution exempting from the Business Combination Act any business
combination between us and any person to the extent that such business combination receives the prior approval
of our board, including a majority of our directors who are not interested persons as defined in the 1940 Act. Our
Board of Directors has already adopted a resolution exempting from the Business Combination Act any business
combination between us and certain investment funds managed by JMP Asset Management, LLC and certain
investment funds managed by Farallon Capital Management, L.L.C., and we have agreed with such investment
funds that we will not alter or repeal such board resolution prior to the date that is two years after such
investment funds cease to own at least 10% of our outstanding common stock in a manner that would make the
Business Combination Act applicable to acquisitions of our stock by such investment funds without the written
consent of such investment funds. In addition, our bylaws contain a provision exempting from the Control Share
Acquisition Act any and all acquisitions by any person of shares of our stock. We have agreed with certain
investment funds managed by JMP Asset Management, LLC and certain investment funds managed by Farallon
Capital Management, L.L.C. that we will not repeal or amend such provision of our bylaws in a manner that
would make the Control Share Acquisition Act applicable to acquisitions of our stock by such investment funds
without the written consent of such investment funds prior to the date that is two years after such investment
funds cease to own at least 10% of our outstanding common stock. If the applicable board resolution is repealed
following such period of time or if our board does not otherwise approve a business combination, the Business
Combination Act and the Control Share Acquisition Act (if we amend our bylaws to be subject to that Act) may
discourage others from trying to acquire control of us and increase the difficulty of consummating any offer.

42

Under our charter, our Board of Directors is divided into three classes serving staggered terms, which will

make it more difficult for a hostile bidder to acquire control of us. In addition, our Board of Directors may,
without stockholder action, authorize the issuance of shares of stock in one or more classes or series, including
preferred stock. See “Description of Capital Stock.” Subject to compliance with the 1940 Act, our Board of
Directors may, without stockholder action, amend our charter to increase the number of shares of stock of any
class or series that we have authority to issue. The existence of these provisions, among others, may have a
negative impact on the price of our common stock and warrants and may discourage third party bids for
ownership of our company. These provisions may prevent any premiums being offered to you for shares of our
common stock or warrants.

Item 1B. Unresolved Staff Comments

Not applicable.

Item 2. Properties

Neither we nor any of our subsidiaries own any real estate or other physical properties materially important
to our operation or any of our subsidiaries. Currently, we lease approximately 4,400 square feet of office space in
Palo Alto, California for our corporate headquarters. We also lease office space in Boston, Massachusetts;
Boulder, Colorado; and Chicago, Illinois.

Item 3. Legal Proceedings

Hercules Technology Growth Capital, Inc. is not a party to any pending legal proceedings.

Item 4. Submission of Matters to a Vote of Security Holders

Not Applicable.

PART II

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of

Equity Securities

43

PRICE RANGE OF COMMON STOCK

Our common stock is traded on the NASDAQ National Market under the symbol “HTGC.” We completed

the initial public offer of our common stock in June 2005 at the price of $13.00 per share. Prior to such date there
was no public market for our common stock.

The following table sets forth the range of high and low closing prices of our common stock as reported on

the NASDAQ National Market and the dividends declared by us for each fiscal quarter since our initial public
offer. The stock quotations are interdealer quotations and do not include markups, markdowns or commissions.

Price Range

NAV(1)

High

Low

Premium
(Discount)
of High Sales
Price to NAV

Premium
(Discount)
of Low Sales
Price to NAV

2005

Second quarter (June 9, 2005 through

June 30, 2005) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Third quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fourth quarter

$11.55
$11.71
$11.67

$13.19
$14.41
$12.68

$12.45
$11.90
$ 9.71

114.2%
123.1%
108.7%

107.8%
101.6%
83.2%

(1) Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect
the net asset value per share on the date of the high and low sales prices. The net asset values shown are
based on outstanding shares at the end of each period.

The last reported price for our common stock on February 10, 2006 was $10.85 per share. As of

February 10, 2006, we had 1,237 stockholders of record.

Shares of business development companies may trade at a market price that is less than the value of the net
assets attributable to those shares. The possibility that our shares of common stock will trade at a discount from
net asset value or at premiums that are unsustainable over the long term are separate and distinct from the risk
that our net asset value will decrease. At times, our shares of common stock have traded at a premium to net asset
value and at times our shares of common stock have traded at a discount to the net assets attributable to those
shares.

SALES OF UNREGISTERED SECURITIES

We did not issue any unregistered shares during the three months ended December 31, 2005.

ISSUER PURCHASES OF EQUITY SECURITIES

We did not repurchase any shares of our common stock during the three months ended December 31, 2005.

DIVIDEND POLICY

If we qualify and elect to be a RIC, we intend to distribute quarterly dividends to our stockholders following
the effective date of such election. In order to avoid certain excise taxes imposed on RICs, we currently intend to
distribute during each calendar year an amount at least equal to the sum of (1) 98% of our ordinary income for
the calendar year, (2) 98% of our capital gains in excess of capital losses for the one year period ending on
October 31 of the calendar year, and (3) any ordinary income and net capital gains for the preceding year that
were not distributed during such year. We will not be subject to excise taxes on amounts on which we are
required to pay corporate income tax (such as retained net capital gains). In order to obtain the tax benefits

44

applicable to RICs, we will be required to distribute to our stockholders with respect to each taxable year at least
90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital
losses. We currently intend to retain for investment realized net long-term capital gains in excess of realized net
short-term capital losses. We generally intend to make deemed distributions to our stockholders of any retained
net capital gains. If this happens, you will be treated as if you received an actual distribution of the capital gains
we retain and then reinvested the net after-tax proceeds in our common stock. You also may be eligible to claim
a tax credit (or, in certain circumstances, a tax refund) equal to your allocable share of the tax we paid on the
capital gains deemed distributed to you. Please refer to “Certain United States Federal Income Tax
Considerations” for further information regarding the consequences of our retention of net capital gains. We
may, in the future, make actual distributions to our stockholders of some or all realized net long-term capital
gains in excess of realized net short-term capital losses. We can offer no assurance that we will achieve results
that will permit the payment of any cash distributions and, if we issue senior securities, we will be prohibited
from making distributions if doing so causes us to fail to maintain the asset coverage ratios stipulated by the 1940
Act or if distributions are limited by the terms of any of our borrowings. See “Regulation.”

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we

declare a dividend, cash dividends will be automatically reinvested in additional shares of our common stock
unless the stockholder specifically “opts out” of the dividend reinvestment plan and chooses to receive cash
dividends. See “Dividend Reinvestment Plan.”

Our ability to make distributions will be limited by the asset coverage requirements under the 1940 Act. For

a more detailed discussion, see “Regulation.”

The following table summarizes dividends declared and paid on all shares to date:

Date Declared

October 27, 2005
December 9, 2005

Record Date

Payment Date

November 1, 2005
January 6, 2006

November 17, 2005
January 27, 2006

Amount

$0.025
0.300

$0.325

45

Item 6. Selected Financial Data

Selected Consolidated Financial Data

The following consolidated financial data is derived from our audited consolidated financial statements.
The selected consolidated financial data should be read in conjunction with “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and
related notes included elsewhere herein. The historical data are not necessarily indicative of results to be
expected for any future period.

Statement of operations data:
Investment Income:
Interest
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses:

Interest
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loan fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Compensation and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
General and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation (2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net investment income (loss) before provision for income tax expense and

investment gains and losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net investment income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net realized gain on equity investment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net increase in unrealized appreciation on investments . . . . . . . . . . . . . . . .

Net gain on investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Year ended
December 31,
2005(1)

Period from
February 2, 2004 to
December 31,
2004(1)

$

9,791,214
875,429

10,666,643

$

214,100
—

214,100

1,800,536
1,098,507
3,705,784
2,285,038
252,000

9,141,865

1,524,778
(255,000)

1,269,778
481,694
353,093

834,787

—
—
1,164,504
411,418
680,000

2,255,922

(2,041,822)

—

(2,041,822)

—
—

—

Change in net assets resulting from operations . . . . . . . . . . . . . . . . . . . . . . .

$

2,104,565

$ (2,041,822)

As of
December 31, 2005

As of
December 31, 2004

Balance sheet data:
Investments at value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Other Data:
Total debt investments, at value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total equity investments, at value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unfunded commitments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net asset value per share (3)

$176,673,226
15,362,447
193,647,879
79,295,549
$114,352,330

$171,805,963
4,867,263
30,200,000
11.67

$

$16,700,000
8,678,329
25,232,672
154,539
$25,078,133

$16,700,000
—
5,000,000
12.18

$

(1) We commenced operations on February 2, 2004 but did not commence investment operations until September 2004 and as a result, there
is no period with which to compare our results of operations for the year ended December 31, 2005 or the period from February 2, 2004
to December 31, 2004.

(2) Non-cash expense under FAS 123R relates to options and warrants granted to employees.
(3) Based on common shares outstanding at period-end.

46

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS; MARKET DATA

The matters discussed in this report, as well as in future oral and written statements by management of
Hercules Technology Growth Capital, that are forward-looking statements are based on current management
expectations that involve substantial risks and uncertainties which could cause actual results to differ materially
from the results expressed in, or implied by, these forward-looking statements. Forward-looking statements relate
to future events or our future financial performance. We generally identify forward-looking statements by
terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,”
“projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these
terms or other similar words. Important assumptions include our ability to originate new investments, achieve
certain margins and levels of profitability, the availability of additional capital, and the ability to maintain certain
debt to asset ratios. In light of these and other uncertainties, the inclusion of a projection or forward-looking
statement in this report should not be regarded as a representation by us that our plans or objectives will be
achieved. The forward-looking statements contained in this report include statements as to:

•

•

•

•

•

•

•

•

•

•

•

our future operating results;

our business prospects and the prospects of our prospective portfolio companies;

the impact of investments that we expect to make;

our informal relationships with third parties;

the dependence of our future success on the general economy and its impact on the industries in which
we invest;

the ability of our portfolio companies to achieve their objectives;

our expected financings and investments;

our regulatory structure and tax status;

our ability to operate as a business development company and a regulated investment company;

the adequacy of our cash resources and working capital; and

the timing of cash flows, if any, from the operations of our portfolio companies.

For a discussion of factors that could cause our actual results to differ from forward-looking statements
contained in this report, please see the discussion under “Risk Factors”. You should not place undue reliance on
these forward-looking statements. The forward-looking statements made in this report relate only to events as of
the date on which the statements are made. We undertake no obligation to update any forward-looking statement
to reflect events or circumstances occurring after the date of this report.

47

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and

related notes and other financial information appearing elsewhere in this report. In addition to historical
information, the following discussion and other parts of this report contain forward-looking information that
involves risks and uncertainties. Our actual results could differ materially from those anticipated by such
forward-looking information due to the factors discussed under “Risk Factors,” “Forward-Looking Statements;
Market Data” appearing elsewhere herein.

Overview

We are a specialty finance company that provides debt and equity growth capital to technology-related
companies at all stages of development. We primarily finance privately-held companies backed by leading
venture capital and private equity firms and also may finance certain publicly-traded companies. We originate
our investments through our principal office located in Silicon Valley, as well as our additional offices in the
Boston, Boulder and Chicago areas. Our goal is to be the leading structured mezzanine capital provider of choice
for venture capital and private equity backed technology-related companies requiring sophisticated and
customized financing solutions. We invest primarily in structured mezzanine debt and, to a lesser extent, in
senior debt and equity investments. We use the term “structured mezzanine debt investment” to refer to any debt
investment, such as a senior or subordinated secured loan, that is coupled with an equity component, including
warrants, options or rights to purchase common or preferred stock. Our structured mezzanine debt investments
will typically be secured by some or all of the assets of the portfolio company.

We are an internally managed, non-diversified closed-end investment company that has elected to be
regulated as a business development company under the 1940 Act. As a business development company, we are
required to comply with certain regulatory requirements. For instance, we generally have to invest at least 70%
of our total assets in “qualifying assets,” including securities of private U.S. companies, cash, cash equivalents,
U.S. government securities and high-quality debt investments that mature in one year or less.

From incorporation through December 31, 2005, we were taxed as a corporation under Subchapter C of the
Code. We intend to seek to be treated for federal income tax purposes as a RIC under Subchapter M of the Code
as of January 1, 2006. To qualify for the benefits allowable to a RIC, we must, among other things, meet certain
source-of-income and asset diversification and income distribution requirements. Pursuant to this election, we
generally will not have to pay corporate-level taxes on any income that we distribute to our stockholders.
However, such an election and qualification to be treated as a RIC requires that we comply with certain
requirements contained in Subchapter M of the Code that may affect our ability to pursue additional business
opportunities or strategies which, if we were to determine we should pursue such strategies, may diminish the
desirability of or impede our ability to qualify as a RIC. For example, a RIC must meet certain requirements,
including source-of-income, asset diversification and income distribution requirements. The income source
requirement mandates that we receive 90% or more of our income from qualified earnings, typically referred to
as “good income.” Qualified earnings may exclude such income as management fees received in connection with
our SBIC or other potential outside managed funds and certain other fees. As of the date of this report, we cannot
determine the probability that during 2006 we will qualify as RIC when we file our 2006 federal tax return. See
“Certain United States Federal Tax Considerations—Taxation as a Regulated Investment Company.”

Portfolio and Investment Activity

We commenced investment operations in September 2004 and entered into our first debt investment in

November 2004. The total value of our investment portfolio was $176.7 million at December 31, 2005 as
compared to $16.7 million at December 31, 2004. The increase in investments was due to newly originated debt
and equity investments in 2005. During 2005, we made debt investments in 28 new portfolio companies totaling
$175.3 million, including two companies that fully repaid outstanding loans totaling $12.5 million, as compared
to debt investments in five portfolio companies totaling $16.7 million in 2004. We also made equity investments

48

in six portfolio companies in 2005 totaling $3.5 million, including $1.0 million of debt converted into equity. In
addition, we exercised a warrant in one public company bringing total equity investments at fair value to
approximately $4.9 million at December 31, 2005. At December 31, 2005 we have unfunded contractual
commitments of $30.2 million to six portfolio companies.

Total portfolio investment activity (exclusive of unearned income) as of and for the periods ended

December 31, 2005 and 2004 was as follows:

($ in millions)

Year Ended
December 31,
2005

Period Ended
December 31,
2004

Beginning portfolio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loan originations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equity investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross payments/Reductions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Early pay-offs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accretion of loan discounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrealized appreciation in investments . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrealized depreciation in investments . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ending portfolio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 16.7
175.3
2.5
(6.3)
(12.5)
0.4
4.0
(3.4)

$176.7

$ —
16.7
—
—
—
—
—
—

$16.7

The following table shows the fair value of our portfolio of investments by asset class as of December 31,

2005 and 2004 (excluding unearned income):

($ in millions)

Investments at Fair Value

Percentage of Total
Portfolio

Investments at Fair Value

Percentage of Total
Portfolio

Year Ended
December 31, 2005

Period Ended
December 31, 2004

Senior debt with

warrants . . . . . . . . . . . .
Subordinated debt . . . . . .
Preferred stock . . . . . . . .
Common stock . . . . . . . .

$163.4
8.4
3.5
1.4

$176.7

92.4%
4.8%
2.0%
0.8%

100.0%

$12.7
4.0
—
—

$16.7

76.0%
24.0%
—
—

100.0%

The following table shows the fair value of our portfolio by industry sector at December 31, 2005 and 2004

(excluding unearned income):

($ in millions)

Investments at Fair Value

Percentage of Total
Portfolio

Investments at Fair Value

Percentage of Total
Portfolio

Year Ended
December 31, 2005

Period Ended
December 31, 2004

Biopharmaceuticals . . . . .
Software . . . . . . . . . . . . .
Consumer & business

products . . . . . . . . . . . .

Communications &

networking . . . . . . . . . .
Medical devices . . . . . . . .
Internet & computer

services . . . . . . . . . . . .

Electronics & computer

hardware . . . . . . . . . . .
Semiconductors . . . . . . . .

$ 43.6
29.0

19.8

32.5
14.8

8.7

17.8
10.5
$176.7

24.7%
16.4%

11.2%

18.4%
8.4%

4.9%

10.1%
5.9%
100.0%

49

$ —
12.0

1.7

3.0
—

—

—
—
$16.7

—
71.8%

10.2%

18.0%
—

—

—
—
100.0%

We use an investment grading system, which grades each investment on a scale of 1 to 5, to characterize and

monitor our expected level of returns on both the debt investments and related warrants or equity positions for
each investment in our portfolio. See “Business—Investment Process—Loan and Compliance Administration.”
The following table shows the distribution of our outstanding debt investments on the 1 to 5 investment grading
scale at fair value as of December 31, 2005 and 2004:

($ in millions)

Investments at Fair Value

Percentage of Total
Portfolio

Investments at Fair Value

Percentage of Total
Portfolio

December 31, 2005

December 31, 2004

Investment Grading

1
2
3
4
5

$

9.9
150.3
5.8
4.5
1.3(1)

$171.8

5.8%

87.4
3.4
2.7
0.7

100.0%

$12.7
—
4.0
—

$16.7

76.0%
—
24.0
—
—

100.00%

(1) Reflects the value of the assets of this portfolio company that were sold in January 2006 for which we received approximately $1.3
million in cash distributions. We received an additional contingent payment of approximately $239,000 in February 2006. We may
receive approximately $700,000 of future distributions related to this sale but such distributions are contingent on future deliverables.

As of December 31, 2005, our investments had a weighted average investment grading of 2.05.

At December 31, 2005, the weighted average yield to maturity of our loan obligations was approximately

12.87%. Yields to maturity are computed using interest rates as of December 31, 2005 and include amortization
of loan facility fees, original issue discounts, commitment fees and market premiums or discounts over the
expected life of the debt investments, weighted by their respective costs when averaged and are based on the
assumption that all contractual loan commitments have been fully funded.

We generate revenue in the form of interest income, primarily from our investments in debt securities,
and commitment and facility fees. Fees generated in connection with our debt investments are recognized over
the life of the loan or, in some cases, recognized as earned. In addition, we generate revenue in the form of
capital gains, if any, on warrants or other equity-related securities that we acquire from our portfolio
companies. Our investments generally range from $1.0 million to $20.0 million, with an average initial
principal balance of between $3.0 million and $7.0 million. Our debt investments have a term of between two
and seven years and typically bear interest at a rate ranging from 8.0% to 14.0% (based on current interest rate
conditions). In addition to the cash yields received on our loans, in some instances, our loans may also include
any of the following: end-of-term payments, exit fees, balloon payment fees, or prepayment fees, and
diligence fees, which may be required to be included in income prior to receipt. In some cases, we
collateralize our investments by obtaining security interests in our portfolio companies’ assets, which may
include their intellectual property. In other cases, we may obtain a negative pledge covering a company’s
intellectual property. Interest on debt securities is generally payable monthly, with amortization of principal
typically occurring over the term of the security for emerging-growth and expansion-stage companies. In
addition, certain loans may include an interest-only period ranging from three to six months. In limited
instances in which we choose to defer amortization of the loan for a period of time from the date of the initial
investment, the principal amount of the debt securities and any accrued but unpaid interest become due at the
maturity date. Our mezzanine debt investments also generally have equity enhancement features, typically in
the form of warrants or other equity-related securities designed to provide us with an opportunity for capital
appreciation.

Results of Operations

We commenced operations on February 2, 2004 but did not commence investment activities until September

2004. As a result, the period from February 2, 2004 to December 31, 2004 is not comparable to the period from

50

January 1, 2005 to December 31, 2005 and is not indicative of the results to be expected for any future period.
Except as noted, references to 2004 refer to the period from February 2, 2004 to December 31, 2004 and
references to 2005 refer to the twelve month period ended December 31, 2005.

For the periods ended December 31, 2005 and 2004

Operating Income

Interest income totaled approximately $9.8 million and $214,000 for 2005 and 2004, respectively. In 2005,
interest income included approximately $351,000 of revenue from accrued exit fees. Income from commitment
and facility fees totaled approximately $875,000 and $0 for 2005 and 2004, respectively. The increases are the
result of origination activity and yield from investments. At December 31, 2005, we had approximately $2.7
million of deferred revenue related to commitment and facility fees. We expect to generate additional interest
income and loan commitment fees as we continue to originate additional investments.

Operating Expenses

Operating expenses totaled approximately $9.1 million and $2.3 million during 2005 and 2004, respectively.
Operating expenses for 2005 included interest expense, loan fees and unused commitment fees under our Bridge
Loan Credit Facility and the Citigroup Facility of approximately $2.9 million. There were no interest or loan fees
in 2004. Employee compensation and benefits were approximately $3.7 million and $1.2 million during 2005 and
2004, respectively. The increase in employee compensation and benefits is due to increased number of
employees from 11 to 19 and bonuses of approximately $1.3 million paid in 2005. General and administrative
expenses increased to $2.3 million from $411,000 in 2004 primarily due to increased legal expenses, professional
service costs related to our status as a public company and the creation of our SBIC subsidiaries as well as
increased business development expenses. In addition, we incurred approximately $252,000 of stock-based
compensation expense in 2005 as compared to $680,000 in 2004. The decrease in stock-based compensation
expense was due to the immediate vesting of certain options granted in 2004. We anticipate that operating
expenses will increase over the next twelve months as we continue to incur higher interest expense on higher
average outstanding debt balances, increase the number of our employees to support our growth and incur
additional expenses related to being a public company, including expenses related to the implementation of the
requirements under Sarbanes-Oxley Act.

Net Investment Income (Loss) Before Income Tax Expense and Investment Gains and Losses

Net investment income before income tax expense for the year ended December 31, 2005 totaled $1.5

million as compared with a net investment loss before income tax expense in 2004 of approximately $2.0
million. This change is made up of the items described above.

Net Investment Gains

For the period ended December 31, 2005, net unrealized investment appreciation totaled approximately
$353,000. The net unrealized appreciation and depreciation of investments is based on portfolio asset valuations
determined in good faith by our Board of Directors, based on the recommendations of the Valuation Committee
of our Board of Directors. For the year ended December 31, 2005, we recognized approximately $4.1 million of
gross unrealized appreciation on 14 of our portfolio investment companies and approximately $3.4 million of
gross unrealized depreciation on 15 of our portfolio investment companies. See “—Recent Developments.”
Approximately $3.3 million of the unrealized depreciation was due to a reduction in the fair value of one
portfolio company. The net unrealized investment gains recognized by the company were reduced by
approximately $342,000 for a warrant participation agreement with Citigroup. We generated a net realized gain
totaling approximately $482,000 from the sale of common stock of one biopharmaceutical portfolio company.
We did not recognize any realized or unrealized gains or losses during the period ended December 31, 2004.

51

Income Taxes

We are taxed under Subchapter C of the Internal Revenue Code and therefore are subject to corporate-level

federal and state income tax.

We account for income taxes in accordance with the provisions of Financial Accounting Standards No. 109,
Accounting for Income Taxes, which requires that deferred income taxes be determined based upon the estimated
future tax effects of differences between the financial statement and tax basis of assets and liabilities given the
provisions of the enacted tax law. Valuation allowances are used to reduce deferred tax assets to the amount
likely to be realized.

We intend to seek to be treated as a RIC under Subchapter M of the Code for 2006. However, such an
election and qualification to be treated as a RIC requires that we comply with certain requirements contained in
Subchapter M of the Code that may affect our ability to pursue additional business opportunities or strategies
which, if we were to determine we should pursue such strategies, may diminish the desirability of or impede our
ability to qualify as a RIC. For example, a RIC must meet certain requirements, including source-of-income,
asset diversification and income distribution requirements. The income source requirement mandates that we
receive 90% or more of our income from qualified earnings, typically referred to as “good income.” Qualified
earnings may exclude such income as management fees received in connection with our SBIC or other potential
outside managed funds and certain other fees. As of the date of this report, we cannot determine the probability
that during 2006 we will qualify as RIC when we file our 2006 federal tax return. See “Certain United States
Federal Tax Considerations—Taxation as a Regulated Investment Company.”

As such, we have elected to report our financial position and results of operations under Subchapter C of the

Code until such time as we can reasonably ascertain that we will meet the required qualifications as a RIC. As a
C corporation, we will accrue income tax expense on a quarterly basis until we are able to reasonably determine
that we will qualify as a RIC under requirements contained in Subchapter M of the Code. If and when, during
2006, we are able to reasonably determine that we can qualify as a RIC, we would reverse any income tax
expense recorded during 2006 and charge to income tax expense the $1.4 million deferred tax asset on the our
balance sheet at December 31, 2005. If we had been able to make the determination as of December 31, 2005, the
impact of charging the deferred tax to operations would have reduced our NAV by approximately $0.15 per
share.

Net Increase in Net Assets Resulting from Operations and Earnings Per Share

For the year ended December 31, 2005 net income totaled approximately $2.1 million compared to a net

loss of approximately $2.0 million for the period ended December 31, 2004. These changes are made up of the
items previously described.

Basic and diluted net income per share for the year ended December 31, 2005 was $0.30 as compared to a

basic loss per share of $1.72 and diluted loss per share of $1.58 for the period ended December 31, 2004. The net
income per share for 2005 was affected by an increase in the number of average shares outstanding in 2005 as
compared to 2004 of approximately 5.9 million shares and 5.7 million shares on a basic and diluted basis,
respectively.

Financial Condition, Liquidity and Capital Resources

We were initially capitalized with approximately $2.6 million in proceeds from the sale of preferred stock in

February 2004. In June 2004, we completed an additional private placement offering of 904,635 units at a price
of approximately $30.00 per unit. Each unit consisted of two shares of our common stock and two warrants to
purchase one share of our common stock at a price of $15.00 per share. All of our then outstanding preferred
stock was exchanged for units concurrent with the closing of our private offering in June 2004. We received

52

approximately $23.9 million in total net proceeds from the June 2004 private offering, net of placement fees and
other offering-related costs. In February 2005, warrants to purchase 1,175,963 shares of our common stock were
exercised, generating proceeds to us of approximately $12.4 million.

In June 2005, we completed our initial public offering of 6,000,000 shares of our common stock at a price of

$13.00 per share resulting in net proceeds to us of approximately $70.9 million after deducting offering costs.

On September 7, 2005, we registered 3,801,905 shares of common stock and 673,223 5-year warrants
pursuant to its obligations under a registration rights agreement between Hercules and certain shareholders. Prior
to registration, these shares of common stock and warrants were restricted within the meaning of the Securities
Act of 1933. We did not receive any proceeds from the registration of these securities.

For 2005, net cash used in operating activities totaled $156.7 million as compared to $17.7 million in 2004.

This increase was due primarily to $177.8 million used for investments in our portfolio company’s, offset by
approximately $18.8 million in principal repayments, as compared to $16.7 million of investments in our
portfolio company’s in 2004. Cash provided by investing activities in 2005 totaled $447,000 and was primarily
due to proceeds of approximately $531,000 from the sale of common stock in one portfolio company offset by
purchases of capital assets and other long-term assets of $84,000. We used $43,000 of cash in investing activities
in 2004 that was primarily related to purchases of capital equipment. Net cash provided by financing activities
totaled $162.9 million in 2005 as compared to $26.4 million in 2004. In 2005, we received $87.2 million in
proceeds from the sale of common stock and $76.0 million from borrowings under our credit facilities, offset by
a dividend payment of $245,000. In 2004 we received approximately $26.4 million from the sale of preferred and
common stock.

As of December 31, 2005, net assets totaled $114.4 million, with a net asset value per share of $11.67, and

we had approximately $15.4 million in cash and cash equivalents. We intend to generate additional cash
primarily from future borrowings as well as cash flows from operations, including income earned from
investments in our portfolio companies and, to a lesser extent, from the temporary investment of cash in U.S.
government securities and other high-quality debt investments that mature in one year or less. Our primary use of
funds will be investments in portfolio companies and cash distributions to holders of our common stock. After
we have used our current capital resources, we expect to raise additional capital to support our future growth
through future equity offerings, issuances of senior securities and/or future borrowings, to the extent permitted by
the 1940 Act.

As defined under the 1940 Act, our asset coverage must be at least 200% after each issuance of senior

securities. Our asset coverage as of December 31, 2005 was approximately 250%.

We anticipate that we will continue to fund our investment activities through a combination of debt and
additional equity capital over the next year. As of December 31, 2005, based on eligible loans in the investment
portfolio and existing advance rates, we had approximately $19.0 million of borrowing capacity available under
our existing $100 million securitized credit facility from Citigroup. As additional new loans are originated and
funded, we will be able to increase our borrowing capacity under the Citigroup Facility beyond the current $19.0
million. Advances under the facility bear interest at one-month LIBOR plus 165 basis points. There was $51
million outstanding under the Citigroup Facility as of December 31, 2005. We anticipate that portfolio fundings
entered into in succeeding periods will allow us to utilize the full borrowing capacity of the Citigroup Facility.
We expect to issue additional equity or debt securities within the next two quarters to continue to fund our
investing activities.

On January 19, 2006, we filed a registration statement to sell approximately 3.3 million shares of our
common stock with estimated net proceeds to the company of approximately $34 million. In addition, we
amended our Citigroup Facility agreement to increase the borrowing capacity from $100.0 million to $125.0
million. We believe these funding sources will allow us to continue investing activities for 3 to 6 months. In

53

order to fund new originations, we intend to pursue additional equity financings and additional borrowing
facilities.

Off Balance Sheet Arrangements

In the normal course of business, we are party to financial instruments with off-balance sheet risk. These
consist primarily of unfunded commitments to extend credit, in the form of loans, to our portfolio companies.
Unfunded commitments to provide funds to portfolio companies will not be reflected on our balance sheet. Our
unfunded commitments may be significant from time to time. As of December 31, 2005, we had unfunded
commitments of approximately $30.2 million. These commitments will be subject to the same underwriting and
ongoing portfolio maintenance as are the on-balance sheet financial instruments that we hold. Since these
commitments may expire without being drawn upon, the total commitment amount does not necessarily represent
future cash requirements.

Contractual Obligations

The following table shows our contractual obligations as of December 31, 2005:

Payments due by period
(dollars in thousands)

Contractual Obligations(1)

Total

Borrowings(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating lease obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$76,000
244

Less than
1 year

$25,000
244

1-3 years

4-5 years

After
5 Years

$51,000 —
—

—

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$76,244

$25,244

$51,000 —

—
—

—

(1) Excludes commitments to extend credit to our portfolio companies.
(2) Borrowings under our Citigroup credit facility are listed based on the contractual maturity of the credit facility. Actual repayments could

differ significantly due to prepayments by our existing portfolio companies, modifications of our current agreements with our existing
portfolio companies and modification of the credit facility. See “Recent Developments.”

Borrowings

In April 2005, we entered into a bridge loan credit facility with Alcmene, a special purpose vehicle that is an

affiliate of Farallon Capital Management, L.L.C., a shareholder of Hercules, which we refer to as the Bridge
Loan Credit Facility. The Bridge Loan Credit Facility is a $25 million secured term loan, which provides for $25
million of available borrowings, all of which was drawn down on April 12, 2005. The Bridge Loan Credit
Facility allows for up to an additional $25 million of discretionary supplemental senior secured loans. See
“Obligations and Indebtedness.” All amounts outstanding under this credit facility were initially due and payable
on October 12, 2005.

On August 1, 2005, we amended our Bridge Loan Credit Facility with Alcmene Funding, LLC. The
amended agreement extended the term of the loan to April 12, 2006, eliminated the loan extension fee, revised
the interest rate effective August 1, 2005 to LIBOR plus 5.6% through December 31, 2005 and thereafter to
13.5% per annum, and amended certain collateral rights and financial covenants. At December 31, 2005, the
interest rate under the Bridge Loan Credit Facility was 9.76% per year. We had $25.0 million of outstanding
borrowings under the Bridge Loan Credit Facility at December 31, 2005.

On August 1, 2005, we, through Hercules Funding Trust I, our affiliated statutory trust, executed a $100
million securitized credit facility with Citigroup Global Markets Realty Corp., which we refer to as the Citigroup
Facility. Our ability to make draws on the Citigroup Facility expires on July 31, 2006 unless extended prior to
such date for an additional 364-day period with the lender’s consent. If the Citigroup Facility is not extended, any
principal amounts then outstanding will be amortized over a six-month period through a termination date in

54

January 2007. The Citigroup Facility is collateralized by loans from our portfolio companies, and includes an
advance rate of approximately 55% of eligible loans. Interest on borrowings under the Citigroup Facility will be
paid monthly and will be charged at one-month LIBOR plus a spread of 1.65%. We also paid a loan origination
fee equal to 0.25% of the Citigroup Facility and will be subject to an unused commitment fee of 0.50% until the
earlier of borrowing $50.0 million under the facility or February 1, 2006, and 0.25% thereafter. The Citigroup
Facility contains covenants that, among other things, require us to maintain a minimum net worth and to restrict
the loans securing the Citigroup Facility to certain dollar amounts, to concentrations in certain geographic
regions and industries, to certain loan grade classifications, to certain security interests and to certain interest
payment terms. There was $51.0 million of outstanding borrowings under the Citigroup Facility at December 31,
2005. We recently increased the size of our Citigroup Facility. See “Recent Developments.”

In addition, we expect to pursue additional debt financing from the Small Business Administration under its

Small Business Investment Company program. We may also seek to enter into an additional securitization
facility. See “Obligations and Indebtedness.”

There can be no assurance that we will be successful in obtaining any additional debt capital on terms
acceptable to us, or at all. If we are unable to obtain debt capital, then our equity investors will not benefit from
the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is
successful. While there can be no assurance that we will be able to borrow from banks or other financial
institutions, we expect that we will at some time in the future obtain additional securitized credit facilities. The
current lenders have and any future lender or lenders will have fixed dollar claims on our assets that are senior to
the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets.
In addition, we may grant a security interest in our assets in connection with any such borrowing. We expect such
a facility to contain customary default provisions such as a minimum net worth amount, a profitability test and a
restriction on changing our business and loan quality standards. An event of default under any credit facility
would likely result, among other things, in termination of the availability of further funds under that facility and
an accelerated maturity date for all amounts outstanding under the facility, which would likely disrupt our
business and, potentially, the business of the portfolio companies whose loans that we financed through the
facility. This could reduce our revenues and, by delaying any cash payment allowed to us under our facility until
the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business.
See “Obligations and Indebtedness.”

Distributions

On October 27, 2005, we declared our first dividend of $0.025 per common share for holders of record on
November 1, 2005. This dividend totaled approximately $245,000 and was distributed on November 17, 2005.
On December 9, 2005 we declared a dividend of $0.30 per share for stockholders of record on January 6, 2006.
The dividend totaled approximately $2.9 million and was distributed on January 27, 2006.

RIC Election

We intend to seek to be taxed as a RIC under Subchapter M of the Code for 2006. However, such an
election and qualification to be treated as a RIC requires that we comply with certain requirements contained in
Subchapter M of the Code that may affect our ability to pursue additional business opportunities or strategies
which, if we were to determine we should pursue, may diminish the desirability of or impede our ability to
qualify as a RIC. For example, in order to qualify as a RIC and obtain the tax benefits of such status, a
corporation must meet certain requirements, including a qualified source-of-income, asset diversification and
income distribution requirements. The income source requirement mandates that we receive 90% or more of our
income from qualified earnings, typically referred to as “good income.” Qualified earnings may exclude such
income as management fees received in connection with our SBIC or other potential outside managed funds and
certain other fees. As of the date of this report, we cannot determine the probability that during 2006 we will
qualify as RIC when we file our 2006 federal tax return.

55

As such, we have elected to report our financial position and results of operations under Subchapter C of the
Code until such time as we can reasonably ascertain that we will meet the required qualifications for a RIC. As a
C corporation, we will accrue income tax expense on a quarterly basis until we are able to reasonably determine
that we will qualify as a RIC under the requirements contained in Subchapter M of the Code. If and when, during
2006, we are able to reasonably determine that we can qualify as a RIC, we will reverse any income tax expense
recorded during 2006 and charge to income tax expense the $1.4 million deferred tax asset on our balance sheet
at December 31, 2005. If we had been able to make the determination as of December 31, 2005, the impact of
charging the deferred tax to operations would have reduced our NAV by approximately $0.15 per share.

As long as we qualify as a RIC, we will not be taxed on our “investment company taxable income” or
realized net capital gains, to the extent that such taxable income and gains are distributed to stockholders on a
timely basis. We may be required, however, to pay federal income taxes on any unrealized net built-in gains in
the assets held by us during the period in which we were not (or in which we failed to qualify as) a RIC that are
recognized within the following 10 years, unless we make a special election to pay corporate-level tax on such
built-in gains at the time of our RIC election or an exception applies. See “Certain United States Federal Income
Tax Considerations—Conversion to Regulated Investment Company Status.” Annual tax distributions generally
will differ from net income for the fiscal year due to temporary and permanent timing differences in the
recognition of income and expenses, returns of capital and net unrealized appreciation or depreciation, which are
not included in taxable income.

In order to qualify as a RIC under Subchapter M of the Code, and to avoid corporate level tax on any
distributed income, we must, in general, for each taxable year: (1) have in effect at all times during the taxable
year an election to be treated as a business development company, (2) derive at least 90% of our gross income
from dividends, interest, gains from the sale of securities and other specified types of income, (3) meet asset
diversification requirements as defined in the Code, and (4) distribute to stockholders at least 90% of our
investment company taxable income as set forth in the Code. In addition, prior to the end of our first taxable year
as a RIC, we must distribute to our stockholders all earnings and profits from periods prior to our qualification as
a RIC.

If we qualify and elect for tax treatment as a RIC, we intend to take the steps necessary to qualify for the
federal tax benefits allowable to RICs, including distributing annually to our stockholders at least 90% of our
ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses.
Unless a stockholder elects otherwise, these distributions will be reinvested in additional shares of our common
stock through our dividend reinvestment plan. While we are a RIC, we generally intend to retain any realized net
long-term capital gains in excess of realized net short-term capital losses and to elect to treat such net capital gain
as deemed distributions to our stockholders. We may, in the future, make actual distributions to our stockholders
of some or all of such net capital gains. See “Certain United States Federal Income Tax Considerations—
Taxation as a Regulated Investment Company” and “Dividend Reinvestment Plan.” There can be no assurance
that we will qualify for treatment as a RIC in 2006 or in any future years.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or

to increase the amount of these distributions from time to time. In addition, we may be limited in our ability to
make distributions due to (i) the asset coverage test for borrowings applicable to us as a business development
company under the 1940 Act and (ii) provisions in our future credit facilities, if any. If we do not distribute a
certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of
the federal income tax benefits allowable to a RIC. We cannot assure stockholders that they will receive any
distributions or distributions at any particular level.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the

United States requires management to make estimates and assumptions that affect the reported amounts of assets

56

and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and revenues
and expenses during the period reported. On an ongoing basis, our management evaluates its estimates and
assumptions, which are based on historical experience and on various other assumptions that we believe to be
reasonable under the circumstances. Actual results could differ from those estimates. Changes in our estimates
and assumptions could materially impact our results of operations and financial condition.

Valuation of Portfolio Investments. The most significant estimate inherent in the preparation of our

financial statements is the valuation of investments and the related amounts of unrealized appreciation and
depreciation of investments recorded.

As a business development company, we invest primarily in illiquid securities, including debt and equity-

related securities of private companies. Our investments are generally subject to restrictions on resale and
generally have no established trading market. Because of the type of investments that we make and the nature of
our business, our valuation process requires an analysis of various factors. Our valuation methodology includes
the examination of, among other things, the underlying investment performance, financial condition and market
changing events that impact valuation.

At December 31, 2005, approximately 91% of our total assets represented investments in portfolio
companies recorded at fair value. Value, as defined in Section 2(a) (41) of the 1940 Act, is (i) the market price
for those securities for which a market quotation is readily available and (ii) for all other securities and assets,
fair value is as determined in good faith by the Board of Directors. Since there is typically no readily available
market value for the investments in our portfolio, we value substantially all of our investments at fair value as
determined in good faith by our Board of Directors pursuant to a valuation policy and a consistent valuation
process. Due to the inherent uncertainty in determining the fair value of investments that do not have a readily
available market value, the fair value of our investments determined in good faith by our Board of Directors may
differ significantly from the value that would have been used had a ready market existed for such investments,
and the differences could be material.

There is no single standard for determining fair value in good faith. As a result, determining fair value

requires that judgment be applied to the specific facts and circumstances of each portfolio investment. Unlike
banks, we are not permitted to provide a general reserve for anticipated loan losses. Instead, we must determine
the fair value of each individual investment on a quarterly basis. We will record unrealized depreciation on
investments when we believe that an investment has decreased in value, including where collection of a loan or
realization of an equity security is doubtful. Conversely, where appropriate, we will record unrealized
appreciation if we believe that the underlying portfolio company has appreciated in value and, therefore, that our
investment has also appreciated in value.

With respect to private debt and equity securities, each investment is valued using industry valuation

benchmarks and, where appropriate, the value is assigned a discount reflecting the illiquid nature of the
investment, and our minority, non-control position. When a qualifying external event such as a significant
purchase transaction, public offering, or subsequent debt or equity sale occurs, the pricing indicated by the
external event will be used to corroborate our private debt or equity valuation.

Interest Income. Interest income is recorded on the accrual basis to the extent that such amounts are

expected to be collected. Original issue discounts are amortized into interest income as adjustments to the related
loan’s yield over the contractual life of the loan. We stop accruing interest on our investments when it is
determined that interest is no longer collectible.

Fee Income. Fee income includes loan commitment and facility fees for due diligence and structuring, as
well as fees for transaction services and management services rendered by us to portfolio companies and other
third parties. These fees are generally recognized as income over the life of the loan or when the services are
rendered.

57

Stock-Based Compensation. We have issued and may, from time to time, issue additional stock options to
employees under our 2004 Equity Incentive Plan. We follow Financial Accounting Standards No. 123 (revised
2004), Share-Based Payments (“FAS 123R”), to account for stock options granted. Under FAS 123R,
compensation expense associated with stock-based compensation is measured at the grant date based on the fair
value of the award and is recognized over the vesting period. Determining the appropriate fair value model and
calculating the fair value of stock-based awards at the grant date requires judgment, including estimating stock
price volatility forfeitures and expected option life.

Recent Developments

At December 31, 2005, we reduced the fair value of an investment in one portfolio company by

approximately $3.3 million to the expected realizable fair value of $1.3 million. In January 2006, the principle
assets of the portfolio company were sold, and we received a cash distribution of approximately $1.3 million. On
February 6, 2006, we received an additional contingent cash distribution of $239,000 which will be accounted for
as a loss recovery in the first quarter of 2006. Terms of the asset sale agreement call for two additional contingent
payments of up to $500,000 each from which we are contractually entitled to receive approximately $350,000
each, but the conditions of the agreement make receipt and amount of payments uncertain and we will account
for any future receipts as loss recoveries at the time of payment.

In December 2005, the Company declared a dividend of $0.30 per share for shareholders of record on
January 6, 2006. The dividend payment totaling approximately $2.9 million was distributed to shareholders on
January 27, 2006.

On March 6, 2006, we increased our Citibank credit facility from $100 million to $125 million. As of

February 28, 2006, we had $61.0 million outstanding under the Citibank credit facility.

On March 6, 2006, we entered into an agreement to repay $10.0 million of the $25.0 million outstanding
under our loan with an affiliate of Farallon Capital. We extended the maturity of the remaining $15.0 million
from April 12, 2006 to June 30, 2006 and decreased the interest rate from 13.5% to 10.86% per annum.

On March 6, 2006, various funds affiliated with Farallon agreed to purchase $5.0 million of our common

stock at a price per share equal to the NAV at February 28, 2006.

Recent Accounting Pronouncements

Recent accounting pronouncements are not considered to have a significant impact on the Company’s

financial statements.

OBLIGATIONS AND INDEBTEDNESS

On April 12, 2005, we entered into a Bridge Loan Credit Facility with an affiliate of Farallon Capital
Management, L.L.C. to provide us with additional capital to invest prior to the completion of our initial public
offering. In addition, on August 1, 2005, we completed the Citigroup Facility, a securitized credit facility. We
expect to pursue additional debt financing from the Small Business Administration under its Small Business
Investment Company program. We may seek to enter into additional securitization facilities. These various types
of facilities are described below.

There can be no assurance that we will be successful in obtaining any additional debt capital on terms
acceptable to us, or at all. If we are unable to obtain debt capital, then positive investment returns for our equity
investors, if any, will not benefit from the potential for increased returns on equity resulting from leverage to the

58

extent that our investment strategy is successful. While there can be no assurance that we will be able to borrow
from banks or other financial institutions, we expect that we will at some time in the future obtain additional
securitized credit facilities. The current lenders have and any future lender or lenders will have fixed dollar
claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our
stockholders with respect to our assets. In addition, we may grant a security interest in our assets in connection
with any such borrowing. We expect such a facility to contain customary default provisions such as a minimum
net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. An
event of default under any credit facility would likely result, among other things, in termination of the
availability of further funds under that facility and an accelerated maturity date for all amounts outstanding under
the facility, which would likely disrupt our business and, potentially, the business of the portfolio companies
whose loans we financed through the facility. This could reduce our revenues and, by delaying any cash payment
allowed to us under our facility until the lender has been paid in full, reduce our liquidity and cash flow and
impair our ability to grow our business.

Bridge Financing

On April 12, 2005, we entered into a Bridge Loan Credit Facility with Alcmene Funding, L.L.C., a special
purpose vehicle that is an affiliate of Farallon Capital Management, L.L.C., a shareholder of the Company. The
Bridge Loan Credit Facility consists of a $25 million senior secured first lien term loan, plus up to an additional
$25 million of discretionary supplemental senior secured first lien term loans. The supplemental loans, if any,
will be made on terms to be agreed upon between us and Alcmene. The Bridge Loan Credit Facility initially
matured on October 12, 2005, subject to one six-month extension at our election. Under the original terms of the
Bridge Loan Credit Facility, if we elected to extend the maturity date, we would have paid an extension fee of
1% of the principal amount of the outstanding loan. The Bridge Loan Credit Facility is prepayable by us at any
time without premium or penalty. The entire principal amount of the Loan is due at maturity. Borrowings under
the Bridge Loan Credit Facility originally bore interest at 8.0% per annum through the initial maturity date, and,
if we elected to extend the maturity date of the Bridge Loan Credit Facility beyond the initial six-month term,
borrowings were to bear interest at 11.5% per annum during any such extension period. In addition, we paid an
upfront fee of $500,000 at the time of our initial draw down under the facility and will be obligated to pay a
maturity fee of $500,000 upon repayment of the Bridge Loan Credit Facility, whether upon maturity or upon
earlier repayment. The Bridge Loan Credit Facility contains a mandatory prepayment provision requiring that we
turn over to Alcmene all principal payments that we receive from our loans to portfolio companies if at such time
we have less than $5 million in cash or cash equivalents on hand. The Bridge Loan Credit Facility is secured by a
first priority lien on substantially all of our assets. Interest on our Bridge Loan Credit Facility is payable in
arrears monthly, on the maturity date and on any prepayment date. As of December 31, 2005 we had
approximately $25.0 million outstanding under the Bridge Loan Credit Facility. In addition, at December 31,
2005, we had approximately $198,000 of prepaid fees related to the upfront draw down fee and accrued $302,000
for fees related to the maturity fee.

On August 1, 2005, we amended the Bridge Loan Credit Facility. The amendment agreement extended the
term of the Bridge Loan Credit Facility to April 12, 2006, eliminated the loan extension fee, revised the interest
rate effective August 1, 2005 to LIBOR plus 5.6% through December 31, 2005 and thereafter to 13.5% per
annum, and amended certain collateral rights and financial covenants.

Our Bridge Loan Credit Facility requires us to meet financial tests with respect to a minimum fixed charge
coverage ratio, a minimum senior secured debt coverage ratio, minimum net assets and minimum net assets per
share as well as concentration and default limits with respect to portfolio company loans. In addition, our Bridge
Loan Credit Facility contains negative covenants limiting, among other things, additional liens and indebtedness,
transactions with affiliates, mergers and consolidations, liquidations and dissolutions, sales of assets, dividends,
loans and advances (other than to our portfolio companies), and other matters customarily restricted in such
agreements. Our Bridge Loan Credit Facility contains customary events of default, including, without limitation,
payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and

59

insolvency, failure of any security document supporting the Bridge Loan Credit Facility to be in full force and
effect, and a change of control of our business. At December 31, 2005 we were in compliance with the covenants
of the Bridge Loan Credit Facility.

Securitized Credit Facility

On August 1, 2005, we, through Hercules Funding Trust I, an affiliated statutory trust, executed a $100
million securitized credit facility with Citigroup Global Markets Realty Corp., which we refer to as the Citigroup
Facility. Our ability to draw on the Citigroup Facility expires on July 31, 2006 unless extended prior to such date
for an additional 364-day period with the lenders’ consent. If the Citigroup Facility is not extended, any principal
amounts then outstanding will be amortized over a six-month period through a termination date in January. The
Citigroup Facility will be collateralized by loans from our portfolio companies, and includes an advance rate of
approximately 55% of eligible loans. Interest on borrowings under the Citigroup Facility will be paid monthly
and will be charged at one-month LIBOR plus a spread of 1.65%. We also paid a loan origination fee equal to
0.25% of the Citigroup Facility and will be subject to an unused commitment fee of 0.50% until the earlier of our
borrowing $50.0 million under the facility or February 1, 2006, and 0.25% thereafter. The Citigroup Facility
contains covenants that, among other things, require us to maintain a minimum net worth and to restrict the loans
securing the Citigroup Facility to certain dollar amounts, to concentrations in certain geographic regions and
industries, to certain loan grade classifications, to certain security interests, and to certain interest payment terms.
There was $51.0 million of borrowings outstanding under the Citigroup Facility at December 31, 2005.

SBIC Financing

We are pursuing, through our wholly-owned subsidiary Hercules Technology II, L.P., additional debt
financing from the Small Business Administration under its Small Business Investment Company program. If we
are able to obtain financing under such program, we will be subject to regulation and oversight by the Small
Business Administration, including requirements with respect to maintaining certain minimum financial ratios
and other covenants. The Small Business Investment Company regulations currently limit the amount that is
available to borrow by any SBIC to $119 million. There is no assurance that we will draw up to the maximum
limit available under the Small Business Investment Company program.

In January 2005, we formed Hercules Technology II, L.P. (“HT II”) and Hercules Technology SBIC
Management, LLC (HTM). On May 3, 2005, HT II filed an application with the Small Business Administration
(the “SBA”) to become licensed as a Small Business Investment Company (“SBIC”) and on June 24, 2005, the
HT II received a letter of acknowledgement of receipt of this application. Upon receipt of this letter from the
SBA, HT II was eligible to make pre-approved investments. If HT II’s application to the SBIC program is
ultimately approved by the SBA, then it will be able to borrow funds from the SBA against eligible pre-approved
investments. During 2005, HT II funded two preapproved loans of which one was fully repaid in October 2005.
At December 31, 2005, Hercules had a net investment of $2.5 million in HT II and there is one outstanding loan
in the amount of $2.0 million. HTM is our wholly-owned subsidiary. Hercules is the sole limited partner of HT II
and HTM is the general partner.

Securitization

We plan to aggregate pools of funded loans using the Citigroup Facility or other conduits that we may seek
until a sufficiently large pool of funded loans is created which can then be securitized. We expect that any loans
included in a securitization facility will be securitized on a non-recourse basis with respect to the credit losses on
the loans. There can be no assurance that we will be able to complete this securitization strategy, or that it will be
successful.

60

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

We are subject to financial market risks, including changes in interest rates. As of December 31, 2005, 24
loans in our portfolio were at fixed rates and 7 loans were at variable rates. Over time additional investments may
be at variable rates. We may, in the future, hedge against interest rate fluctuations by using standard hedging
instruments such as futures, options, and forward contracts. While hedging activities may insulate us against
changes in interest rates, they may also limit our ability to participate in the benefits of lower interest rates with
respect to our borrowed funds and higher interest rates with respect to our portfolio of investments. Interest rates
on our borrowings are based on LIBOR. At December 31, 2005, the borrowing rate under the Citigroup Facility
was LIBOR plus 1.65% and the rate under the Bridge Loan Credit Facility was LIBOR plus 5.6%.

Item 8. Financial Statements and Supplementary Data

INDEX TO FINANCIAL STATEMENTS

AUDITED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Assets and Liabilities as of December 31, 2005 and 2004 . . . . . . . . . . . . . .
Consolidated Schedules of Investments as of December 31, 2005 and 2004 . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Operations for the year ended December 31, 2005 and for the period from

62
63
64

February 2, 2004 (commencement of operations) to December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . .

69

Consolidated Statements of Changes in Net Assets for the year ended December 31, 2005 and for the

period from February 2, 2004 (commencement of operations) to December 31, 2004 . . . . . . . . . . . . .
Consolidated Statements of Cash Flows for the year ended December 31, 2005 and for the period from
February 2, 2004 (commencement of operations) to December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . .
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

70

71
72

61

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors
Hercules Technology Growth Capital, Inc.

We have audited the accompanying consolidated statements of assets and liabilities of Hercules Technology

Growth Capital, Inc., including the consolidated schedules of investments, as of December 31, 2005 and 2004,
and the related consolidated statements of operations, changes in net assets and cash flows for the year ended
December 31, 2005 and for the period from February 2, 2004 (commencement of operations) to December 31,
2004. These financial statements are the responsibility of the Company’s management. Our responsibility is to
express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with auditing standards of the Public Company Accounting

Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements and financial highlights are free of material misstatement. We
were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audit
included consideration of internal control over financial reporting as a basis for designing audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the
Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also
includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements
and financial highlights, assessing the accounting principles used and significant estimates made by management,
and evaluating the overall financial statement presentation. Our procedures included correspondence with each
portfolio company. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects,
the consolidated financial position of Hercules Technology Growth Capital, Inc. at December 31, 2005 and 2004,
the consolidated results of its operations, the changes in its net assets and its cash flows for the year ended
December 31, 2005 and for the period from February 2, 2004 (commencement of operations) to December 31,
2004, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young LLP

San Francisco, California
January 30, 2006,
except for Note 16, as to which the date is
March 6, 2006

62

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

Assets
Investments, at value (cost of $176,004,865 and $16,700,000, respectively)
. . . . .
Deferred loan origination revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred tax asset
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property and equipment, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

December 31,
2005

December 31,
2004

$176,673,226
(2,729,982)
15,362,447
1,479,375
1,310,594
1,454,000
77,673
20,546

$16,700,000
(285,232)
8,678,329
80,902
20,942
—
35,231
2,500

Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

193,647,879

25,232,672

Liabilities
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term loans payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

150,081
1,709,000
1,436,468
76,000,000

Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

79,295,549

1,979

152,560
—

154,539

Net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$114,352,330

$25,078,133

Net assets consist of:

Par value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Paid-in capital in excess of par value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
Distributable earnings (accumulated deficit)

9,802
$
114,524,833
(182,305)

2,059
$
27,117,896
(2,041,822)

Total net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$114,352,330

$25,078,133

Shares of common stock outstanding ($0.001 par value, 30,000,000

authorized) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9,801,965

2,059,270

Net asset value per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$

11.67

$

12.18

See notes to consolidated financial statements.

63

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2005

Portfolio Company

Industry

Type of Investment(1)

Principal Amount Cost(2)

Value(3)(4)

Acceleron Pharmaceuticals, Inc.

Biopharmaceuticals Senior Debt

(3.50%)*

Matures June 2009
Interest rate 10.25% . . . . . . .
Preferred Stock Warrants . . . . .

$ 4,000,000

$ 3,932,539 $ 3,932,539
68,054

69,106

Total Acceleron Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,001,645

4,000,593

Guava Technologies, Inc. (3.94%)

Biopharmaceuticals Senior Debt

Matures July 2009
Interest rate Prime + 3.25% .
Preferred Stock Warrants . . . . .

$ 4,500,000

4,397,111
105,399

4,397,111
103,837

Total Guava Technologies, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,502,510

4,500,948

Labopharm USA, Inc. (8.63%)

Biopharmaceuticals Senior Debt

Labopharm USA, Inc. (1.20%)

Matures July 2008
Interest rate 11.95% . . . . . . .
Common Stock . . . . . . . . . . . . .

$ 9,837,901

9,869,420
112,335

9,869,420
1,367,268

Total Labopharm USA, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9,981,755 11,236,688

Merrimack Pharmaceuticals, Inc.

Biopharmaceuticals Senior Debt

(7.89%)

Matures October 2008
Interest rate 11.15% . . . . . . .
Preferred Stock Warrants . . . . .

$ 9,000,000

8,878,668
155,456

8,878,668
140,675

Total Merrimack Pharmaceuticals, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9,034,124

9,019,343

Omrix Biopharmaceuticals, Inc.

Biopharmaceuticals Senior Debt

(4.16%)

Matures March 2008
Interest rate 11.45% . . . . . . .
Common Stock Warrants . . . . .

$ 4,709,994

4,701,782
11,370

4,701,782
58,399

Total Omrix Biopharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,713,152

4,760,181

Paratek Pharmaceuticals, Inc. (8.76%)

Biopharmaceuticals Senior Debt

Matures June 2008
Interest rate 10.6% . . . . . . . .
Preferred Stock Warrants . . . . .

$10,000,000

9,889,320
137,396

9,889,320
141,881

Total Paratek Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10,026,716 10,031,201

Total Biopharmaceuticals (38.08%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

42,259,902 43,548,954

Atrenta, Inc. (4.38%)

Software

Senior Debt

Matures June 2009
Interest rate 11.50% . . . . . . .
Preferred Stock Warrants . . . . .
Preferred Stock Warrants . . . . .

$ 5,000,000

4,869,095
102,396
33,760

4,869,095
102,886
33,760

Total Atrenta, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,005,251

5,005,741

Concuity, Inc. (3.99%)

Software

Senior Debt

Matures March 2008
Interest rate 9.95% . . . . . . . .
Preferred Stock Warrants . . . . .

$ 4,570,498

4,567,873
3,500

4,567,873
—

Total Concuity, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,571,373

4,567,873

Gomez, Inc. (1.93%)

Software

Senior Debt

Matures December 2007
Interest rate 12.25% . . . . . . .
Preferred Stock Warrants . . . . .

$ 2,197,436

$ 2,175,075 $ 2,175,075
32,467

35,000

Total Gomez, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,210,075

2,207,542

See notes to consolidated financial statements.

64

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED SCHEDULE OF INVESTMENTS—(Continued)

December 31, 2005

Portfolio Company

Industry

Type of Investment(1)

Principal Amount

Cost(2)

Value(3) (4)

Inxight Software, Inc. (4.38%)

Software

Senior Debt

Matures February 2008
Interest rate 10.00% . . . . . . . .
Preferred Stock Warrants . . . . .

$ 5,000,000

$ 4,956,279 $ 4,956,279
46,735

55,963

Total Inxight Software, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,012,242

5,003,014

Metreo, Inc. (1.11%)

Software

Senior Debt

Matures November 2007
Interest rate 12.95% . . . . . . . .
Preferred Stock Warrants . . . . .

$

500,000

4,525,714
50,000

1,266,000
—

Total Metreo, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,575,714

1,266,000

Proficiency, Inc. (3.51%)

Software

Senior Debt

Total Proficiency, Inc.

Sportvision, Inc. (3.08%)

Software

Senior Debt

Matures July 2008
Interest rate 12.00% . . . . . . . .
Preferred Stock Warrants . . . . .

$ 4,000,000

3,917,802
96,370

3,917,802
94,105

4,014,172

4,011,907

Matures June 2008
Interest rate 9.95% . . . . . . . . .
Preferred Stock Warrants . . . . .

$ 3,518,716

3,488,119
39,339

3,488,119
38,523

Total Sportvision, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3,527,458

3,526,642

Talisma Corp. (2.99%)

Software

Subordinated Debt

Matures December 2007
Interest rate 11.25% . . . . . . . .
Preferred Stock Warrants . . . . .

$ 3,410,120

3,378,814
49,000

3,378,814
43,428

Total Talisma Corp.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3,427,814

3,422,242

Total Software (25.37%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

32,344,099

29,010,961

Wageworks, Inc. (17.12%)

Wageworks, Inc. (0.22%)

Consumer &
business
prodcuts

Senior Debt

Matures November 2008
Interest rate Prime + 4.00% . .
Preferred Stock Warrants . . . . .
Preferred Stock . . . . . . . . . . . . .

$18,583,966

18,379,995
251,964
249,995

18,379,995
1,197,735
249,995

Total Wageworks, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

18,881,954

19,827,725

Total Consumer & Business Products (17.34%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

18,881,954

19,827,725

IKANO Communications, Inc.

(14.44%)

Communications
& networking

Senior Debt Matures December
2008 Interest rate 9.25% . . . .
Preferred Stock Warrants . . . . .
Preferred Stock Warrants . . . . .

$16,454,540

16,402,789
45,460
72,344

16,402,789
43,710
71,000

Total IKANO Communications, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

16,520,593

16,517,499

Interwise, Inc. (2.46%)

Communications
& networking

Senior Debt

Matures August 2008
Interest rate 17.50% . . . . . . . .

$ 2,809,653

2,809,653

2,809,653

Total Interwise, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,809,653

2,809,653

Occam Networks, Inc. (2.79%)

Communications
& networking

Senior Debt

Matures December 2007
Interest rate 11.95% . . . . . . . .
Preferred Stock Warrants . . . . .
Common Stock Warrants . . . . .

$ 2,559,827

2,540,021
14,000
17,000

2,540,021
286,364
368,935

Total Occam Networks, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,571,021

3,195,320

See notes to consolidated financial statements.

65

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED SCHEDULE OF INVESTMENTS—(Continued)

December 31, 2005

Portfolio Company

Industry

Type of Investment(1)

Principal Amount Cost(2)

Value(3)(4)

Optovia Corporation (4.37%)

Communications
& networking

Senior Debt

Matures September 2006
Interest rate Prime + 7.25% . . .

$5,000,000

$ 5,000,000 $ 5,000,000

Total Optovia Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,000,000

5,000,000

Pathfire, Inc. (4.38%)

Communications
& networking

Senior Debt

Matures December 2008
Interest rate Prime + 3.65% . . .
Preferred Stock Warrants . . . . . . .

$5,000,000

4,938,482
63,276

4,938,482
64,144

Total Pathfire, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,001,758

5,002,626

Total Communications & Networking (28.44%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

31,903,025 32,525,098

Adiana, Inc. (1.76%)

Adiana, Inc. (0.44%)

Medical devices
& equipment

Senior Debt

Matures June 2008
Interest rate Prime + 6.00% . . .
Preferred Stock Warrants . . . . . . .
Preferred Stock . . . . . . . . . . . . . . .

$2,000,000

1,943,979
67,225
500,000

1,943,979
66,404
500,000

Total Adiana, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,511,204

2,510,383

Optiscan Biomedical, Corp. (1.54%)

Medical devices
& equipment

Optiscan Biomedical, Corp. (0.87%)

Senior Convertible Term Loan

Matures March 2008
Interest rate 15.00% . . . . . . . . .
Preferred Stock Warrants . . . . . . .
Preferred Stock . . . . . . . . . . . . . . .

$1,753,164

1,683,063
80,486
1,000,000

1,683,063
81,185
1,000,000

Total Optiscan Biomedical, Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,763,549

2,764,248

Power Medical Interventions, Inc.

(3.52%)

Medical devices
& equipment

Senior Debt

Matures June 2008
Interest rate 10.71% . . . . . . . . .
Common Stock Warrants . . . . . . .

$4,000,000

3,969,515
39,195

3,969,515
56,490

Total Power Medical Interventions, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,008,710

4,026,005

Xillix Technologies Corp. (4.83%)

Medical devices
& equipment

Senior Debt

Matures December 2008
Interest rate 12.40% . . . . . . . . .
Preferred Stock Warrants . . . . . . .

$5,500,000

5,195,589
313,108

5,195,589
325,601

Total Xillix Technologies Corp.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,508,697

5,521,190

Total Medical Devices & Equipment (12.96%)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

14,792,160 14,821,826

Affinity Express, Inc. (1.54%)

Affinity Express, Inc. (0.22%)

Internet
consumer &
business services

Senior Debt

Matures November 2007
Interest rate 13.50% . . . . . . . . .
Common Stock Warrants . . . . . . .
Common Stock Warrants . . . . . . .
Preferred Stock . . . . . . . . . . . . . . .

$1,583,531

1,560,450
17,000
15,000
250,000

1,560,450
187,922
12,995
250,000

Total Affinity Express, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,842,450

2,011,367

Invoke Solutions, Inc. (1.31%)

Internet
consumer &
business services

Senior Debt

Matures December 2008
Interest rate 11.25% . . . . . . . . .
Preferred Stock Warrants . . . . . . .

$1,500,000

1,457,391
43,826

1,457,391
44,155

Total Total Invoke Solutions, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,501,217

1,501,546

See notes to consolidated financial statements.

66

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED SCHEDULE OF INVESTMENTS—(Continued)

December 31, 2005

Portfolio Company

Industry

Type of Investment(1)

Principal
Amount

Cost(2)

Value(3)(4)

RazorGator Interactive Group, Inc.

(3.64%)

Internet consumer
& business
services

Senior Debt

Matures January 2008
Interest rate 9.95% . . . . . . . . . . . $4,104,553 $

Preferred Stock Warrants . . . . . . . .

4,095,853 $
13,050

4,095,853
64,833

RazorGator Interactive Group, Inc.

(0.87%)

Preferred Stock . . . . . . . . . . . . . . . .

1,000,000

1,000,000

Total RazorGator Interactive Group, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,108,903

5,160,686

Total Internet Consumer & Business Services (7.58%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8,452,570

8,673,599

Cornice, Inc. (11.24%)

Electronics &
computer hardware

Senior Debt

Matures November 2008
Interest rate Prime + 4.50% . . . . $5,000,000

Revolving Line of Credit

Matures November 2006
Interest rate Prime + 3.00% . . . . $7,834,131

Preferred Stock Warrants . . . . . . . .
Preferred Stock Warrants . . . . . . . .
Preferred Stock Warrants . . . . . . . .

4,915,455

4,915,455

7,663,375
101,597
35,353
135,403

7,663,375
99,336
34,230
132,390

Total Cornice, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12,851,183

12,844,786

Sling Media, Inc. (4.29%)

Electronics &
computer hardware

Senior Debt

Matures January 2009
Interest rate 10.25% . . . . . . . . . . $4,000,000

Preferred Stock Warrants . . . . . . . .

3,965,029
38,968

3,965,029
945,365

Total Sling Media, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,003,997

4,910,394

Total Electronics & Computer Hardware (15.53%)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

16,855,180

17,755,180

Ageia Technologies (7.00%)

Semiconductors

Senior Debt

Ageia Technologies (0.44%)

Matures August 2008
Interest rate 10.25% . . . . . . . . . . $8,000,000

Preferred Stock Warrants . . . . . . . .
Preferred Stock . . . . . . . . . . . . . . . .

7,914,586
99,190
500,000

7,914,586
93,518
500,000

Total Ageia Technologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8,513,776

8,508,104

Cradle Technologies (1.75%)

Semiconductors

Senior Debt

Matures December 2008
Interest rate Prime + 4.70% . . . . $2,000,000

Preferred Stock Warrants . . . . . . . .

1,923,049
79,150

1,923,049
78,730

Total Cradle Technologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,002,199

2,001,779

Total Semiconductors (9.20%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10,515,975

10,509,883

Total Investments (154.50%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $176,004,865 $176,673,226

* Value as a percent of net assets
(1) All debt investments are income producing. Preferred and common stock and all warrants are non-income producing.
(2) Tax cost at December 31, 2005 equals book cost. Gross unrealized appreciation, gross unrealized depreciation, and net appreciation

totaled $4,035,789, $3,367,428 and $668,361, respectively, at December 31, 2005.

(3) Except for common stock held in Labopharm Biopharmaceuticals, all investments are restricted at December 31, 2005 and were valued
at fair value as determined in good faith by the Board of Directors. No unrestricted securities of the same issuer are outstanding. The
Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.

(4) Citigroup has an equity participation right on warrants collateralized under the Citigroup facility (see Note 5). The value of their

participation right on unrealized gains in the related equity investments was approximately $342,000 at December 31, 2005 and is
included in accrued liabilities and reduces the unrealized gain recognized by the Company at December 31, 2005.

(5) All investments are less than 5% owned.

See notes to consolidated financial statements.

67

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED SCHEDULE OF INVESTMENTS
DECEMBER 31, 2004

(The following investments are all United States enterprises)

Portfolio Company

Industry

Type of Investment(1)

Principal
Amount

Cost(2)

Value(3)

Affinity Express, Inc. (6.78%)*

Internet Consumer and
business services

Senior Debt

Matures November 2007
Interest rate 13.50% . . . . . . $1,700,000 $ 1,683,000 $ 1,683,000
17,000

Common Stock Warrants . . .

17,000

Total Affinity Express, Inc.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,700,000

1,700,000

Occam Networks, Inc. (11.96%)

Communications &
networking

Senior Debt

Matures December 2007
Interest rate 11.95% . . . . . . $3,000,000

Preferred Stock Warrants . . .
Common Stock Warrants . . .

2,969,000
14,000
17,000

2,969,000
14,000
17,000

Total Occam Networks, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3,000,000

3,000,000

Gomez, Inc. (11.96%)

Software

Senior Debt

Matures December 2007
Interest rate 12.25% . . . . . . $3,000,000

Preferred Stock Warrants . . .

2,965,000
35,000

2,965,000
35,000

Total Gomez, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3,000,000

3,000,000

Metreo, Inc. (19.94%)

Software

Senior Debt

Matures November 2007
Interest rate 10.95% . . . . . . $5,000,000

Preferred Stock Warrants . . .

4,950,000
50,000

4,950,000
50,000

Total Metreo, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5,000,000

5,000,000

Talisma Corp. (15.95%)

Software

Subordinated Debt

Matures December 2007
Interest rate 11.25% . . . . . . $4,000,000

Preferred Stock Warrants . . .

3,951,000
49,000

3,951,000
49,000

Total Talisma Corp.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4,000,000

4,000,000

Total investments (66.59%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $16,700,000 $16,700,000

Value as a percent of net assets

*
(1) All debt investments are income producing. All warrants are non-incoming producing.
(2) Tax cost at December 31, 2004 equals book cost. The Company has no gross unrealized appreciation or depreciation at December 31,

2004.

(3) All investments are restricted at December 31, 2004, and were valued at fair value as determined in good faith by the Board of Directors.
No unrestricted securities of the issuer are outstanding. The Company uses the Standard Industrial Code for classifying the industry
grouping of its portfolio companies.
(4) All investments are less than 5% owned.

See notes to consolidated financial statements.

68

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

Period from
February 2, 2004
(commencement of
operations) to
December 31,
2004

Year Ended
December 31,
2005

Investment income:

Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 9,791,214
875,429

$

Total investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10,666,643

Operating expenses:

Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loan fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Compensation and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
General and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,800,536
1,098,507
3,705,784
2,285,038
252,000

Total operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9,141,865

Net investment income (loss) before provision for income tax expense and

investment gains and losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net investment income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net realized gain on equity investment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net increase in unrealized appreciation on investments . . . . . . . . . . . . . . . . . . . .

1,524,778
255,000

1,269,778
481,694
353,093

Net gain on investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

834,787

214,100
—

214,100

—
—
1,164,504
411,418
680,000

2,255,922

(2,041,822)

—

(2,041,822)

—
—

—

Change in net assets resulting from operations . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 2,104,565

$(2,041,822)

Net investment income (loss) before provision for income tax expense and

investment gains and losses per common share:

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Change in net assets per common share:

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$

$

$

$

0.22

0.22

0.30

0.30

$

$

$

$

(1.72)

(1.58)

(1.72)

(1.58)

Weighted average shares outstanding

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6,939,000

1,187,000

Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7,016,000

1,293,000

See notes to consolidated financial statements.

69

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS

Common Stock

Preferred Stock

Shares Par Value Shares Par Value

Paid-In
Capital

Distributable earnings
(accumulated
deficit)

Net Assets

Balance at February 2, 2004

(commencement of operations) . . . . . .

— $ —

—

$—

$

—

$

—

$

—

Increase in net assets from capital share

transactions:

Issuance of convertible preferred

stock, net of placement fees . . . .

—

—

600

1

2,574,999

Issuance of common stock, net of

offering costs . . . . . . . . . . . . . . . . 1,809,270

1,809

—

—

23,863,146

Conversion of preferred stock to

common stock . . . . . . . . . . . . . . .

250,000

250

(600)

(1)

(249)

Net increase in net assets from

capital share transactions . . . . . . . 2,059,270
—

Stock-based compensation . . . . . . . . . . .
Net decrease in net assets resulting from
operations . . . . . . . . . . . . . . . . . . . . . .

—

Balance at December 31, 2004 . . . . . . . . 2,059,270
Increase in net assets from capital share

transactions:

Issuance of common stock, net of

offering costs . . . . . . . . . . . . . . . .

268,134

Issuance of shares in lieu of 5 year

warrants . . . . . . . . . . . . . . . . . . . .

298,598

Issuance of shares on exercise of 1

2,059
—

—

2,059

268

299

year warrants . . . . . . . . . . . . . . . . 1,175,963

1,176

Issuance of common stock in IPO,

net of offering costs . . . . . . . . . . . 6,000,000

6,000

Net increase in net assets from

capital share transactions . . . . . . . 7,742,695
—
—

Stock-based compensation . . . . . . . . . . .
Distribution to shareholders . . . . . . . . . .

7,743
—
—

Increase in net assets from operations:

Net investment income . . . . . . . . . .
Net realized gain on investments . .
Net unrealized depreciation on

investments . . . . . . . . . . . . . . . . .

Net unrealized appreciation on

equity investments . . . . . . . . . . . .

Net unrealized appreciation on

warrants . . . . . . . . . . . . . . . . . . . .

Net increase in net assets resulting

from operations . . . . . . . . . . . . . .

—
—

—

—

—

—

—
—

—

—

—

—

Balance at December 31, 2005 . . . . . . . . 9,801,965

$9,802

—
—

—

—

—

—

—

—

—
—
—

—
—

—

—

—

—

—

—
—

—

—

—

—

—

—

—
—
—

—
—

—

—

—

—

$—

—

—

—

—

26,439,955
680,000

26,437,896
680,000

—

(2,041,822)

(2,041,822)

27,117,896

(2,041,822)

25,078,133

3,870,542

(299)

12,428,744

70,855,950

87,154,937
252,000
—

—
—

—

—

—

—

—

—

—

—

—
—

(245,048)

1,269,778
481,694

(3,285,392)

1,118,208

2,520,277

87,162,680
252,000
(245,048)

2,104,565

2,104,565

$114,524,833

$ (182,305)

$114,352,330

See notes to consolidated financial statements.

70

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Cash flows from operating activities:

Net increase (decrease) in net assets resulting from operations . . . . . . . .
Adjustments to reconcile net increase (decrease) in net assets resulting

from operations to net cash used in operating activities:

Purchase of investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Principal payments received on investments . . . . . . . . . . . . . . . . . . . . . . .
Net unrealized appreciation on investments . . . . . . . . . . . . . . . . . . . . . . .
Net unrealized appreciation on investments due to lender
. . . . . . . . . . . .
Net realized gain on sale of equity investment
. . . . . . . . . . . . . . . . . . . . .
Accretion of loan discounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accretion of loan exit fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of deferred loan origination revenue . . . . . . . . . . . . . . . . . .
Change in operating assets and liabilities:

Interest receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets . . . . . . . . . . . . . . . . . . . . .
Deferred tax asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred loan origination revenue . . . . . . . . . . . . . . . . . . . . . . . . . . .

Period from
February 2, 2004
(commencement of
operations) to
December 31,
2004

Year Ended
December 31,
2005

$

2,104,565

$ (2,041,822)

(177,834,136)
18,822,828
(353,093)
(342,297)
(481,694)
(358,611)
(350,944)
23,605
252,000
(790,169)

(1,047,529)
(1,289,652)
(1,454,000)
148,102
1,709,000
1,283,908
3,277,238

(16,700,000)

—
—
—
—
—
—
7,533
680,000
—

(80,902)
(23,442)
—
(2,481)
—
157,020
285,232

Net cash used in operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(156,680,879)

(17,718,862)

Cash flows from investing activities:

Proceeds from sale of equity investment . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchases of capital equipment
Other long-term assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net cash used in investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

531,458
(66,047)
(18,046)

447,365

—
(40,264)
(2,500)

(42,764)

Cash flows from financing activities:

. . . . . . . . . . .
Proceeds from issuance of convertible preferred stock, net
Proceeds from issuance of common stock, net
. . . . . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from short-term loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

—
87,162,680
(245,048)
76,000,000

2,575,000
23,864,955

—

Net cash provided by financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

162,917,632

26,439,955

Net increase in cash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . . . . . . . . . .

6,684,118
8,678,329

8,678,329
—

Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 15,362,447

$ 8,678,329

Supplemental disclosures:

Interest paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$

1,704,244
—

$

—
—

See notes to consolidated financial statements.

71

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Description of Business and Basis of Presentation

Hercules Technology Growth Capital, Inc. (the “Company”) is a specialty finance company that provides
debt and equity growth capital to technology-related and life-science companies at all stages of development. The
Company sources its investments through its principal office located in Silicon Valley, as well as through its
additional offices in the Boston, Boulder and Chicago areas. The Company was incorporated under the General
Corporation Law of the State of Maryland in December 2003. The Company commenced operations on
February 2, 2004, when it sold 600 shares of convertible preferred stock to investors and commenced investment
activities in September 2004.

The Company is an internally managed, non-diversified closed-end investment company that has elected to

be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as
amended (the “1940 Act”). In conjunction with the filing of its December 31, 2006 tax return, the Company
intends to seek to be treated for federal income tax purposes as a registered investment company (“RIC”). As of
December 31, 2005, the Company cannot determine the probability that during 2006 it will qualify as a RIC
when its 2006 tax return is filed. If the Company qualifies as a RIC as of December 31, 2006, the election will be
effective as of January 1, 2006.

On June 11, 2005, the Company raised approximately $70.9 million, net of issuance costs, from an initial

public offering (“IPO”) of 6,000,000 shares of its common stock.

In January 2005, the Company formed Hercules Technology II, L.P. (“HT II”) and Hercules Technology

SBIC Management, LLC (HTM). On May 3, 2005, HT II filed an application with the Small Business
Administration (the “SBA”) to become licensed as a Small Business Investment Company (“SBIC”) and on
June 24, 2005, the HT II received a letter of acknowledgement of receipt of this application. Upon receipt of this
letter from the SBA, HT II was eligible to make pre-approved investments. If HT II’s application to the SBIC
program is ultimately approved by the SBA, then it will be able to borrow funds from the SBA against eligible
pre-approved investments and additional contributions to regulatory capital. During 2005, HT II funded two
preapproved loans of which one was fully repaid in October 2005. At December 31, 2005, the Company has a net
investment of $2.5 million in HT II and there is one outstanding loan in the amount of $2.0 million. HTM is a
wholly-owned subsidiary of the Company. The Company is the sole limited partner of HT II and HTM is the
general partner.

In July 2005, the Company formed Hercules Funding I LLC and Hercules Funding Trust I, an affiliated
statutory trust, and executed a $100 million securitized credit facility with Citigroup Global Markets Realty
Corp. (see Note 5).

The consolidated financial statements include the accounts of the Company and its subsidiaries. All
significant intercompany balances and transactions have been eliminated in consolidation. In accordance with
Article 6 of Regulation S-X under the Securities Act of 1933 and the Securities and Exchange Act of 1934, the
Company does not consolidate portfolio company investments. The financial statements for the period ended
December 31, 2004 include all activities from February 2, 2004 to December 31, 2004. Certain prior period
amounts have been reclassified to conform with the current year presentation.

2. Significant Accounting Policies

Use of estimates

The accompanying consolidated financial statements are presented in conformity with accounting principles
generally accepted in the United States. This requires management to make estimates and assumptions that affect
the amounts and disclosures reported in the financial statements and accompanying notes. Such estimates and
assumptions could change in the future as more information becomes known, and actual results could differ from
those estimates.

72

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Valuation of Investments

Value is defined in Section 2(a)(41) of the 1940 Act, as (i) the market price for those securities for which a

market quotation is readily available and (ii) for all other securities and assets, fair value is as determined in good
faith by the Board of Directors. Because the Company invests primarily in structured mezzanine debt
investments (“Debt”) and equity growth capital (“Equity”) of privately-held technology-related and life-science
companies backed by leading venture capital and private equity firms for which market prices are not available,
the Company values substantially all of its investments at fair value, as determined in good faith by the Board of
Directors in accordance with established valuation policies and consistent procedures and the recommendations
of the Valuation Committee of the Board of Directors. At December 31, 2005, approximately 87.4% of the
Company’s net assets are investments in privately held companies which are valued at fair value and
approximately 12.6% are valued based on readily available market quotations.

Estimating fair value requires that judgment be applied to the specific facts and circumstances of each
portfolio investment. The Board of Directors estimates fair value to be the amount for which an investment could
be exchanged in an orderly disposition over a reasonable period of time between willing parties other than in a
forced or liquidation sale. Due to the inherent uncertainty in the valuation process, the Board’s estimate of fair
value may differ significantly from the values that would have been used had a ready market for the securities
existed, and the differences could be material. In addition, changes in the market environment and other events
that may occur over the life of the investments may cause the gains or losses ultimately realized on these
investments to be different than the valuations currently assigned.

When originating a Debt instrument, the Company will receive warrants or other equity-related securities

from the borrower. The Company determines the cost basis of the warrants or other equity-related securities
received based upon their respective fair values on the date of receipt in proportion to the total fair value of the
Debt and warrants or other equity-related securities received. The Board of Directors estimates the fair value of
warrants and other equity-related securities in good faith using a Black-Scholes pricing model and consideration
of the issuer’s earnings, sales to third parties of similar securities, the comparison to publicly traded securities,
and other factors. Any resulting discount on the loan from recordation of the warrant or other equity instruments
is accreted into interest income over the life of the loan.

At each reporting date, privately held Debt and Equity securities are valued based on an analysis of various
factors including, but not limited to, the portfolio company’s operating performance and financial condition and
general market conditions that could impact the valuation. When an external event occurs, such as a purchase
transaction, public offering, or subsequent equity sale, the pricing indicated by that external event is utilized to
corroborate the Company’s valuation of the Debt and Equity securities. An unrealized loss is recorded when an
investment has decreased in value, including: where collection of a loan is doubtful, there is an adverse change in
the underlying collateral or operational performance, there is a change in the borrower’s ability to pay, or there
are other factors that lead to a determination of a lower valuation for the debt or equity security. Conversely, an
unrealized gain is recorded when the investment has appreciated in value. Securities that are traded in the over
the counter markets or on a stock exchange will be valued at the prevailing bid price at period end.

As required by the 1940 Act, the Company classifies its investments by level of control. “Control
Investments” are defined in the 1940 Act as investments in those companies that the Company is deemed to
“Control”. “Affiliate Investments” are investments in those companies that are “Affiliated Companies” of the
Company, as defined in the 1940 Act, which are not Control Investments. “Non-Control/Non-Affiliate
Investments” are those that are neither Control Investments nor Affiliate Investments. Generally, under the 1940
Act, the Company is deemed to “Control” a company in which it has invested if it owns 25% or more of the
voting securities of such company or has greater than 50% representation on its board. The Company is deemed

73

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

to be an “Affiliate” of a company in which it has invested if it owns 5% or more but less than 25% of the voting
securities of such company. At December 31, 2005 and 2004, all of the Company’s investments were in
Non-Control/Non-Affiliate companies.

Income Recognition

Interest on loans are computed using a method that results in a level rate of return on principal amounts

outstanding. Interest income is recognized as earned in accordance with the contractual terms of the loan
agreement. Any difference between the face amount of a loan and its cost basis is accreted into income over the
term of the loan. When a loan becomes 90 days or more past due, or if the Company otherwise does not expect to
receive interest and principal repayments, we will place the loan on non-accrual status and cease recognizing
interest income. The Company placed one loan on non-accrual status during the period ended December 31, 2005
and none in 2004.

Loan origination and commitment fees received in full at the inception of a loan are deferred and amortized

into fee income over the contractual life of the loan. Loan exit fees to be paid at the termination of the loan are
accreted into fee income over the contractual life of the loan. Original issue discounts are accreted into interest
income over the life of the loan. These fees and discounts are reflected as adjustments to the loan yield. The
Company had approximately $2.7 million and $285,000 of unamortized fees at December 31, 2005 and 2004,
respectively, and approximately $351,000 and $0 in exit fees receivable at December 31, 2005 and 2004.
respectively.

In certain investment transactions, the Company may provide advisory services. For services that are
separately identifiable and external evidence exists to substantiate fair value, income is recognized as earned,
which is generally when the investment transaction closes. The Company had no income from advisory services
in 2005 or 2004.

Financing costs

Debt financing costs are fees and other direct incremental costs incurred in obtaining debt financing and are

recognized as prepaid expenses or accrued liabilities in the case of back end fees, and are amortized into the
consolidated statement of operations as loan fees over the term of the related debt instrument. At December 31,
2005, prepaid debt financing costs of approximately $537,000, net of accumulated amortization, and accrued
debt financings costs of approximately $387,000 are included in the consolidated statements of net assets and
liabilities.

Cash Equivalents

The Company considers money market funds and other highly liquid short-term investments with a maturity

of less than 90 days to be cash equivalents.

Depreciation and Amortization

Equipment is depreciated on a straight-line basis over an estimated useful life of five years. Software is

amortized over three years.

Distributions to Shareholders

Dividends payable to shareholders are recorded on the ex-dividend date.

74

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Federal Income Taxes

For the periods ended December 31, 2005 and 2004, the Company is taxed under Subchapter C of the

Internal Revenue Code and therefore is subject to corporate-level federal and state income tax.

The Company accounts for income taxes in accordance with the provisions of Financial Accounting

Standards No. 109, Accounting for Income Taxes, which requires that deferred income taxes be determined based
upon the estimated future tax effects of differences between the financial statement and tax bases of assets and
liabilities given the provisions of the enacted tax law. Valuation allowances are used to reduce deferred tax assets
to the amount likely to be realized.

Organization Expenses

Organization expenses, totaling $15,000, were expensed upon commencement of operations.

Offering Costs and Placement Fees

Offering costs and placement fees are charged to paid-in capital when shares of the Company are issued.

Offering costs and placement fees totaled approximately $7.7 million and $2.9 million for the periods ended
December 31, 2005 and 2004, respectively.

Stock-Based Compensation

The Company follows Financial Accounting Standards No. 123 (revised 2004), Share-Based Payment
(“FAS 123R”), to account for stock options granted. Under FAS 123R, compensation expense associated with
stock based compensation is measured at the grant date based on the fair value of the award and is recognized
over the vesting period. Determining the appropriate fair value model and calculating the fair value of stock-
based awards at the grant date requires judgment, including estimating stock price volatility, forfeiture rate and
expected option life.

Earnings per share

Basic earnings per share is computed by dividing net income applicable to common stockholders by the
weighted average number of shares of common stock outstanding for the period. Diluted earnings per share is
computed by dividing such net income by the sum of the weighted average number of shares outstanding for the
period, the dilutive effect of potential shares that could occur upon exercise of warrants and common stock
options.

Segments

The Company lends to and invests in customers in various sectors of technology-related and life-sciences

sectors. The Company separately evaluates the performance of each of its lending and investment relationships.
However, because each of these loan and investment relationships has similar business and economic
characteristics, they have been aggregated into a single lending and investment segment. All segment disclosures
are included in or can be derived from the Company’s consolidated financial statements.

75

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

3. Investments

A summary of the composition of the Company’s investment portfolio as of December 31, 2005 and 2004 at

fair value is shown as follows:

($ in millions)

Senior debt with warrants . . . . . . . . .
Subordinated debt . . . . . . . . . . . . . . .
Preferred stock . . . . . . . . . . . . . . . . .
Common stock . . . . . . . . . . . . . . . . .

December 31, 2005

December 31, 2004

Investments at Fair
Value

Percentage of Total
Portfolio

Investments at Fair
Value

Percentage of Total
Portfolio

$163.4
8.4
3.5
1.4

$176.7

92.4%
4.8%
2.0%
0.8%

100.0%

$12.7
4.0
—
—

$16.7

76.0%
24.0%
—
—

100.0%

A Summary of the Company’s investment portfolio, at fair value, by geographic location is as follows:

($ in millions)

December 31, 2005

December 31, 2004

Investments at Fair
Value

Percentage of Total
Portfolio

Investments at Fair
Value

Percentage of Total
Portfolio

United States . . . . . . . . . . . . . . . . . . .
Canada . . . . . . . . . . . . . . . . . . . . . . .

$159.9
16.8

$176.7

90.5%
9.5%

100.0%

$16.7
—

$16.7

100.0%
—

100.0%

During the periods ended December 31, 2005 and 2004, the Company purchased debt investments totaling

approximately $175.3 million and $16.7 million, respectively. During the year ended December 31, 2005, the
Company exercised an equity participation right with one portfolio company and converted $1,000,000 of debt to
equity. In addition, during 2005, the Company purchased equity securities totaling $2.5 million and exercised a
warrant for common shares in one public company. The common shares had a fair value of approximately $1.4
million at December 31, 2005. Security transactions are recorded on the trade-date basis.

4. Credit Facility

On April 12, 2005, the Company entered into a bridge loan credit facility (the “Bridge Loan Credit Facility”

or the “Loan”) with Alcmene Funding, L.L.C. (“Alcmene”), a special purpose vehicle that is an affiliate of
Farallon Capital Management, L.L.C., a shareholder of the Company. The Loan is a $25 million senior secured
term loan, which allows for up to an additional $25 million of discretionary supplemental senior secured loans.
The Loan matures on April 12, 2006 and is secured by a first lien on all of the Company’s assets, except loans
pledged under the Securitization Agreement (See Note 5) which are secured by a second lien. The Loan may be
prepaid at any time by the Company without penalty. The Loan contains a mandatory pay-down provision
requiring the Company to turn over to Alcmene all principal payments received by the Company from portfolio
companies if at such time the Company has less than $5 million in cash or cash equivalents on hand. At
December 31, 2005, there was $25 million outstanding under the Loan. The average debt outstanding under the
Credit Facility in 2005 was approximately $18.0 million and the average interest rate was approximately
9.02% per annum.

The interest rate on borrowings under the Loan was set at 8% per annum for the initial six-month period. On

August 1, 2005, the Company amended the Loan with an agreement extending the term of the Bridge Loan

76

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Credit Facility to April 12, 2006. The amendment eliminated the loan extension fee, revised the interest rate
effective August 1, 2005 to LIBOR plus 5.6% through December 31, 2005 and thereafter to 13.5% per annum,
and amended certain collateral rights and financial covenants. At December 31, 2005, the interest rate on the loan
was 9.76% per annum. The loan fees are being amortized over the remaining four-month period. See Note 16.

5. Securitization Agreement

On August 1, 2005, the Company, through Hercules Funding Trust I, an affiliated statutory trust, executed a

$100 million securitized credit facility (the “Citigroup Facility”) with Citigroup Global Markets Realty Corp.
(“Citigroup”). The Company’s ability to make draws on the Citigroup Facility expires on July 31, 2006 unless
extended prior to such date for an additional 364-day period with the lenders’ consent. If the Citigroup Facility is
not extended, any principal amounts then outstanding will be amortized over a six-month period through a
termination date in January 2007. The Citigroup Facility is collateralized by loans from the Company’s portfolio
companies, and includes an advance rate of approximately 55% of eligible loans. The Citigroup Facility contains
covenants that, among other things, require the Company to maintain a minimum net worth and to restrict the
loans securing the Citigroup Facility to certain dollar amounts, to concentrations in certain geographic regions
and industries, to certain loan grade classifications, to certain security interests, and to certain interest payment
terms. In addition, the Citigroup Facility provides that Citigroup shall have a participation right equal to 10% of
any realized gains, to a maximum of $3.0 million, on equity instruments included in the loan collateral. At
December 31, 2005, the Company had recorded an accrued liability for approximately $59,000 for amounts owed
to Citigroup on the sale of common stock of one portfolio company. In addition, the Company has recorded an
accrued liability of approximately $342,000 related to unrealized gains on equity investments currently included
in the collateral pool.

Interest on borrowings under the Citigroup Facility will be paid monthly and will be charged at one-month

LIBOR plus a spread of 1.65%. The Company also paid a loan origination fee equal to 0.25% of the Citigroup
Facility and will be subject to an unused commitment fee of 0.50% until the earlier of the Company borrowing
$50.0 million under the facility or February 1, 2006, and 0.25% thereafter. At December 31, 2005, the interest
rate on the loan was 6.04% per annum. See Note 16.

At December 31, 2005, the Company, through its special purpose entity (SPE), had transferred pools of
loans with a face value of approximately $103.6 million to Citibank and had drawn $51.0 million under the
facility. Transfers of loans have not met the requirements of SFAS No. 140, “Accounting for Transfers and
Servicing of Financial Assets and Extinguishments of Liabilities”, for sales treatment and are, therefore, treated
as secured borrowings, with the transferred loans remaining in investments and the related liability recorded in
borrowings. The average debt outstanding under the Citigroup Facility in 2005 was approximately $2.3 million
and the average interest rate was approximately 6.42% per annum.

77

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

6. Income Taxes

The benefit from (provision for) taxes on earnings was as follows (in thousands):

Years Ended December 31,

2005

2004

Federal:
Current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

State:
Current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 1,365.0
(1,266.0)

99.0

344.0
(188.0)

156.0

Foreign withholding tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

—

$—
—

—

—
—

—

—

Total benefit from (provision for) income taxes . . . . . . . . . . . . . . .

$

255.0

$—

At December 31, 2004, the Company had deferred tax assets of approximately $785,718 which were fully

reserved with a tax valuation allowance. During 2005, the prior year’s deferred tax asset was fully utilized.
Additionally during 2005, the Company determined that it is more likely than not that certain future tax benefits
will be realized as a result of historic and current income, and the prospects of future taxable income due to
uncertainties that exist regarding the Company’s ability to qualify as a RIC as of December 31, 2006.

Deferred tax assets are related to the following (in thousands):

Years Ended December 31,

Net operating loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalized assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expenses not currently deductible . . . . . . . . . . . . . . . . . . . . . . . . .

$

Gross deferred tax asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2005

—
2.0
1,452.0

1,454.0
—

2004

$ 535.0
5.0
246.0

786.0
(786.0)

Net deferred tax asset

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,454.00

$ —

A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective rate is as follows:

Tax at federal statutory rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State, net of federal benefit
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other Items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Years Ended December 31,

2005

35.0%
5.7
3.4
(33.3)

10.8%

2004

35.0%
5.8
—
(40.8)

— %

As of December 31, 2005, the Company had no net operating loss carryforwards.

78

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Company intends to seek to be treated as a RIC when it files its December 31, 2006 tax return. If the
Company meets the required qualifications as a RIC, any income timely distributed to its shareholders will not be
subject to corporate level federal taxes in those periods that the Company qualifies as a RIC. As such, the
deferred tax asset of approximately $1.4 million may have to be charged against earnings as there would be no
federal tax expense to offset the deferred tax asset. As of December 31, 2005, the impact of charging off the
deferred tax asset would be to reduce the Company’s NAV from $11.67 to $11.52.

7. Shareholders’ Equity

The Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.001. Each

share of common stock entitles the holder to one vote.

On February 2, 2004, the Company sold 600 shares of convertible preferred stock for gross proceeds of
$2,750,000 ($2,575,000 net of the placement fee of $175,000) to officers of the Company and JMP Group LLC
(“JMPG”), an affiliate of the placement agent.

In June 2004, the Company sold in a private placement, 904,635 units for gross proceeds of $26,614,080
($23,864,955 net of placement fees and offering costs of $2,749,125), and all the convertible preferred stock was
converted into 125,000 units on a 208.3333-for-1 basis. Each unit consisted of two shares of common stock,
which were accompanied by a warrant to purchase one share of common stock within one year (the “1 Year
Warrant”), and a warrant to purchase one share of common stock within five years (the “5 Year Warrant”). Each
warrant had an exercise price of $15.00 per share through January 13, 2005. As of December 31, 2004, there
were no authorized shares of preferred stock.

In conjunction with the Company’s decision to elect to be regulated as a BDC, approximately 55% of the 5

Year Warrants were subject to mandatory cancellation under the terms of the Warrant Agreement with the
warrant holder receiving one share of common stock for every two warrants cancelled and the exercise price of
all warrants was adjusted to the then current net asset value of the common stock, subject to certain adjustments
described in the Warrant Agreement. In addition, the 1 Year Warrants became subject to expiration immediately
prior to the Company’s election to become a BDC, unless exercised. On January 14, 2005, the Company notified
all shareholders of its intent to elect to be regulated as a BDC and reduced the exercise price of all remaining 1
and 5 Year Warrants from $15.00 to $10.57. On February 22, 2005, the Company cancelled 47% of all
outstanding 5 Year Warrants and issued 298,598 shares of common stock to holders of warrants upon exercise. In
addition, the majority of shareholders owning 1 Year Warrants exercised them, and purchased 1,175,963 of
common shares at $10.57 per share, for total consideration to the Company of $12,429,920. All unexercised 1
Year Warrants were then cancelled.

On January 26, 2005, the CEO, the President, and four employees purchased 40,000, 13,500, and 8,567
units for $1,200,000, $405,000 and $257,010, respectively. On January 26, 2005, JMPG also purchased 72,000
units for $2,008,800, which number is net of a placement fee of $151,200, which was paid to an affiliate of
JMPG.

On June 9, 2005, the Company raised approximately $70.9 million, net of offering costs, from an IPO of

6,000,000 shares of its common stock.

On September 7, 2005, the Company registered 3,801,905 shares of common stock and 673,223 5-year
warrants pursuant to its obligations under a registration rights agreement between the Company and certain
shareholders. Prior to registration, the common stock and warrants were restricted securities within the meaning
of the Securities Act of 1933. The Company did not receive any proceeds from the registration of these
securities.

79

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

A summary of activity in the 1 Year and 5 Year Warrants initially attached to units issued for the periods

ended December, 2005 and 2004 is as follows:

Warrants outstanding at February 2, 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warrants issued in June 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

—
1,029,635

—
1,029,635

Warrants outstanding at December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warrants issued in January 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warrants cancelled in February 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warrants exercised in February 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,029,635
134,067
(83,334)
(1,080,368)

1,029,635
134,067
(547,030)

—

Warrants outstanding at December, 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

—

616,672

One-Year
Warrants

Five-Year
Warrants

Common stock is reserved is as follows:

Stock options and warrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Warrants issued in June 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7,904,405
616,672

5,000,000
2,059,270

Common stock reserved at December, 2005 . . . . . . . . . . . . . . . . . .

8,521,077

7,059,270

December 31,

2005

2004

8. Equity Incentive Plan

The Company has authorized and adopted an equity incentive plan (the “2004 Plan”) for purposes of

attracting and retaining the services of its executive officers and key employees. Under the 2004 Plan as amended
and approved by the shareholders in 2005, the Company is authorized to issue 8,000,000 shares of common stock
under the 2004 Plan. Unless terminated earlier by the Company’s Board of Directors, the 2004 Plan will
terminate on June 9, 2014, and no additional awards may be made under the 2004 Plan after that date.

In 2004, each employee stock option to purchase two shares of common stock was accompanied by a
warrant to purchase one share of common stock within one year and a warrant to purchase one share of common
stock within five years. Both options and warrants had an exercise price of $15.00 per share on date of grant. On
January 14, 2005, the Company notified all shareholders of its intent to elect to be regulated as a BDC and
reduced the exercise price of all remaining 1 and 5 Year Warrants from $15.00 to $10.57 but did not reduce the
strike price of the options (see Note 7). The unexercised one-year warrants expired and 55% of the five-year
warrants were cancelled immediately prior to the Company’s election to become a BDC.

80

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

A summary of the Company’s common stock options and warrant activity under the 2004 Plan for the

periods ended December 31, 2005 and 2004, is as follows:

Outstanding at February 2, 2004 (commencement of operations) . . . . . . . . . .
Granted—2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercised—2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expired—2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

—
273,436
—
—

—
106,718
—
—

—
106,718
—
—

Common
Stock
Options

One-Year
Warrants

Five-Year
Warrants

Outstanding, December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted—2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercised—2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cancelled—2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expired—2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

273,436
1,270,000

106,718

106,718

(206,000)

— (95,595)
(11,123)
—

—

—
(50,167)
—

Outstanding, December 31, 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,337,436

—

56,551

Weighted-average exercise price at December 31, 2005 . . . . . . . . . . . . . . . . .

$

13.32

— $

10.57

All of the options granted in 2004 are 100% vested on the date of grant, except for options granted to
directors to acquire 30,000 shares which were cancelled in 2005 and options to acquire 16,000 shares granted to
employees in December 2004. Options generally vest 25% one year after the date of grant and ratably over the
succeeding 24 months. All options may be exercised for a period ending seven years after the date of grant. At
December 31, 2005 options for 202,827 shares were exercisable at a weighted average exercise price of $15.00
per share with a weighted average exercise term of 5.5 years. The outstanding five year warrants have an
expected life of five years.

The Company determined that the fair value of options and warrants granted during the periods ended

December 31, 2005 and 2004 was approximately $1,427,000 and $865,000. During the periods ended
December 31, 2005 and 2004, $252,000 and $680,000 of share-based cost was expensed, respectively. The total
income tax benefit recognized in the income statement for share-based compensation arrangements for 2005 was
approximately $325,000 and no tax benefit was recognized in 2004. The fair value of options granted in 2005
and 2004 was based upon a Black-Scholes option pricing model using the assumptions in the following table:

Expected volatility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected dividends . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected term (in years) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2005

2004

25% 0%
8% 0%

4.5

5.0

3.88-4.06% 3.9%

9. Earnings per Share

Shares used in the computation of the Company’s basic and diluted earnings (loss) per share are as follows:

Weighted average common shares outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dilutive effect of warrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dilutive effect of convertible preferred stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6,939,000
77,000
—

1,187,000
—
106,000

Weighted average common shares outstanding, assuming dilution . . . . . . . . . . . . . . . . . .

7,016,000

1,293,000

2005

2004

81

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Weighted average common shares outstanding, assuming dilution, includes the incremental effect of shares

that would be issued upon the assumed exercise of warrants. The Company has excluded all outstanding stock
options from the calculation of diluted net income per share because these securities are antidilutive for all
periods presented. These excluded common share equivalents could be dilutive in the future. Options for
approximately 1,337,000 and 273,000 shares of common stock have been excluded for the periods ended
December 31, 2005 and 2004, respectively.

10. Related-Party Transactions

In January 2005, the Chief Executive Officer (“CEO”), the President, JMPG and four employees purchased

40,000, 13,500, 72,000 and 8,567 units for $1,200,000, $405,000, $2,008,800 and $257,010, respectively. On
January 26, 2005, JMPG also purchased 72,000 units for $2,008,800, which is net of an underwriting discount of
$151,200. Each unit consisted of two shares of our common stock, a 1 Year Warrant and a 5 Year Warrant.

The Henriquez Family Trust (the “Trust”) and Glen C. Howard, President of the Company (the “President”)

were each issued 100 shares of Series A-2 convertible preferred stock (“Series A-2”) for a total of $250,000 in
February 2004. The Trust is affiliated with Manuel A. Henriquez, Chairman of the Board of Directors and CEO.

JMPG, formerly known as Jolson Merchant Partners Group, LLC, purchased 400 shares of Series A-1

convertible preferred stock (“Series A-1”) in February 2004 for $2,500,000 and, in connection therewith, the
Company paid a placement fee of $175,000 to JMP Securities LLC (“JMP”), the placement agent for such
offering and a wholly-owned subsidiary of JMPG. The CEO owns approximately 0.1% of the fully diluted equity
of JMPG.

The Series A-1 and Series A-2 shares described above were sold at a price of $6,250 and $1,250 per share,

respectively, to reflect the fact that Series A-1 shares have separate preferential voting rights, and a preference on
any distribution of assets over Series A-2.

On June 8, 2005, the Company entered into an Underwriting Agreement with JMP Securities LLC pursuant
to which JMP Securities LLC served as the lead underwriter in the Company’s initial public offering completed
on June 9, 2006. The Company paid JMP Securities LLC a fee of approximately $3.8 million in connection with
their services as the lead underwriter.

11. Commitments and Contingencies

In the normal course of business, the Company is party to financial instruments with off-balance sheet risk.

These instruments consist primarily of unused commitments to extend credit, in the form of loans, to the
Company’s investee companies. The balance of unused commitments to extend credit at December 31, 2005
totaled approximately $30.2 million. Since these commitments may expire without being drawn upon, the total
commitment amount does not necessarily represent future cash requirements.

Certain premises are leased under agreements which expire at various dates through December 31, 2006.

Total expense amounted to approximately $221,000 and $102,000 during the periods ended December 31, 2005
and 2004. Future minimum rental commitments totaled $244,000 as of December 31, 2005, all of which are due
in 2006.

12. Concentrations of Credit Risk

The Company’s customers are primarily small and medium sized companies in the biopharmaceutical,
communications and networking, consumer and business products, electronics and computers, medical device,
semicondutor and software industry sectors. These sectors are characterized by high margins, high growth rates,
consolidation and product and market extension opportunities. Value is often vested in intangible assets and
intellectual property.

82

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The largest companies vary from year to year as new loans are recorded and loans pay off. Loan revenue,

consisting of interest, fees, and recognition of gains on equity interests, can fluctuate dramatically when a loan is
paid off or a related equity interest is sold. Revenue recognition in any given year can be highly concentrated
among several customers. At December 31, 2005, the Company’s ten largest customers represented
approximately 58.7% of the total fair value of its investments. The Company had six investments that represent
5% or more of the fair value of its investments at December 31, 2005. At December 31, 2005, the Company had
seven equity investments which represented 100% of the total fair value of its equity investments and each
represents 5% or more of the total fair value of such investments.

13. Selected Quarterly Data (Unaudited)

The following tables set forth certain quarterly financial information for each of the eight quarters ended

with the quarter ended December 31, 2005. This information was derived from our unaudited consolidated
financial statements. Results for any quarter are not necessarily indicative of the results for the full year or for
any future quarter.

Investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net investment income (loss) before provision for income
tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per common share basic . . . . . . . . . . . . . . . . . .

Investment income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net investment income (loss) before provision for income
tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per common share basic . . . . . . . . . . . . . . . . . .

Quarter Ended

3/31/05

6/30/05

9/30/05

12/31/05

$ 753,973

$1,912,824

$3,659,998

$4,339,848

$ 32,370
$ 32,370
0.01
$

$ (333,597) $ 884,834
$1,561,924
$ 709,795
0.16
$
0.14
$

$ 941,171
$ (199,524)
(0.02)
$

Quarter Ended

3/31/2004(1)(2)

6/30/04

9/30/04

12/31/04

$

2,435

$

2,822

$

49,418

$ 159,425

$(166,915) $ (993,029) $ (335,823) $ (546,055)
$(166,915) $ (993,029) $ (335,823) $ (546,055)
(0.27)
$

(0.16) $

(5.43) $

— $

(1) Operations commenced February 2, 2004.
(2) There were no common shares outstanding in the first quarter of 2004.

83

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

14. Financial Highlights

Following is a schedule of financial highlights for the years ended December 31, 2005, and for the period

from February 2, 2004 (commencement of operations) to December 31, 2004:

Period from
February 2, 2004
(commencement of
operations) to
December 31,
2004

Year Ended
December 31,
2005

Per share data:
Net asset value at beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net investment income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net realized gain on investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net unrealized appreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total from investment operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net decrease in net assets from capital share transactions . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation expense included in investment loss (3)
. . . .
Net asset value at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ratios and supplemental data:

Per share market value at end of period (4)
. . . . . . . . . . . . . . . . . . . . . . .
Total return . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shares outstanding at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average number of common shares outstanding . . . . . . . . . . .
Net assets at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ratio of operating expense to average net assets . . . . . . . . . . . . . . . . . .
Ratio of net investment income/(loss) before provision for income tax

expense and investment gains and losses to average net assets . . . . .
Average debt outstanding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average debt per common share outstanding . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Portfolio turnover

$

$

$

12.18
0.18
0.07
0.05
0.30
(0.82)
(0.03)
0.04
11.67

$

$

13.19(1)
(0.99)
—
—
(0.99)
(0.35)(2)

—
0.33
12.18

$

—
N/A
2,059,270
1,187,000
$25,078,133

11.99
-7.58%(6)

9,801,965
6,939,000
$114,352,330

11.57%

1.93%

$ 20,284,932
2.92
$
0.60%

$
$

8.81%(7)

7.95%(7)
—
—
0.00%

(1) On June 29, 2004, the Company completed its sale of common stock in a private placement at $15.00 per

(2)

share ($13.19 per share net of offering costs).
Immediately after the private placement of common stock in June 2004, 600 convertible preferred shares
were converted into 125,000 units (see Note 7).

(3) Stock option expense is a non-cash expense that has no effect on net asset value. Pursuant to Financial

Accounting Standards No. 123 (revised 2004), net investment loss includes the expense associated with the
granting of stock options which is offset by a corresponding increase in paid-in capital.

(4) The Company completed the initial public offering of its common stock in June 2005, therefore, no market

value data is presented as of December 31, 2004.

(5) The total return for the period ended December 31, 2005; is for a shareholder who owned common shares

throughout the period, and received one additional common share for every two 5 Year Warrants cancelled.
Shareholders who purchased common shares on January 26, 2005, exercised 1 Year Warrants, or purchased
common shares in the initial public offering will have a different total return. The Company completed its
initial public offering on June 11, 2005, prior to that date shares were issued in a private placement.
(6) Total market value is the return to an investor who participated in the June 2005 initial public offering and

purchased shares at $13.00 per share ($12.18 per share net of offering costs). As no common shares were
publicly traded during the period ended December 31, 2004, market value total investment return is not
presented.
(7) Not annualized.

84

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

15. Indemnification

The Company and its executives are covered by Directors and Officers Insurance, with the directors and
officers being indemnified by the Company to the maximum extent permitted by Maryland law subject to the
restrictions in the 1940 Act.

16. Subsequent Events

At December 31, 2005, the Company reduced the fair value of an investment in one portfolio company by
approximately $3.3 million to the expected realizable fair value of $1.3 million. In January 2006, the principle
assets of the portfolio company were sold, and the Company received a cash distribution of approximately $1.3
million. Terms of the asset sale agreement call for two additional contingent payments of up to $500,000 from
which we are entitled to received approximately $350,000 each, but the condition of the agreement, make receipt
of payments uncertain and the Company will account for any future receipts as loss recoveries at the time of
payment. On February 6, 2006, the Company received an additional cash distribution of $239,000 which will be
accounted for as a loss recovery in the first quarter of 2006.

In December 2005, the Company declared a dividend of $0.30 per share for shareholders of record on
January 6, 2006. The dividend payment totaling approximately $2.9 million was distributed to shareholders on
January 27, 2006.

On January 19, 2006, the Company filed a registration statement with the SEC to sell approximately
3.3 million shares of its common stock to existing shareholders in a Rights Offering. The final number of shares
sold and the offering price will not be determined until closing of the offering which the Company anticipates
will be completed in March 2006. Proceeds from the offering, if completed, will be used to invest in portfolio
companies in accordance with the Company’s investment objective and strategy and to pay operating expenses.

On March 6, 2006, the Company entered into an agreement to repay $10.0 million of the $25.0 million
outstanding under its Bridge Loan Credit Facility. The Company also extended the maturity of the remaining
$15.0 million from August 12, 2006 to June 30, 2006 and decreased the interest rate from 13.5% to 10.86% per
annum.

On March 6, 2006, the Company amended the Citigroup facility with an agreement that increased the
borrowing capacity under the facility to $125.0 million, increased the advance rate to 60% of eligible loans and
increased the eligible capacity for loans by geographic region. The amendment allows for an interest rate of
LIBOR plus 2.5% on amounts borrowed in excess of $100.0 million and an interest rate of LIBOR plus 5.0% for
amounts borrowed in excess of 55% of eligible loans. The Company agreed to pay a restructuring fee of
$150,000 that will be expensed ratably through maturity on July 31, 2006.

On March 6, 2006, various funds affiliated with Farallon agreed to purchase $5.0 million of the Company’s

common stock at a price per share equal to the NAV at February 28, 2006.

85

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Not applicable.

Item 9a. Controls and Procedures

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and

with the participation of our management, including our Chief Executive Officer and our Chief Financial and
Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as
defined in Rule 13a-15 of the Securities Exchange Act of 1934). Based on that evaluation, our Chief Executive
Officer and Chief Financial and Accounting Officer have concluded that our current disclosure controls and
procedures are effective in timely alerting them of material information relating to the Company that is required
to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934.

Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their
objectives, and our Chief Executive Officer and our Chief Financial and Accounting Officer have concluded that
these controls and procedures are effective at the “reasonable assurance” level. We believe that a control system,
no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control
system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances
of fraud, if any, within a company can be detected.

Management’s Report on Internal Control over Financial Reporting and the Report of Independent
Registered Public Accounting Firm thereon are set forth in Part II, Item 8 of the Annual Report on Form 10-K.

There have been no changes in the Company’s internal control over financial reporting that occurred during
the quarter ended December 31, 2005 that have materially affected, or are reasonably likely to materially affect,
the Company’s internal control over financial reporting.

Item 9b. Other Information

None.

Item 10. Directors and Executive Officers of the Registrant

PART III

Our business and affairs are managed under the direction of our Board of Directors. Our Board of Directors

elects our officers who serve at the discretion of the Board of Directors. Our Board of Directors currently
consists of three members, one who is an “interested person” of Hercules Technology Growth Capital as defined
in Section 2(a)(19) of the 1940 Act and two who are not interested persons and who we refer to as our
independent directors. We anticipate that at least one additional independent director will be elected to our Board
of Directors by June 2006.

86

Our executive officers, directors and key employees and their positions are set forth below. The address for
each executive officer, director and key employee is c/o Hercules Technology Growth Capital, Inc., 525 University
Avenue, Suite 700, Palo Alto, California 94301.

Name

Age

Positions

Interested Director (1)
Manuel A. Henriquez . . . . . . . . . . . . . . . . . .

42 Chairman of the Board of Directors; President and

Chief Executive Officer

Independent Directors
Joseph W. Chow (2)(3)(4)(5) . . . . . . . . . . . .
. . . . . .
Allyn C. Woodward, Jr. (2)(3)(4)(5)

53 Director
65 Director

Executive Officers
Manuel A. Henriquez . . . . . . . . . . . . . . . . . .

42 Chairman of the Board of Directors; President and

Chief Executive Officer

H. Scott Harvey . . . . . . . . . . . . . . . . . . . . . . .

51 Chief Legal Officer; and Chief Compliance

David M. Lund . . . . . . . . . . . . . . . . . . . . . . .

52 Vice President of Finance and Corporate

Officer

Controller

Shane A. Stettenbenz . . . . . . . . . . . . . . . . . .

35 Chief Technology Officer

Key Employees
Glen C. Howard . . . . . . . . . . . . . . . . . . . . . .
Samir Bhaumik . . . . . . . . . . . . . . . . . . . . . . .
Kathleen Conte . . . . . . . . . . . . . . . . . . . . . . .
John Hershey . . . . . . . . . . . . . . . . . . . . . . . . .
Roy Y. Liu . . . . . . . . . . . . . . . . . . . . . . . . . .
Edward M. Messman . . . . . . . . . . . . . . . . . .
Parag I. Shah . . . . . . . . . . . . . . . . . . . . . . . . .

Senior Managing Director

49
42 Managing Director
59 Managing Director
44 Managing Director
45 Managing Director
35 Managing Director
34 Managing Director

(1) Mr. Henriquez is an interested person, as defined in section 2(a)(19) of the 1940 Act, of the Company due to

his position as an officer of the Company and because he is a beneficial owner of securities of JMP Group
LLC, the ultimate parent entity of one of the co-dealer managers in this offering.

(2) Member of the Audit Committee.
(3) Member of the Valuation Committee.
(4) Member of the Compensation Committee.
(5) Member of the Nominating and Corporate Governance Committee.

Interested Director

Manuel A. Henriquez is a co-founder of the company and has been our Chairman and Chief Executive

Officer since December 2003 and our President since April 2005. Prior to co-founding our company,
Mr. Henriquez was a Partner at VantagePoint Venture Partners, a $2.5 billion multi-stage technology venture
fund, from August 2000 through July 2003. Prior to VantagePoint Venture Partners, Mr. Henriquez was the
President and Chief Investment Officer of Comdisco Ventures, a division of Comdisco, Inc., a leading
technology and financial services company, from November 1999 to March 2000. Prior to that, from March 1997
to November 1999, Mr. Henriquez was a Managing Director of Comdisco Ventures. Mr. Henriquez was a senior
member of the investment team at Comdisco Ventures that originated over $2.0 billion of equipment lease, debt
and equity transactions from 1997 to 2000. Mr. Henriquez received a B.S. in Business Administration from
Northeastern University.

87

Independent Directors

Joseph W. Chow has served as a director since February 2004. Mr. Chow is Executive Vice President and

Chief Risk and Corporate Administration Officer at State Street Corporation, having retired from the company in
August 2003 and rejoined it in July 2004. Prior to August 2003, Mr. Chow was Executive Vice President and
Head of Credit and Risk Policy at State Street. Before joining State Street in 1990, Mr. Chow worked at Bank of
Boston in various international and corporate banking roles and specialized in the financing of emerging-stage
high technology companies from 1983 to 1989. Mr. Chow is a graduate of Brandeis University with a B.A. in
Economics. He also received an M.C.P. from the Massachusetts Institute of Technology and an M.S. in
Management (Finance) from the MIT Sloan School of Management.

Allyn C. Woodward, Jr. has served as a director since February 2004, Mr. Woodward was Vice Chairman
of Adams Harkness Financial Group (AHFG—formerly Adams, Harkness & Hill) from April 2001 until January
2006, when AHFG was sold to Canaccord, Inc. He previously served as President from 1995—2001. AHFG was
an independent institutional research, brokerage and investment banking firm headquartered in Boston, MA.
Prior to joining AHFG, Mr. Woodward worked for Silicon Valley Bank from April, 1990 to April 1995, initially
as Executive Vice President and Co-founder of the Wellesley MA office and more recently as Senior Executive
Vice President and Chief Operating Officer of the parent bank in California. Silicon Valley Bank is a commercial
bank, headquartered in Santa Clara, CA whose principal lending focus is directed toward the technology,
healthcare and venture capital industries. Prior to joining Silicon Valley Bank, Mr. Woodward was Senior Vice
President and Group Manager of the Technology group at Bank of New England, Boston, MA where he was
employed from 1963-1990. Mr. Woodward is currently a Director, Chairman of the Compensation Committee
and a member of the Audit Committee of Lecroy Corporation (NASDAQ:LCRY). He is also a former Director of
Viewlogic (NASDAQ:VIEW) and Cayenne Software, Inc (NASDAQ:CAYN). Mr. Woodward serves on the
Board of Directors of three private companies and is on the Board of Advisors of several venture capital firms.
Mr. Woodward is on the Board of Overseers and a member of the Finance Committee of Newton Wellesley
Hospital, a 250 bed hospital located in Newton, MA. Mr. Woodward is on the Board of Overseers and the
Investment Committee and the Finance Committee of Babson College in Babson Park, MA. Mr. Woodward
graduated from Babson College with a degree in finance and accounting. He also graduated from the Stonier
Graduate School of Banking at Rutgers University.

Executive Officers who are not Directors

H. Scott Harvey is a co-founder of the company and has been our Chief Legal Officer since December
2003. Mr. Harvey has over 20 years of legal and business experience with leveraged finance and financing public
and private technology-related companies. Since July 2002, and prior to Joining us, Mr. Harvey was in a
diversified private practice. Previously, Mr. Harvey was Deputy General Counsel of Comdisco, Inc., a leading
technology and financial services company, from January 1997 to July 2002. From 1991 to 1997, Mr. Harvey
served as Vice President of Marketing, Administration & Alliances with Comdisco, Inc. and was Corporate
Counsel from 1983 to 1991. Mr. Harvey received a B.S. in Agricultural Economics from the University of
Missouri, a J.D. and LLM in taxation from The John Marshall Law School and an M.B.A. from Illinois Institute
of Technology.

David M. Lund joined us in July 2005 as Vice President of Finance and Corporate Controller, and is our

Principal Financial and Accounting Officer. He has over 20 years of experience in finance and accounting
serving companies in the technology sector. Prior to joining Hercules, Mr. Lund served in senior financial
positions for publicly traded companies: InterTrust Technologies, Centillium Communications and Rainmaker
Systems, and in private companies: Urban Media, Scion Photonics and APT Technology. Mr. Lund also served
in public accounting with Ernst & Young LLP and Grant Thornton LLP. He received a B.S. degree in Business
Administration with an emphasis in Accounting from San Jose State University and a B.S. degree in Business
Administration with an emphasis in Marketing from California State University, Chico. Mr. Lund is a Certified
Public Accountant in the State of California.

88

Shane A. Stettenbenz joined the company in February 2004 as Vice President—Information Systems and

has served as Chief Technology Officer since December 2004. Mr. Stettenbenz previously served as an IT
Director for VantagePoint Venture Partners from May 2001 to June 2003. Prior to that, Mr. Stettenbenz was an
IT Manager for Comdisco Ventures, a division of Comdisco, Inc. from May 1997 to May 2001. Mr. Stettenbenz
attended San Jose State University from 1991 to 1995 while majoring in Management Information Systems.

Key Employees

Samir Bhaumik joined the company in November 2004 as a Managing Director. Mr. Bhaumik previously
served as Vice President-Western Region of the New York Stock Exchange from March 2003 to October 2004.
Prior to working for the New York Stock Exchange, Mr. Bhaumik was Senior Vice President of Comerica Bank,
previously Imperial Bank, from April 1993 to February 2003. Mr. Bhaumik received a B.A. from San Jose State
University and an M.B.A from Santa Clara University. He serves on the advisory boards of Santa Clara
University Leavey School of Business, Junior Achievement of Silicon Valley and the American Electronics
Association- Bay Area council.

Kathleen Conte joined the company as a Managing Director of Life Sciences in November 2004. From
December 2003 to November 2004, she worked as an independent consultant. From 1993 to December 2003, she
served as Senior Vice President at Comerica Bank running its West Coast Life Sciences Group. Ms. Conte was at
Prudential Capital Corporation from 1987 to 1993 originating structured private placements. Prior to that she
spent 13 years at Wells Fargo Bank in various lending positions. Ms. Conte holds a B.A. degree and an M.B.A.
from the University of Delaware.

John D. Hershey joined the company in September 2005 as a Managing Director. From July 2004 to
August 2005, he worked as an independent consultant. From October 2000 to June 2004, Mr. Hershey served as a
Managing Director at Infinity Capital, an early stage venture capital firm where he co-managed the firm’s
software and services investing group. Prior to Infinity Capital, Mr. Hershey worked as a Managing Director at
Banc of America Securities from May 1995 to September 2000. At Banc of America Securities, Mr. Hershey
managed the firm’s Internet Investment Banking group and served on the firm’s Fairness Opinion Commitment
Committee. From July 1990 to November 2003, Mr. Hershey was an Associate at James D. Wolfensohn, Inc.,
where he helped manage Wolfensohn Associates L.P., an all stage venture capital fund. Mr. Hershey received a
B.A. degree in Economics from University of California, Davis and an M.B.A from the University of Chicago.

Glen C. Howard is a co-founder of the company, served as our President from December 2003 until April

2005 and is currently our Senior Managing Director. Mr. Howard has over 18 years of experience with structured
finance and financing public and private technology-related companies. Prior to co-founding Hercules
Technology Growth Capital, Mr. Howard served as a Principal with Pearl Street Group, a specialty finance
company, from May 2001 to October 2003. From September 1999 to May 2001, Mr. Howard was a Managing
Director of Comdisco Ventures, a division of Comdisco, Inc., a leading technology and financial services
company. Prior to that, Mr. Howard was a Senior Associate of Comdisco Ventures from February 1997 to
September 1999. Mr. Howard was a senior member of the investment team at Comdisco Ventures that originated
over $2.5 billion of equipment lease, debt and equity transactions from 1997 to 2001. Prior to joining Comdisco
Ventures, Mr. Howard was Vice President of Comdisco, Inc. where he was actively involved in the management
and marketing of structured finance products to private and public technology-related companies. Mr. Howard
received a B.S. in Systems Industrial Engineering from the University of Arizona and an M.B.A. from Saint
Mary’s College.

Roy Y. Liu joined the company as a Managing Director in April 2004. Mr. Liu has over 20 years experience

in operations and finance of technology companies. Formerly, Mr. Liu was a Vice President at GrandBanks
Capital, an early-stage, information technology-focused venture capital firm. From 2000 to 2002, Mr. Liu was a
founding principal of VantagePoint Structured Investments, a debt fund affiliated with VantagePoint Venture
Partners. Prior to joining VantagePoint, Mr. Liu was VP Finance and Chief Financial Officer for toysmart.com,

89

Inc. Prior to joining toysmart.com, he was a First Vice President and co-founded Imperial Bank’s Emerging
Growth Industries Boston office in 1997, where he focused specifically on debt financing for venture-backed
companies. Prior to co-founding Imperial Bank’s Emerging Growth Industries Boston office, Mr. Liu was the
Chief Financial Officer of Microwave Bypass Systems, Inc. Prior to joining Microwave Bypass, Mr. Liu was
Vice President and head of the High Tech Lending group for State Street Bank & Trust Co. Mr. Liu started his
finance career in the Acquisition Finance Division of the Bank of Boston. Prior to his career in finance, Mr. Liu
worked four years at IBM in research and product development. He holds a B.S. degree in Electrical Engineering
and an M.B.A. from the University of Michigan.

Edward M. Messman joined the company in July 2005 as a Managing Director. From June 2004 to July

2005, Mr. Messman served as the Southwest Regional Market Manager of the Structured Finance Group of
Silicon Valley Bank. Prior to Silicon Valley Bank, Mr. Messman worked as an independent consultant from
December 2003 to June 2004. From October 1998 to December 2003, Mr. Messman was Vice President of
Comerica Bank, previously Imperial Bank, where he formed and managed the Technology and Life Sciences
group in Denver, Colorado covering the Rocky Mountain region. Mr. Messman received a B.S. degree in
International Business from Grand Canyon University and an M.B.A from the University of Colorado.

Parag I. Shah joined the company in November 2004 as Managing Director of Life Sciences. From April
2000 to April 2004, Mr. Shah served as a Senior Vice President in Imperial Bank’s Life Sciences Group, which
was acquired by Comerica Bank in early 2001. Prior to working at Comerica Bank, Mr. Shah was an Assistant
Vice President at Bank Boston from January 1997 to March 2000. Bank Boston was acquired by Fleet Bank in
1999. Mr. Shah completed his Masters degrees in Technology, Management and Policy as well as his Bachelors
degree in Molecular Biology at the Massachusetts Institute of Technology (MIT). During his tenure at MIT,
Mr. Shah conducted research at the Whitehead Institute for Biomedical Research and was chosen to serve on the
Whitehead Institute’s Board of Associates in 2003.

Board of Directors

The number of directors is currently fixed at three directors. We expect that at least one additional

independent director will be elected to our Board of Directors by June 2006.

Our Board of Directors is divided into three classes. One class holds office for a term expiring at the annual
meeting of stockholders to be held in 2006, a second class holds office for a term expiring at the annual meeting
of stockholders to be held in 2007, and a third class holds office for a term expiring at the annual meeting of
stockholders to be held in 2008. Each director holds office for the term to which he or she is elected and until his
or her successor is duly elected and qualifies. Mr. Woodward’s term expires in 2006, Mr. Henriquez’s term
expires in 2007 and Mr. Chow’s term expires in 2008. At each annual meeting of our stockholders, the
successors to the class of directors whose terms expire at such meeting will be elected to hold office for a term
expiring at the annual meeting of stockholders held in the third year following the year of their election and until
their successors are duly elected and qualify.

In connection with its purchase of our preferred stock in February 2004, we granted JMP Asset Management

LLC the right to designate one observer to attend meetings of our Board of Directors, other than executive
sessions, committee meetings or subcommittee meetings consisting solely of independent directors until
February 2007. After the expiration of this initial period, the independent directors on our board will consider, on
an annual basis, the extension of such observation rights for an additional one year period. Upon certain events
resulting in a change of control of JMP Asset Management LLC, its observation rights will immediately
terminate.

Compensation of Directors

As compensation for serving on our Board of Directors, each of our independent directors receives an
annual fee of $50,000 and an additional $2,000 per each meeting of the board attended. Employee directors and

90

non-independent directors do not receive compensation for serving on the board. Independent directors who
serve on board committees receive cash compensation in addition to the compensation they receive for service on
our Board of Directors. The chairperson of each committee of our Board of Directors receives an additional
$15,000 per year and all committee members receive an additional $2,000 for each committee meeting they
attend. In addition, we reimburse our directors for their reasonable out-of-pocket expenses incurred in attending
meetings of the Board of Directors.

On June 21, 2005, we applied for exemptive relief from the SEC to permit us to grant options to purchase

our common stock to our non-employee directors as a portion of their compensation for service on our Board of
Directors. If we do not receive exemptive relief we will put in place and consider alternative compensation
benefits for the independent directors, which would include an immediate grant or retainer as well as an ongoing
annual grant or retainer.

Committees of the Board of Directors

Audit Committee. Our Board of Directors has established an Audit Committee. The Audit Committee is

comprised of Messrs. Chow and Woodward, each of whom is considered an independent director and satisfies
the independence requirements for purposes of the Nasdaq National Market listing standards, and we will add
another independent director to our board by June 2006 who will become a member of the Audit Committee.
Mr. Chow serves as Chairman of the Audit Committee. The qualifications of each member of the Audit
Committee are set forth in the preceding paragraphs of this Item 10.

The Audit Committee is responsible for approving our independent accountants, reviewing with our

independent accountants the plans and results of the audit engagement, approving professional services provided
by our independent accountants, reviewing the independence of our independent accountants and reviewing the
adequacy of our internal accounting controls. During the last fiscal year, the Audit Committee held two meetings.

Valuation Committee. Our Board of Directors has established a Valuation Committee. The Valuation
Committee is comprised of Messrs. Chow and Woodward, each of whom is an independent director and, we will
add another independent director to our board by June 2006 who will become a member of the Valuation
Committee. Mr. Woodward serves as chairman of the Valuation Committee. The Valuation Committee is
responsible for reviewing and recommending to the full board the fair value of debt and equity securities that are
not publicly traded in accordance with established valuation procedures. The Valuation Committee may utilize
the services of an independent valuation firm in arriving at fair value of these securities. During the last fiscal
year, the Valuation Committee held three meetings.

Compensation Committee. Our Board of Directors has established a Compensation Committee. The

Compensation Committee is comprised of Messrs. Chow and Woodward, each of whom is an independent
director and satisfies the independence requirements for purposes of the Nasdaq National Market listing
standards, and we will and another independent director to our board by June 2006 who will become a member
of the Compensation Committee. Mr. Woodward serves as Chairman of the Compensation Committee. The
Compensation Committee determines compensation for our executive officers, in addition to administering our
2004 Equity Incentive Plan, which is described below. During the last fiscal year, the Compensation Committee
held three meetings.

Nominating and Corporate Governance Committee. Our Board of Directors has established a Nominating

and Corporate Governance Committee. The nominating and corporate governance committee is comprised of
Messrs. Chow and Woodward, each of whom is an independent director and satisfies the independence
requirements for purposes of the Nasdaq National Market listing standards, and we will add another independent
director to our board by June 2006 will become a member of the Nominating and Corporate Governance
Committee. Mr. Chow serves as chairman of the Nominating and Corporate Governance Committee. The

91

Nominating and Corporate Governance Committee will nominate to the Board of Directors for consideration
candidates for election as directors to the Board of Directors. During the last fiscal year, the Nominating and
Corporate Governance Committee did not hold a meeting to discuss candidate nominations. Discussions
regarding corporate governance were held in conjunction with the meetings of the Board of Directors.

Until investment funds controlled by Farallon Capital Management, L.L.C. beneficially own less than 10%
of our outstanding common stock, Farallon Capital Management, L.L.C. has the right to recommend one person
to our Nominating and Corporate Governance Committee for consideration as a nominee to our Board of
Directors, provided that such person qualifies as an independent director under the 1940 Act. Farallon Capital
Management, L.L.C. has not chosen to recommend any nominees to our Board of Directors.

Until investment funds controlled by JMP Asset Management LLC beneficially own less than 10% of our

outstanding common stock, JMP Asset Management LLC has the right to recommend two people to our
Nominating and Corporate Governance Committee for consideration as a nominee to our Board of Directors,
provided that such persons qualify as independent directors under the 1940 Act. JMP Asset Management LLC
has not chosen to recommend any nominees to our Board of Directors.

Section 16(a) Beneficial Ownership Reporting Compliance

During 2005, David Lund failed to file one Form 3 on a timely basis and Allyn Woodward failed to file one

Form 4 on a timely basis.

Code of Ethics

We have adopted a code of business conduct and ethics that applies to directors, officers and employees.
The code of business conduct and ethics is available on our website at http://www.herculestech.com. We will
report any amendments to or waivers of a required provision of the code of business conduct and ethics in a
Form 8-K.

92

Item 11. Executive Compensation

Compensation of Executive Officers

Under SEC rules applicable to business development companies, we are required to set forth certain
information regarding the compensation of certain of our executive officers and directors. The following table
sets forth information regarding the compensation earned by our directors and our five highest paid executive
officers (collectively, they are referred to as “Compensated Persons”) in all capacities during the fiscal year
ending December 31, 2005. No compensation is paid to directors, in their capacity as such, who are “interested
persons.”

Summary Compensation Table

Annual Compensation

Awards

Payouts

Long-Term Compensation

Other Annual
(Aggregate)
Compensation
(from the
Company)
($)

(Number of)
Securities
Underlying
Options/
SARS
(#)

Restricted
Stock
Award(s)
($)

(Pension or
Retirement
Benefits
Accrued as Part
of Company
Expenses (1))
LTIP Payouts
($)

Name and Principal
Position

Year

Salary
($)

Bonus
($)

Independent Directors:

Joseph W. Chow . . . . . 2005
Allyn C. Woodward,

Jr. . . . . . . . . . . . . . . . 2005

Executive Officers:

Manuel A.

Henriquez . . . . . . . . . 2005 $308,506 $700,000
. . . . . 2005 151,200 100,000
50,000

H. Scott Harvey.
David M. Lund . . . . . . 2005
Shane A.

74,490

$

77,500

79,000

1,008,506
251,200
124,490

Stettenbenz . . . . . . . . 2005 129,446

60,000

189,446

Former Officer:

All Other
Compensation (2)
($)

$77,500

79,000

—
—
—

—

—

—

—

605,000(3)
141,000(4)
40,000(6)

95,000(7)

—

—

—
—
—

—

—

Glen C. Howard . . . . . . 2005 216,231

—

216,231

32,000(8)

(1) We do not have a profit sharing or retirement plan, and directors do not receive any pension or retirement
benefits. Officers and employees are eligible for annual bonuses based on performance measured against
specific goals and approved by the Board of Directors.

(2) Consists only of directors’ fees we paid in 2005. Such fees are also included in the column titled “Aggregate

Compensation from the Company.”

(3) Represents options to purchase 605,000 shares of our common stock at an exercise price per share equal to

$13.00 issued under our 2004 Equity Incentive Plan.

(4) Represents options to purchase 141,000 shares of our common stock at an exercise price per share equal to

$13.00 issued under our 2004 Equity Incentive Plan.

(5) Mr. Lund joined us in July 2005, and his compensation reflects less than a full year of service.
(6) Represents options to purchase 40,000 shares of our common stock at an exercise price per share equal to

$13.00 issued under our 2004 Equity Incentive Plan.

(7) Represents options to purchase 95,000 shares of our common stock at an exercise price per share equal to

$13.00 issued under our 2004 Equity Incentive Plan.

(8) Represents options to purchase 32,000 shares of our common stock at an exercise price per share equal to

$13.00 issued under our 2004 Equity Incentive Plan.

93

Compensation of Portfolio Management Employees

The compensation of our investment committee, consisting of our Chief Executive Officer, our Senior
Managing Director, our Chief Legal Officer and our Vice President of Finance, is set by the compensation
committee of our Board of Directors. The investment committee is compensated in the form of annual salaries,
annual cash bonuses based on performance measured against specific goals and long-term compensation in the
form of stock option grants. The compensation program is designed so that a substantial portion of each member
of the investment committee’s compensation is dependent upon the performance of our portfolio of investments
and our profitability.

Salaries and Annual Bonus

The compensation committee of our Board of Directors meets with the Chief Executive Officer to receive

his recommendations regarding the salary and annual bonus for each member of the investment committee other
than the Chief Executive Officer. The committee also considers the recent performance of our portfolio of
investments and our profitability in light of general economic and competitive conditions. Based on this
information and any other considerations it deems relevant, the compensation committee sets salaries and annual
bonus guidelines in its sole discretion.

Long Term Compensation

Long-term performance-based compensation generally includes stock option grants under our 2004 Equity

Incentive Plan. Stock option grants to each investment committee member are based on criteria established by
the compensation committee, including responsibility level, salary level, committee member performance,
overall investment portfolio performance and overall profitability.

Option Grants in Last Fiscal Year

The following table sets forth information concerning options and warrants to purchase shares of our

common stock granted to our Compensated Persons.

Option Grants During 2005

Number of
Securities
Underlying
Option

Expiration
Date

Percent of
Total Options
Granted to
Employees in
Fiscal Year

Potential Realizable Value at
Assumed Annual Rates of
Stock Price Appreciation for
Option Term(3)

5%

10%

Name

Manuel A. Henriquez . . . . . . . . . . . . . . . . . . . . .
H. Scott Harvey . . . . . . . . . . . . . . . . . . . . . . . . .
David M. Lund . . . . . . . . . . . . . . . . . . . . . . . . . .
Shane A. Stettenbenz . . . . . . . . . . . . . . . . . . . . .
Glen C. Howard . . . . . . . . . . . . . . . . . . . . . . . . .

605,000(1) 6/17/12
141,000(1) 6/17/12
40,000(2) 7/15/12
95,000(1) 6/17/12
32,000(1) 6/17/12

47.64% $3,201,845
746,215
11.10%
211,692
3.15%
502,769
7.48%
169,354
2.52%

$7,461,660
1,738,998
493,333
1,171,666
394,666

Issued in connection with the Company’s initial public offering.
Issued in connection with employment.

(1)
(2)
(3) The amounts shown on this table represent hypothetical gains that could be achieved for the respective options
or warrants if exercised at the end of the term. These gains are based on assumed rates of stock appreciation of
5% and 10% compounded annually from the date the respective options or warrants were granted to their
expiration date. The gains shown are net of the applicable exercise price, but do not include deductions for
taxes or other expenses associated with the exercise. Actual gains, if any, on exercises will depend on the
future performance of our common stock, the holder’s continued employment through the option or warrant
period and the date on which the options or warrants are exercised. If our common stock does not increase in
value after the grant date of the options and warrants, the options and warrants are valueless.

94

Employment Agreement

We intend to enter into an employment agreement with Mr. Henriquez which will provide for a three-year

term with automatic one-year renewals.

The employment agreement for Mr. Henriquez will provide a base salary and provide that he is entitled to

participate in an annual incentive performance based bonus and long term retention program. Under such
program, he will be eligible to receive up to 200% of his base salary depending on our performance against
certain criteria to be established annually by the compensation committee of the Board of Directors. He will also
be contractually entitled to participate in our 2004 Stock Option Plan described below.

If we terminate Mr. Henriquez’s employment by reason of a disability, he would be entitled to receive from
us the difference between his then current base salary plus annual incentive bonus, long-term retention program
and any long-term disability benefits for two years. Additionally, Mr. Henriquez’s unvested options, which are
scheduled to vest within two years of the termination date, would immediately vest. All vested options would
expire unless exercised within 18 months of the termination date. If we terminate Mr. Henriquez’s employment
for any reason other than for a disability or cause, he would be entitled to receive his base salary and annual
incentive bonus for a period of two years from the date of termination. These payments would also be made if
Mr. Henriquez resigned for good reason. Mr. Henriquez will also receive severance if he is terminated in
connection with a change of control or if he is not notified that the employment agreement will be continued
upon a change in control.

In the event that we terminate Mr. Henriquez’s employment for cause or in the event that he voluntarily
terminates his employment for other than good reason, all unvested stock options would be forfeited and he
would have no more than 90 days to exercise any vested but unexercised options.

Upon termination of employment, Mr. Henriquez would be subject to certain non-compete covenants. These

covenants would generally apply for one year, although should Mr. Henriquez resign with good reason, the
covenants would apply for only six months following the date of resignation. Mr. Henriquez’s employment
agreement will require that he maintain the confidentiality of our confidential information during and after the
period of his employment.

Other than as described above, we have not entered into any employment agreements.

2004 Equity Incentive Plan

Our Board of Directors and our stockholders have approved the 2005 Amendment and Restatement of the
Hercules Technology Growth Capital, Inc. 2004 Equity Incentive Plan, for the purpose of attracting and retaining
the services of executive officers, directors and other key employees. Under the 2004 Equity Incentive Plan, our
compensation committee may award incentive stock options within the meaning of Section 422 of the Code, or
ISOs, to employees, and nonstatutory stock options to employees and directors.

Under the 2004 Equity Incentive Plan, we have authorized for issuance up to 8,000,000 shares of common

stock. Participants in the 2004 Equity Incentive Plan may receive awards of options to purchase our common
stock, as determined by our compensation committee. Options granted under the 2004 Equity Incentive Plan
generally may be exercised for a period of no more than seven years from the date of grant. Unless sooner
terminated by our Board of Directors, the 2004 Equity Incentive Plan will terminate on the tenth anniversary of
its adoption and no additional awards may be made under the 2004 Equity Incentive Plan after that date. The
2004 Equity Incentive Plan provides that all awards granted under the plan are subject to modification as
required to ensure that such awards do not conflict with the requirements of the 1940 Act applicable to us.

In connection with certain awards made under the 2004 Equity Incentive Plan prior to our initial public
offering, we issued warrants to purchase one share of common stock with up to a 1-year term, which we refer to

95

as the “1-year warrants”, and warrants to purchase one share of common stock with a 5-year term, which we refer
to as the “5-year warrants”. The 1-year warrants and 5-year warrants issued to executive officers and other key
employees under our 2004 Equity Incentive Plan are generally subject to the same terms and conditions as the
warrants included in the units offered by us in our June 2004 private placement, except that the warrants issued in
connection with option grants under the 2004 Equity Incentive Plan will be transferable only by will or intestacy.
See “Description of Capital Stock—5-Year Warrants.”

In connection with our election to be regulated as a business development company, the exercise price for

all of our outstanding 1-year warrants and 5-year warrants, including those granted under the 2004 Equity
Incentive Plan, was reduced to $10.57 per share, the net asset value per share of our common stock on the date of
determination, as adjusted in accordance with the terms of such warrants. All 1-year warrants, including those
outstanding under the 2004 Equity Incentive Plan, that were not exercised in connection with our election to be
regulated as a business development company were canceled. In addition, 5-year warrants, including those
granted under the 2004 Equity Incentive Plan, to purchase an aggregate of 597,196 shares of our common stock
were canceled pro rata among holders of 5-year warrants and 298,598 shares of our common stock were
simultaneously issued to such holders at a rate of one share of common stock for two 5-year warrants so
cancelled, in each case in accordance with the terms of such warrants. Following our election to be regulated as a
business development company, 5-year warrants to purchase an aggregate of 673,223 shares of our common
stock remained outstanding at an exercise price per share equal to $10.57. We do not anticipate issuing any
additional warrants under the 2004 Equity Incentive Plan.

Options granted under the 2004 Equity Incentive Plan will entitle the optionee, upon exercise, to purchase
shares of common stock from us at a specified exercise price per share. ISOs must have a per share exercise price
of no less than the fair market value of a share of stock on the date of the grant or, if the optionee owns or is
treated as owning (under Section 424(d) of the Code) more than 10% of the total combined voting power of all
classes of our stock, 110% of the fair market value of a share of stock on the date of the grant. Nonstatutory stock
options granted under the 2004 Equity Incentive Plan must have a per share exercise price of no less than the fair
market value of a share of stock on the date of the grant. Options will not be transferable other than by laws of
descent and distribution, or in the case of nonstatutory stock options, by gift, and will generally be exercisable
during an optionee’s lifetime only by the optionee.

Our compensation committee administers the 2004 Equity Incentive Plan and has the authority, subject to the

provisions of the 2004 Equity Incentive Plan, to determine who will receive awards under the 2004 Equity Incentive
Plan and the terms of such awards. Our compensation committee will have the authority to adjust the number of
shares available for awards, the number of shares subject to outstanding awards and the exercise price for awards
following the occurrence of events such as stock splits, dividends, distributions and recapitalizations. The exercise
price of an option may be paid in the form of shares of stock that are already owned by such optionholder.

Upon specified covered transactions (as defined in the 2004 Equity Incentive Plan), all outstanding awards

under the 2004 Equity Incentive Plan may either be assumed or substituted for by the surviving entity. If the
surviving entity does not assume or substitute similar awards, the awards held by the participants will be
accelerated in full and then terminated to the extent not exercised prior to the covered transaction.

Awards under the 2004 Equity Incentive Plan will be granted to our executive officers and other employees
as determined by our compensation committee at the time of each issuance. In connection with our initial public
offering, our compensation committee approved the grant of:

•

•

•

•

options to purchase an aggregate of 266,000 shares common stock to our officers and employees other
than Messrs. Henriquez, Howard, Harvey and;

an option to Mr. Henriquez to purchase 605,000 shares of common stock;

an option to Mr. Howard to purchase 32,000 shares of common stock; and

an option to Mr. Harvey to purchase 141,000 shares of common stock.

96

The exercise price per share for all such options is $13.00 per share, the public offering price of our
common stock in our initial public offering. Including the foregoing grants, the outstanding options granted to
our executive officers and other employees represent approximately 10.6% of our fully-diluted equity
capitalization. We expect that, subject to compliance with applicable regulations governing business
development companies, we will grant additional awards to our officers and employees. The options and
warrants granted to our executive officers and employees in connection with our initial public offering (including
those granted following the closing of our initial public offering described in the preceding sentence) will
generally vest over a three-year period, one-third after one year and monthly thereafter. We expect that any
options granted to our non-employee directors will generally vest over two years, in equal installments on each of
the first two anniversaries of the date of grant, subject to our receipt of exemptive relief from the SEC.

Option Grants to Non-Employee Directors

Under current SEC rules and regulations applicable to business development companies, a business

development company may not grant options to non-employee directors. On June 21, 2005, we applied for
exemptive relief from the SEC to permit us to grant options to purchase shares of our common stock to our
non-employee directors as a portion of their compensation for service on our Board of Directors. We cannot
provide any assurance that we will receive any exemptive relief from the SEC.

Restricted Stock, Dividend Equivalent Rights or Other Similar Rights

Under current SEC rules and regulations applicable to business development companies, a business

development company may not grant restricted stock to employees or dividend equivalent rights to option
holders. Dividend equivalent rights allow an optionholder to receive the economic value of dividends on the
stock underlying the options prior to exercise of the option. We intend to apply for exemptive relief from the
SEC to permit us to issue restricted stock to our employees. We cannot provide any assurance that we will
receive any such exemptive relief from the SEC. If the SEC does not grant us exemptive relief, we will evaluate
alternative incentive plan arrangements.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Securities Authorized for Issuance Under Equity Compensation Plan

The following table sets forth, as of December 31, 2005, information with respect to compensation plans

under which equity securities of the registrant are authorized for issuance, aggregated as follows:

• All compensation plans previously approved by security holders; and

• All compensation plans not previously approved by security holders.

97

A description of the 2004 Equity Incentive Plan from which forms the basis of the Equity Compensation

Plan Information below can be found in this Annual Report on Form 10-K in response to Part III, Item 10.

Equity Compensation Plan Information

Number
Of Securities To Be Issued Upon
Exercise Of Outstanding Options,
Warrant And Rights

Weighted-Average Exercise
Price Of Outstanding
Options, Warrants And
Rights

Number Of Securities Remaining
Available For Future Issuance
Under Equity Compensation
Plans (Excluding Securities
Reflected In Column (a))

(a)

(b)

(c)

1,393,987

0

$13.39

$ 0.00

6,510,418

0

Plan Category

Equity Compensation Plans
Approved By Security
Holders . . . . . . . . . . . . . . .

Equity Compensation Plans

Not Approved By
Security Holders . . . . . . .

Total

Security Ownership of Certain Beneficial Owners and Management

No person will be deemed to control us, as such term is defined in the 1940 Act.

The following table sets forth, as of December 31, 2005, information with respect to the beneficial

ownership of our common stock by:

•

•

•

each person known to us to beneficially own more than 5% of the outstanding shares of our common
stock based on our records of ownership of our common stock as of the date of our initial public
offering and filings submitted by these companies to the SEC regarding their ownership of our common
stock.

each of our directors and each executive officers; and

all of our directors and executive officers as a group.

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or

investment power with respect to the securities. Common stock subject to options or warrants that are currently
exercisable or exercisable within 60 days of January 19, 2006 are deemed to be outstanding and beneficially
owned by the person holding such options or warrants. Such shares, however, are not deemed outstanding for the
purposes of computing the percentage ownership of any other person. Percentage of beneficial ownership is
based on 9,801,965 shares of common stock outstanding as of December 31, 2005.

98

Unless otherwise indicated, to our knowledge, each stockholder listed below has sole voting and investment

power with respect to the shares beneficially owned by the stockholder, except to the extent authority is shared
by spouses under applicable law, and maintains an address of c/o Hercules Technology Growth Capital, Inc., 525
University Avenue, Suite 700, Palo Alto, California 94301.

Name and Address

Principal Stockholders:
JMP Group LLC (1)

600 Montgomery Street,
Suite 1100
San Francisco, CA 94111 . . . . . . . . . . . . . . . . . .

Farallon Capital Management, L.L.C. (2)

One Maritime Plaza,
Suite 1325
San Francisco, CA 94111 . . . . . . . . . . . . . . . . . .

T. Rowe Price Associates, Inc. (4)

100 E. Pratt Street
Baltimore, MD 21202 . . . . . . . . . . . . . . . . . . . . .

Cornell Place, LLC (3)

225 Broadway, 15th Floor
New York, NY 10007 . . . . . . . . . . . . . . . . . . . . .

Wellington Management Company, LLP (3)

75 State Street
Boston, MA 02109 . . . . . . . . . . . . . . . . . . . . . . .

Jolson 1996 Trust (5) . . . . . . . . . . . . . . . . . . . . . . . .

Shares of Common Stock Beneficially Owned

Number
Of Shares

Percentage
of Class

1,233,882

12.4%

941,240

656,900

627,496

536,600

481,698

9.5%

6.7%

6.3%

5.5%

4.9%

(1)

(2)

(3)

(4)

(5)

Information as of January 17, 2006 includes 152,797 shares of common stock that can be acquired upon the
exercise of outstanding 5-year warrants. JMP Group LLC may be deemed to beneficially own shares of our
common stock, including shares of common stock issuable upon the exercise of outstanding 5-year
warrants, held of record by certain investment funds for which its wholly-owned subsidiary, JMP Asset
Management LLC, acts as either general partner or investment adviser. JMP Group LLC and JMP Asset
Management LLC each disclaim beneficial ownership of all shares held of record by the funds to the extent
attributable to partnership or equity interests therein held by persons other than JMP Group LLC, JMP Asset
Management LLC, or their affiliates. Joseph A. Jolson serves as Chief Executive Officer of JMP Group
LLC.
Includes 132,480 shares of common stock that can be acquired upon the exercise of outstanding 5-year
warrants. Farallon Capital Management, L.L.C. may be deemed to beneficially own shares of our common
stock, including shares of common stock issuable upon the exercise of outstanding 5-year warrants, held of
record by certain investment funds affiliated with Farallon Capital Management, L.L.C.
Information about the beneficial ownership of our principal stockholders is derived from filings made by
them with the SEC.
Includes 88,323 shares of common stock that can be acquired upon the exercise of outstanding 5-year
warrants. D.B. Zwirn Special Opportunities Fund, L.P. manages Cornell Place, LLC. D.B. Zwirn & Co.,
L.P. is the manager of D.B. Zwirn Special Opportunities Fund, L.P. Daniel B. Zwirn controls Zwirn
Holdings, LLC, which in turn is the managing member of and thereby controls DBZ GP, LLC, which in turn
is the general partner of and thereby controls D.B. Zwirn & Co., L.P.
Includes 337,200 shares of our common stock and 52,994 shares of our common stock issuable upon the
exercise of outstanding 5-year warrants held by the Jolson 1996 Trust. Joseph A. Jolson serves as the trustee
of the Jolson 1996 Trust and, as a result, mat be deemed to beneficially own such shares of common stock,

99

including such 5-year warrants to purchase shares of common stock. This does not include 54,996 shares of
our common stock and 9,008 shares of our common stock that can be acquired upon the exercise of 5-year
warrants held by The Jolson Family Foundation. Mr. Jolson may be deemed to beneficially own the shares
of common stock, including the 5-year warrants to purchase shares of common stock held of record by The
Jolson Family Foundation, for which he serves as the President. Mr. Jolson disclaims beneficial ownership
of all such shares held of record by the The Jolson Family Foundation.

Name and Address

Directors and Executive Officers
Manuel A. Henriquez (1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H. Scott Harvey (2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
David M. Lund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shane A. Stettenbenz . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allyn C. Woodward, Jr. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Joseph W. Chow (3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . .
All directors and executive officers as a group (5 persons) (4)

Shares of Common Stock Beneficially Owned

Number
Of Shares

543,572
23,933
2,000
1,100
4,000
5,647
580,252

Percentage
of Class

5.5%
*
*
*
*
*
5.9%

*
(1)

(2)

(3)
(4)

Less than 1%.
Includes 75,075 shares of common stock that can be acquired upon the exercise of outstanding 5-year
warrants and 125,000 shares of common stock that can be acquired upon the exercise of outstanding
options. Includes shares of our common stock and 5-year warrants held by certain trusts controlled by
Mr. Henriquez.
Includes 4,279 shares of common stock that can be acquired upon the exercise of outstanding 5-year
warrants and 12,821 shares of common stock that can be acquired upon the exercise of outstanding options.
Includes 794 shares of common stock that can be acquired upon the exercise of outstanding 5-year warrants.
Includes 80,148 shares of common stock that can be acquired upon the exercise of outstanding 5-year
warrants and 137,821 shares of common stock that can be acquired upon the exercise of outstanding
options.

The following table sets forth as of January 17, 2006, the dollar range of our securities owned by our
directors and employees primarily responsible for the day-to-day management of our investment portfolio.

Name

Independent Directors
Joseph W. Chow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . .
Allyn C. Woodward, Jr.

Interested Director/Portfolio Management Employee
Manuel A. Henriquez . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Portfolio Management Employees
Glen C. Howard . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
H. Scott Harvey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
David M. Lund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Dollar Range of Equity
Securities in the Company

Aggregate Dollar Range of Equity
Securities in all Registered
Investment Companies Overseen
By Director in Family of
Investment Companies

$50,001-$100,000
$10,001-$50,000

$50,001-$100,000
$10,001-$50,000

over $1,000,000

over $1,000,000

over $1,000,000
$50,001-$100,000
$10,001-$50,000

over $1,000,000
$50,001-$100,000
$10,001-$50,000

100

Item 13. Certain Relationships and Related Transactions

In December 2003, we entered into an engagement letter with JMP Securities LLC, the lead underwriter in

our initial public offering. The engagement letter expired on June 16, 2004. Pursuant to the engagement letter, we
offered to JMP Securities LLC the opportunity to act as the initial purchaser and placement agent in connection
with our June 2004 private offering. As compensation for the services rendered, we agreed to pay to JMP
Securities LLC an aggregate amount equal to 7% of the gross proceeds of the private offering, subject to limited
exceptions in connection with sales of our securities to persons affiliated with us. In addition, we agreed to
reimburse JMP Securities LLC, upon its request, for up to $150,000 of its reasonable out-of-pocket expenses. In
accordance with the foregoing, we paid $1,343,619 in placement fees to JMP Securities LLC in connection with
our June 2004 private placement. We have agreed to indemnify JMP Securities LLC, its affiliates and other
related parties against certain liabilities, including liabilities under the Securities Act, and to contribute to
payments that such persons may be required to make for these liabilities.

In February 2004, we issued and sold 400 shares of our Series A-1 preferred stock to JMP Group LLC, the
ultimate parent entity of JMP Securities LLC, for an aggregate purchase price of $2.5 million and, in connection
with such sale, we paid a $175,000 placement fee to JMP Securities LLC. In addition, we issued and sold 100
shares of our Series A-2 preferred stock to an entity related to Mr. Henriquez for an aggregate purchase price of
$125,000, and we issued and sold 100 shares of our Series A-2 preferred stock to Mr. Howard for an aggregate
purchase price of $125,000. Our Series A-1 preferred stock held a liquidation preference over our Series A-2
preferred stock and also carried separate, preferential voting rights. In June 2004, each share of Series A-1
preferred stock and Series A-2 preferred stock was exchanged for 208.3333 units with the same terms as the units
sold in our June 2004 private offering.

In connection with the issuance of our Series A-1 preferred stock and Series A-2 preferred stock, we entered

into a registration rights agreement with the holders of our Series A-1 preferred stock and Series A-2 preferred
stock. In June 2004, in connection with the conversion of the Series A preferred stock, the registration rights
agreement entered into in connection with the issuance of our preferred stock was terminated and the shares of
our common stock issued upon conversion were included in the registration rights agreement entered into in
connection with our June 2004 private offer. See “Description of Capital Stock—Registration Rights.”

We have entered into a letter agreement with Farallon Capital Management, L.L.C. that provides that until

such time as investment funds controlled by Farallon Capital Management, L.L.C. beneficially own less than
10% of our outstanding common stock, Farallon Capital Management, L.L.C. will have the right to recommend
one person to our nominating committee for consideration as a nominee to our Board of Directors, provided that
such person would not be considered an “interested person” of the Company under the 1940 Act. The letter
agreement also provides that if, after a shelf registration statement filed in accordance with the requirements of
the registration rights agreement entered into in connection with our June 2004 private offering is declared
effective, investment funds controlled by Farallon Capital Management, L.L.C. acquire registrable securities (or
warrants that are then eligible for registration under such shelf registration statement) with an aggregate market
value in excess of $1 million, then we will, subject to certain provisions of the registration rights agreement,
prepare and file a supplement or post-effective amendment to such shelf registration statement following receipt
of a written request therefor from Farallon Capital Management, L.L.C. Such right will terminate when those
registrable securities are eligible for resale by Farallon Capital Management, L.L.C. without volume limitation
under Rule 144(k) under the Securities Act. Under the terms of the letter agreement, we have also agreed that
prior to the date that is two years after certain investment funds controlled by Farallon Capital Management,
L.L.C. cease to own at least 10% of our outstanding common stock and without the written consent of Farallon
Capital Management, L.L.C., we will not (i) take any action to alter or repeal the resolution adopted by our board
exempting from the Business Combination Act any business combination between us and certain investment
funds managed by Farallon Capital Management, L.L.C. in a manner that would make the Business Combination
Act applicable to acquisitions of our stock by such investment funds or (ii) amend the applicable provision of our
bylaws in a manner that would make the Control Share Acquisition Act applicable to an acquisition of the
Company’s common stock by investment funds controlled by Farallon Capital Management, L.L.C.

101

We have also entered into a letter agreement with JMP Asset Management LLC that provides that until such

time as investment funds controlled by JMP Asset Management LLC beneficially own less than 10% of our
outstanding common stock, JMP Asset Management LLC will have the right to recommend two people to our
nominating committee for consideration as nominees to our Board of Directors, provided that such persons would
not be considered “interested persons” of the Company under the 1940 Act. The letter agreement also provides that
if, after a shelf registration statement filed in accordance with the requirements of the registration rights agreement
entered into in connection with our June 2004 private offering is declared effective, investment funds controlled by
JMP Asset Management LLC acquire registrable securities (or warrants that are then eligible for registration under
such shelf registration statement) with an aggregate market value in excess of $1 million, then we will, subject to
certain provisions of the registration rights agreement, prepare and file a supplement or post-effective amendment to
such shelf registration statement following receipt of a written request therefor from JMP Asset Management LLC.
Such right will terminate when those registrable securities are eligible for resale by JMP Asset Management LLC
without volume limitation under Rule 144(k) under the Securities Act. Under the terms of the letter agreement, we
have also agreed that prior to the date that is two years after certain investment funds controlled by JMP Asset
Management LLC cease to own at least 10% of our outstanding common stock and without the written consent of
JMP Asset Management LLC that we will not (i) take any action to alter or repeal the resolution adopted by our
board exempting from the Business Combination Act any business combination between us and certain investment
funds managed by JMP Asset Management LLC in a manner that would make the Business Combination Act
applicable to acquisitions of our stock by such investment funds or (ii) amend the applicable provision of our
bylaws in a manner that would make the Control Share Acquisition Act applicable to an acquisition of the
Company’s common stock by investment funds controlled by JMP Asset Management LLC.

In connection with our June 2004 private offering, we agreed to obtain the approval of each of JMP Asset

Management LLC and Farallon Capital Management, L.L.C. for each investment made by us. Though this
arrangement was terminated in connection with our election to be regulated as a business development company,
under the terms of the letter agreements described above, we have agreed to indemnify, to the maximum extent
permitted by Maryland law and the 1940 Act, representatives of JMP Asset Management LLC and Farallon
Capital Management, L.L.C. in connection with their activities in evaluating our investment opportunities prior
to our election to be regulated as a business development company on terms similar to those afforded to our
directors and officers under our charter and bylaws.

In accordance with a letter agreement dated June 22, 2004 between us and JMP Group LLC, in January
2005 we issued and sold 72,000 units to funds managed by JMP Asset Management LLC at a price equal to
$30.00 per unit, less a $2.10 initial purchaser’s discount per unit.

On April 12, 2005, we entered into our Bridge Loan Credit Facility with Alcmene Funding, LLC, a special

purpose entity affiliated with Farallon Capital Management, L.L.C., one of our significant stockholders. See
“Obligations and Indebtedness—Bridge Financing.” In connection with the closing of the Bridge Loan Credit
Facility, we paid a $500,000 upfront fee and will be obligated to pay additional fees under the terms of the
facility. On August 1, 2005, we amended our Bridge Loan Credit Facility. The amendment agreement extended
the term of the loan to April 12, 2006, eliminated the loan extension fee, revised the interest rate effective
August 1, 2005 to LIBOR plus 5.6% through December 31, 2005 and thereafter to 13.5% per annum, and
amended certain collateral rights and financial covenants. At September 30, 2005, the interest rate on the loan
was 9.76% per annum. The loan fees are being amortized over the remaining ten-month period.

On June 8, 2005, we entered into an Underwriting Agreement with JMP Securities LLC pursuant to which
JMP Securities LLC purchased 4,200,000 shares of our common stock and served as the lead underwriter in our
initial public offering.

In August 2000, Mr. Henriquez acquired an interest in JMP Group LLC, the ultimate parent entity of the
lead underwriter in our initial public offering. Mr. Henriquez’s interest represents approximately 0.1% of the
fully-diluted equity of JMP Group LLC.

102

Item 14. Principal Accountant Fees and Services

The information with respect to principal accountant fees and services is contained under the captions
“Audit Committee Report” and “Proposal II : Ratification of Selection of Independent Auditors” in our definitive
Proxy Statement for the 2006 Annual Meeting of Stockholders to be filed with the Securities and Exchange
Commission pursuant to Regulation 14A under the Securities Exchange Act of 1934 and is incorporated in this
Annual Report by reference to this item.

103

PART IV

Item 15. Exhibits and Financial Statements

1. Financial Statements

The following financial statements of Hercules Technology Growth Capital, Inc. (the “Company” or the

“Registrant”) are filed herewith:

AUDITED FINANCIAL STATEMENTS

Consolidated Statements of Assets and Liabilities as of December 31, 2005 and December 31, 2004 . . .
Consolidated Schedule of Investments as of December 31, 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Schedule of Investments as of December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Operations for the year ended December 31, 2005 and for the period from

63
64
68

February 2, 2004 (commencement of operations) to December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . .

69

Consolidated Statements of Changes in Net Assets for the year ended December 31, 2005 and for the

period from February 2, 2004 (commencement of operations) to December 31, 2004 . . . . . . . . . . . . .
Consolidated Statements of Cash Flows for the year ended December 31, 2005 and for the period from
February 2, 2004 (commencement of operations) to December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . .
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

70

71
72

2. Exhibits

Exhibit
Number

Description

3(a)*

3(b)*

4(a)*

4(b)*

4(c)**

4(d)*

5(a)*

5(b)*

10(a)*

10(b)*

10(c)**

10(d)**

10(e)**

Articles of Amendment and Restatement.

Amended and Restated Bylaws.

Specimen certificate of the Company’s common stock, par value $.001 per share.

Form of Dividend Reinvestment Plan.

Indenture between Hercules Funding Trust I and U.S. Bank National Association dated as of August
1, 2005.

Registration Rights Agreement dated June 22, 2004 between the Company and JMP Securities LLC.

Opinion of Venable LLP.

Consent of Venable LLP (included in Exhibit 1).

Credit Agreement dated as of April 12, 2005 between Hercules Technology Growth Capital, Inc.
and Alcmene Funding, L.L.C.

Pledge and Security Agreement dated as of April 12, 2005 between Hercules Technology Growth
Capital, Inc. and Alcmene Funding, L.L.C.

First Amendment to Credit and Pledge Security Agreement dated August 1, 2005 between Hercules
Technology Growth Capital, Inc. and Alcmene Funding L.L.C.

Loan Sale Agreement between Hercules Funding LLC and Hercules Technology Growth Capital,
Inc. dated as of August 1, 2005.

Sale and Servicing Agreement among Hercules Funding Trust I, Hercules Funding LLC, Hercules
Technology Growth Capital, Inc., U.S. Bank National Association and Lyon Financial Services, Inc.
dated as of August 1, 2005.

104

Exhibit
Number

10(f)**

Description

Note Purchase Agreement among Hercules Funding Trust I, Hercules Funding I LLC, Hercules
Technology Growth Capital, Inc. and Citigroup Global Markets Realty Corp. dated as of August 1,
2005.

10(g)*

Hercules Technology Growth Capital, Inc. 2004 Equity Incentive Plan (2005 Amendment and
Restatement).

10(h)*

Form of Incentive Stock Option Award under the 2004 Equity Incentive Plan.

10(i)*

10(j)*

10(k)*

10(l)*

Form of Nonstatutory Stock Option Award under the 2004 Equity Incentive Plan.

Form of Registrar Transfer Agency and Service Agreement between the Company and American
Stock Transfer & Trust Company.

Warrant Agreement dated June 22, 2004 between the Company and American Stock Transfer &
Trust Company, as warrant agent.

Side Letter dated February 2, 2004 between the Company and Jolson Merchant Partners Group LLC
(now known as JMP Group LLC).

10(m)*

Letter Agreement dated February 22, 2005 between the Company and JMP Asset Management LLC.

10(n)*

10(o)*

14*

21

23

31(a)

31(b)

32(a)

32(b)

99

*

Letter Agreement dated February 22, 2005 between the Company and Farallon Capital Management,
L.L.C.

Subscription Agreement dated February 2, 2004 between the Company and the subscribers named
therein

Code of Ethics.

List of Subsidiaries.

Consent of Ernst & Young LLP.

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of
1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Principal Financial and Accounting Officer Certification Pursuant to Rule 13a-14 of the Securities
Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States
Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Principal Financial and Accounting Officer Certification pursuant to Section 1350, Chapter 63 of
Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Consent of VentureOne.

Previously filed as part of a Registration Statement filed with the Commission on June 8, 2005 (Registration
No. 333-122950).

** Previously filed as part of a Form 8-K filed with the Commission on August 5, 2005.

105

SIGNATURES

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby

constitutes and appoints Manuel A. Henriquez, and David M. Lund, and each of them, as his true and lawful
attorneys-in-fact and agents, with power to act with or without the others and with full power of substitution and
resubstitution, to do any and all acts and things and to execute any and all instruments which said attorneys and
agents and each of them may deem necessary or desirable to enable the registrant to comply with the U.S.
Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the U.S. Securities
and Exchange Commission thereunder in connection with the registrant’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2005 (the “Annual Report”), including specifically, but without limiting the
generality of the foregoing, power and authority to sign the name of the registrant and the name of the
undersigned, individually and in his capacity as a director or officer of the registrant, to the Annual Report as
filed with the U.S. Securities and Exchange Commission, to any and all amendments thereto, and to any and all
instruments or documents filed as part thereof or in connection therewith; and each of the undersigned hereby
ratifies and confirms all that said attorneys and agents and each of them shall do or cause to be done by virtue
hereof.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant

has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 7, 2006

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

By

/s/ MANUEL A. HENRIQUEZ

Manuel A. Henriquez
Chief Executive Officer

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following

persons on behalf of the registrant and in the following capacities on March 7, 2006.

Signature

Title

Date

/s/ MANUEL A. HENRIQUEZ

Manuel A. Henriquez

Chairman of the Board, President and
Chief Executive Officer (principal
executive officer)

March 7, 2006

/s/ DAVID M. LUND

David M. Lund

Vice President of Finance (principal
financial and accounting officer)

March 7, 2006

/s/ ALLYN C. WOODWARD, JR.

Director

March 7, 2006

Allyn C. Woodward, Jr.

/s/

JOSEPH W. CHOW
Joseph W. Chow

Director

March 7, 2006

106

Exhibit
Number

Description

EXHIBIT INDEX

3(a)*

3(b)*

4(a)*

4(b)*

4(c)**

4(d)*

5(a)*

5(b)*

10(a)*

10(b)*

10(c)**

10(d)**

10(e)**

10(f)**

Articles of Amendment and Restatement.

Amended and Restated Bylaws.

Specimen certificate of the Company’s common stock, par value $.001 per share.

Form of Dividend Reinvestment Plan.

Indenture between Hercules Funding Trust I and U.S. Bank National Association dated as of August
1, 2005.

Registration Rights Agreement dated June 22, 2004 between the Company and JMP Securities LLC.

Opinion of Venable LLP.

Consent of Venable LLP (included in Exhibit 1).

Credit Agreement dated as of April 12, 2005 between Hercules Technology Growth Capital, Inc.
and Alcmene Funding, L.L.C.

Pledge and Security Agreement dated as of April 12, 2005 between Hercules Technology Growth
Capital, Inc. and Alcmene Funding, L.L.C.

First Amendment to Credit and Pledge Security Agreement dated August 1, 2005 between Hercules
Technology Growth Capital, Inc. and Alcmene Funding L.L.C.

Loan Sale Agreement between Hercules Funding LLC and Hercules Technology Growth Capital,
Inc. dated as of August 1, 2005.

Sale and Servicing Agreement among Hercules Funding Trust I, Hercules Funding LLC, Hercules
Technology Growth Capital, Inc., U.S. Bank National Association and Lyon Financial Services, Inc.
dated as of August 1, 2005.

Note Purchase Agreement among Hercules Funding Trust I, Hercules Funding I LLC, Hercules
Technology Growth Capital, Inc. and Citigroup Global Markets Realty Corp. dated as of August 1,
2005.

10(g)*

Hercules Technology Growth Capital, Inc. 2004 Equity Incentive Plan (2005 Amendment and
Restatement).

10(h)*

Form of Incentive Stock Option Award under the 2004 Equity Incentive Plan.

10(i)*

10(j)*

10(k)*

10(l)*

10(m)*

10(n)*

10(o)*

Form of Nonstatutory Stock Option Award under the 2004 Equity Incentive Plan.

Form of Registrar Transfer Agency and Service Agreement between the Company and American
Stock Transfer & Trust Company.

Warrant Agreement dated June 22, 2004 between the Company and American Stock Transfer &
Trust Company, as warrant agent.

Side Letter dated February 2, 2004 between the Company and Jolson Merchant Partners Group LLC
(now known as JMP Group LLC).

Letter Agreement dated February 22, 2005 between the Company and JMP Asset Management
LLC.

Letter Agreement dated February 22, 2005 between the Company and Farallon Capital
Management, L.L.C.

Subscription Agreement dated February 2, 2004 between the Company and the subscribers named
therein

Exhibit
Number

14*

21

23

31(a)

31(b)

32(a)

32(b)

99

*

Description

Code of Ethics.

List of Subsidiaries.

Consent of Ernst & Young LLP.

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of
1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Principal Financial and Accounting Officer Certification Pursuant to Rule 13a-14 of the Securities
Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States
Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Principal Financial and Accounting Officer Certification pursuant to Section 1350, Chapter 63 of
Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Consent of VentureOne.

Previously filed as part of a Registration Statement filed with the Commission on June 8, 2005 (Registration
No. 333-122950).

** Previously filed as part of a Form 8-K filed with the Commission on August 5, 2005.